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ABSTRACT 
Assessing the Photoprotective Effects of Fluorescent Sphingomyelin Against UVB Induced DNA 
Damage in Human Keratinocytes 
Rebecca Marie Kandell 
Non Melanoma Skin Cancer (NMSC) affects 3.3 million Americans each year and results 
from Ultra Violet Radiation (UVR) damage to DNA in the form of pyrimidine dimers and 
photoproducts [1]–[5]. Cells directly detect the damage and initiate apoptosis, cell cycle arrest, or 
DNA repair by modulating p53 and p21 levels [6]–[9]. Current methods of photoprotection 
include sunscreen, but controversy over safety of some active ingredients necessitates research 
into more natural alternatives [10]–[12]. In particular, 24 hour incubation with bovine milk 
sphingomyelin (BSM) has demonstrated photoprotective potential by reducing p21 and p53 levels 
in keratinocytes (KRTs) after UV radiation [13], [14]. This thesis aims to expand on past BSM 
research by exploring the mechanism for photoprotection. Normally, sphingomyelin (SM) is 
metabolically degraded to ceramide which then leads to cell apoptosis [6]. The goals of this thesis 
were to characterize a fluorescent SM (FSM) to assess changes in intracellular fluorescence 
distribution after various incubation and post-UV exposure times. FSM was deemed functionally 
equivalent to BSM by reducing levels of p21 after UV. Furthermore, quantification demonstrated 
that FSM trafficking and intracellular fluorescence were independent of continuous incubation 
time, warranting further investigation into shorter timepoints like 1 hour. Across several post-UV 
timepoints, the 1 hour incubation had a consistently higher average cytoplasmic mean gray value 
compared to 24 hour incubation. In addition, the no UV control was significantly lower compared 
to the 24 hour and 12 hour post-UV timepoints. No post-UV differences were observed for the 24 
hour incubation, suggesting future work is necessary for the 1 hour incubation, which potentially 
streamlines future experiments. Two immunofluorescence stains for endogenous SM (lysenin) 
and ceramide were also optimized for preliminary fluorescence distribution studies and 
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colocalization with FSM. Finally, a 3T3 fibroblast spheroid model was utilized as proof-of-
concept for future 3D KRT cultures and depth of dye penetration quantification methods. These 
findings suggest FSM is an appropriate model for BSM trafficking, a shorter FSM incubation 
time could potentially be adopted in future studies, dual immunofluorescence staining for SM and 
ceramide is viable, and spheroids provide a promising model for future 3D KRT studies. 
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1. INTRODUCTION 
 
The skin is one of the largest organs in the human body and provides a physical barrier 
while regulating temperature and water content, among many other crucial functions [15], [16]. 
Non-Melanoma Skin Cancer (NMSC) affects approximately 3.3 million Americans each year and 
is currently the most commonly diagnosed disease [1], [2], [5]. The common forms of NMSC are 
Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), with BCC representing 
about 80% of NMSCs [2], [17]  Given the prevalence of NMSC in the human population, 
understanding the cause and potential treatments is crucial.  
Ultra Violet Radiation (UVR) is mainly responsible for damage to skin and NMSC 
occurrence [4]. UVB light (280-320 nm) is the most damaging to skin and causes direct damage 
to Deoxyribonucleic Acid (DNA) in the form of cyclobutene pyrimidine dimers and (6-4) 
photoproducts which disturb the double helix structure [3], [4]. These two photoproduct lesions 
can lead to further DNA mutations like CC->TT base substitutions predominantly referenced as a 
‘UV signature mutation’ [18], [19]. Mutations in oncogenes like the p53 tumor suppressor gene 
increase the rate of developing cancer such as NMSC [18].  
Cells directly detect UV DNA damage with molecular sensors like Mre11, NBS1, and 
Rad 50 which initiate the DNA Damage Response (DDR), a group of signaling pathways which 
lead to either apoptosis, DNA repair, or cell cycle arrest in order to maintain genome integrity [6]. 
The tumor suppressor protein p53, also coined the ‘guardian of the genome’, serves as a 
transcription factor to regulate genes involved with cell cycle arrest and apoptosis [7], [8]. For 
example, p53 activates downstream p21 protein which is a cyclin-dependent kinase inhibitor that 
arrests DNA replication to allow time for DNA repair [9]. Skin carcinogenesis can develop when 
DNA mutations cause loss-of-function mutations in the p53 tumor suppressor gene leading to cell 
evasion of normal DNA repair and apoptosis processes [18], [20]. Repeated exposures to 
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environmental triggers (e.g. solar UVR) can cause a progression of NMSC cancer from pre-
malignant lesions to tumors and eventually metastatic lesions [20]. 
Current methods to avoid NMSC include protective actions like avoiding sun, wearing 
protective clothes, and regularly applying sunscreen [12], [17].  Sunscreen is an essential 
component of photoprotection, but according to a 2016 poll of US dermatologists, 99% believed 
their patients did not apply enough sunscreen or use it according to product guidelines [21]. 
Furthermore, some controversy exists around certain chemical active ingredients such as 
oxybenzone [10]–[12]. Not only has research demonstrated that oxybenzone pollutes the 
environment, a 2001 animal study demonstrated endocrine disruption [10], [12]. In addition, a 10-
year retrospective study of 24,000 patients asserted that 70.2% of patients confirmed positive for 
oxybenzone allergies when patch tested [12]. Given the prevalence of skin cancer and 
controversy over the systemic safety of oxybenzone, the need for safer, more natural alternatives 
is of scientific importance. 
Bovine milk sphingomyelin (BSM) has demonstrated photoprotective potential [13], 
[14], [22], [23]. Orally administered BSM in mice accumulated in the stratum corneum layer of 
the skin and reduced transepidermal water loss after UVB radiation [22], [23]. Furthermore, 
research by De Guzman and Campbell have demonstrated that BSM administration to a 
monolayer of keratinocyte (KRT) skin cells reduced p21 and p53 levels after UVB compared to 
the control [13], [14]. The decrease in both p21 and p53 DDR proteins was correlated with an 
increase in photoprotection offered by BSM to KRT cells. 
 The success of BSM treatment in UVB KRT models has prompted research into the 
reason for the observed photoprotection. Sphingomyelin (SM) is normally degraded to ceramide 
in the plasma membrane by SMase enzymes [6]. Furthermore, ceramide levels have been 
demonstrated to increase after UVB radiation in KRTs which offers photoprotection by 
increasing the apoptosis rates of potentially damaged cells [24]–[26]. A current hypothesis for 
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SM photoprotection is that exogenous addition to cells increases the amount of ceramide 
production through hydrolysis mechanisms and subsequently increases rates of apoptosis in UV 
exposed cells. However, the levels of intracellular SM after UVB irradiation in KRTs is less 
characterized, and no groups combine exogenous SM treatment with UVB to quantify changes in 
intracellular SM levels. Quantifying intracellular SM could answer questions about lipid 
homeostasis, trafficking, and mechanisms of photoprotection in a cell. Additionally, fluorescence 
imaging methodologies to quantify cellular localization were not employed in past BSM research 
[13], [14]. Therefore, the goals of this thesis were to characterize Fluorescent SM (FSM) as an 
analogue to BSM and assess the changes in intracellular FSM distribution after different 
incubation times and after UV. Different metabolic processes occur in different locations in a cell 
(plasma membrane, golgi, endoplasmic reticulum) and trafficking fluorescence location 
elucidates mechanisms of metabolism and degradation in a cell [27]. Two immunofluorescence 
stains for endogenous SM (lysenin) and ceramide were also optimized and used for a preliminary 
fluorescence distribution studies to characterize FSM with colocalization in the future. Finally, 
the use of spheroids as a more relevant 3D model was assessed by characterizing NIH 3T3 mouse 
fibroblasts as proof-of-concept. 
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2. BACKGROUND 
 
2.1 Integumentary System 
 
The skin is an organ member of the Integumentary System and primarily forms a barrier to 
protect the body from damage and disease [15]. In adult humans, skin and accessory organs 
comprise approximately 16 percent of body weight and cover about 2.0 m2 (22 ft2)  of surface 
area, making the Integumentary System the largest organ system in humans [15], [28]. Exhibiting 
a multilayered and complicated structure, the Integumentary System performs numerous 
functions crucial for overall health.  
The skin consists of two main layers, an epidermis and an underlying dermis (Figure 1). 
Directly beneath the dermis is the hypodermis, also called the subcutaneous, subcutis, or 
superficial fascia [15], [28].  
 
Figure 1: The Three Layers of the Skin and Associated Accessory Organs [15]. 
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Skin thickness varies from 0.5mm lining the eyelids to 4.0mm surrounding the heel of the 
feet [28]. Although its main function is protection from Ultra Violet (UV) radiation, injury, 
infection, and external stresses, skin also provides thermoregulation, absorption/secretion of 
water and metabolites, production of vitamin D, and sensation touch and pain [15]. The epidermis 
also dictates cutaneous movement of water and electrolytes because of its high lipid content and 
hydrophobic nature [29]. The malfunction of skin in diseases and disorders like cancer 
demonstrate the essential function of the Integumentary System and the need to cherish it. 
Although the focus of this section is the structure and function of the epidermis, the 
dermis and hypodermis play an integral role in skin health. The dermis is a vascularized and 
innervated connective tissue layer comprised of connective tissue (collagen and elastin), 
fibroblasts, sweat glands, and hair [28]. The dermal papillae form the superficial layer and serve 
as an adhesion site and partition between the epidermis and dermis [28]. Dermal papillae also 
shunt nutrients from the vasculature to the epidermis which lacks a clear blood supply [28]. The 
dermis is divided into the superficial region, which contains the dermal papillae and deeper 
region of collagen and fibroblasts [15], [28]. Beneath the dermis lies the hypodermis, a layer 
mainly made of adipose tissue and sweat glands [15], [28]. Taken together, the epidermis, dermis, 
and hypodermis protect the body from external insults, enable sensory function, perform 
thermoregulation, and synthesize Vitamin D and other essential nutrients [15]. The subsequent 
sections will focus on the different layers of the epidermis, with an emphasis on the resident 
keratinocyte cells and lipid metabolism. 
2.1.1 Epidermis 
 
The epidermis is the most superficial layer of skin and first line of defense between the 
body and the external environment [15], [28], [30]. About 100 microns thick, this layer is an 
avascular and self-renewing stratified squamous epithelial cell structure composed of four layers 
(listed from most superficial to deep): stratum corneum, stratum granulosum, stratum spinosum, 
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and stratum basale [15], [28], [30]. In thick callous skin (i.e. lining soles of feet, fingertips or 
palms of hands), the epidermis has a fifth layer of translucent cells between the stratum corneum 
and stratum granulosum called the stratum lucidum (Figure 2) [15], [28]. 
The skin is comprised of three main cell types: keratinocytes (KRTs), melanocytes, and 
fibroblasts [31].  KRTs are the predominant epidermal cell type comprising 95% of total cells 
[30]. KRTs exhibit a differential phenotype depending on the layer [30], [31]. They start off as 
viable, nucleated, and cobblestone-shaped cells in the stratum basale then undergo remarkable 
changes leading to the conventional “flaky” stratified cell phenotype in the stratum corneum [30], 
[31].  KRTs also produce keratin, an intracellular fibrous protein and structural component 
responsible for the hardness and water-resistance of hair, nails, and skin [32]. The type of keratin 
produced depends on the layer and KRT differentiation stage [32]. 
 
Figure 2: Layers of the Skin Epidermis [15]. The layers of the skin from most superficial to 
deep are Stratum corneum, Stratum lucidum (absent in thin skin), Stratum granulosum, Stratum 
spinosum, and Stratum basale. 
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KRTs are produced in the basal layer, then undergo keratinization (cornification) as they 
push up through the layers of skin and ultimately shed as dead skin flakes from the stratum 
corneum [30]. The process of KRT differentiation in the basal layer and shedding at the corneum 
is a cyclic process that replaces the epidermis every four weeks [15]. Melanocytes (1-2% of 
epidermis cells) and fibroblasts (dermal layer), are also crucial for skin health and cell phenotype 
[30]. 
2.1.1.1 Stratum Corneum 
 
The stratum corneum is the most superficial layer of the dermis made up of 15-30 layers 
of flattened, dead, and densely-packed cornified KRTs [15], [28]. These terminally differentiated 
KRTs are known as corneocytes because they are flattened and anucleate [15], [16], [28], [30]. 
Corneocytes, building blocks of the stratum corneum, originate from stratum granulosum KRTs 
that rise to the surface before undergoing apoptosis in the corneum [16], [30]. Directly 
surrounding the corneocytes is a hydrophobic extracellular matrix (ECM) made of mostly 
ceramide, cholesterol, fatty acids, and proteins including filaggrin and keratin [29]. On average, 
each KRT cell takes two weeks to rise from the basale to corneum, then another two weeks to 
cornify before flaking off in a process called desquamation [30].  
Lipids originate from lamellar body secretions by cells in the stratum granulosum [16], 
[29]. In a normal keratinocyte, lipids are synthesized during cell differentiation in the granulosum 
and packaged into lamellar bodies, small bilayer and circular organelles [29]. In the granulosum, 
the concentration of calcium peaks and drops rapidly in the corneum, triggering the exocytosis of 
lipid-filled lamellar bodies into the extracellular space of the stratum corneum [16]. The released 
lipids are subsequently processed and rearranged parallel to the corneocyte membrane to form a 
cornified envelope [33]. The lipids are further metabolized into ceramide which accounts for over 
30-40% of lipid weight in the corneum [16]. Cholesterol and sphingomyelin are also present in 
8 
 
the corneum interstitial space [29]. In total, the high lipid content maintains fluid balance by 
preventing water loss [33]. When the skin barrier is disrupted, lamellar body secretion and 
sphingolipid metabolism increase to reestablish the hydrophobic barrier [29], [33].    
Filaggrin and keratin together compose 80-90% of protein mass in the epidermis [16]. 
Filaggrin ensures corneum water retention while maintaining barrier function [34]. Filaggrin also 
interacts with keratin to form tight bundles and promote cornification [34]. Loss of filaggrin 
function can lead to skin conditions like dermatitis, and increases UV sensitivity as demonstrated 
by an in vitro skin model [34]. 
2.1.1.2 Stratum Granulosum and Lucidum 
 
The stratum granulosum, 3-5 layers superficial to the stratum spinosum, is named 
because of the grainy appearance of the KRTs [15], [28]. The granular nature is due to 
accumulation of keratin and keratohyalin which are bundles of profilaggrin [35]. Lamellar bodies 
also accumulate in this layer before cells release the lipid into the stratum corneum [35]. The cells 
in the granulosum eventually flatten, lose their nucleus, and differentially terminate before 
reaching the stratum corneum [15], [28]. 
The stratum lucidum is another layer directly above the granulosum, and only present in 
thicker skin [15], [28]. The extracellular matrix is filled with a clear protein called eleidin, 
derived from keratohyalin [16].  
2.1.1.3 Stratum Spinosum 
 
Directly above the stratum basale is the stratum spinosum, a region of 8-10 layers of 
KRTs [28]. Cells are anchored by desmosome proteins and keratin [16]. The name of the layer 
comes from the desmosome ‘spiny’ appearance after histology staining [15], [28]. Spinosum 
KRTs also begin synthesis of keratin protein and lamellar bodies which are secretary lipid 
vesicles instrumental in maintaining the hydrophobicity of the skin [15], [33]. Interspersed within 
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the KRTs are Langerhans cells, dendric antigen presenting cells that play an integral part in the 
epidermal immune response [36]. 
2.1.1.4 Stratum Basale 
 
The stratum basale, also described as the stratum germinativum, is the deepest layer of 
the epidermis [15], [28]. It is a single layer of basal cells, cuboidal-shaped stem cells and 
precursors of the epidermal KRT cell lineage [15], [28]. Only 15% of basal cells constantly 
undergo mitosis to rapidly produce KRTs that are eventually pushed upward to replace the 
previous superficial layer [15], [16]. The remaining basal cells are activated to undergo 
differentiation during wound healing [15], [16].  
Merkel and melanocytes are non-keratinizing cells scattered among the basal cell layer 
[31]. Merkel cells receive and transmit touch sensations to the brain while melanocytes produce 
melanosomes and melanin pigment that protect cells from UV radiation [15], [16]. Melanin is up-
regulated after UV exposure and aids in photoprotection [30]. KRTs and melanocytes have a 
collaborative relationship; KRT paracrine factors regulate melanocyte function [31]. 
2.1.2 Functions of the Epidermis 
 
The epidermis provides innate immunity with a physical barrier and antimicrobial 
secretion [15], [28]. From a lipid standpoint, the stratum corneum also maintains water secretion 
and prevents water loss from the body due to its high lipid content [16]. The transfer of water 
from the stratum corneum is measured by the Transepidermal Water Loss (TEWL) [16]. The high 
lipid content in the stratum corneum reduces TEWL, and perturbations of lipid content 
demonstrate how TEWL is affected. For example, mouse skin damaged by UV light showed an 
increase in TEWL [37]. In addition, severely burned skin leads to massive dehydration because of 
increased TEWL [15]. Furthermore, Gaucher and Neimann Pick disease are two disorders of 
sphingolipid enzymes that result in dysregulated skin permeation [29].  
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2.2 Non-Melanoma Skin Cancer 
 
     Cancer is described as the uncontrollable growth of abnormal cells [38]. Genetically 
mutated cells proliferate and form tumors with genomic and chromosomal instability which can 
lead to a metastatic cancer [38]. One cause of genetic mutations is UV radiation which enables 
mutated cells to ignore normal signaling processes that regulate proliferation and cell death [5]. 
Skin cancer manifests into two main types: Non-Melanoma and Melanoma.  
     Non-Melanoma Skin Cancer, abbreviated NMSC, is the most commonly diagnosed 
disease and is a significant health concern in terms of incidence rate and economic health care 
costs [1], [2]. According to the American Cancer Society, approximately 3.3 million Americans 
are diagnosed with NMSC each year [5]. NMSC prevalence has increased by 300% since 1994 
and generates over $650 million in US healthcare costs [2], [39]. 
     NMSC takes two main forms – Basal Cell Carcinoma (BCC) and Squamous Cell 
Carcinoma (SCC). BCC occurs most frequently in the human population, representing 
approximately 80% of all NMSCs [2], [5]. BCC and SCC originate in the basal and squamous 
cell layers respectively. In general, BCC rarely yields malignant tumors, while SCCs are more 
likely to invade and metastasize [5]. 
2.2.1 Basal and Squamous Cell Carcinoma 
 
BCC, the most common skin cancer subtype, develops when mutated cells in the basal 
layer, the lowest region of the epidermis, become mutated and proliferate uncontrollably [5]. 
Over 3 million Americans are diagnosed with BCC each year [5]. Although rarely metastatic and 
easily treatable in early stages, surgical removal of BCC can leave scars, and identifying cancer 
phenotypes is crucial before a large lesion develops [5]. According to the Skin Cancer 
Foundation, BCC manifests into five common sore variants (Figure 3): open sore, red irritated 
skin, shiny (pearly) nodule, pink growth with elevated border, and wavy scar-like patch [5].    
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Figure 3: Types of BCC Tumor Skin Growths [5]. (A) Open Sore. (B) Red Patch of Irritated 
Skin. (C) Shiny Bump or Nodule. (D) Pink Growth. (E) Scar-Like Area.            
           SCC is the second prevalent NMSC subtype and involves cancerous proliferation of the 
squamous cells of the epidermis [5].  Over 1 million cases of SCC are diagnosed in the United 
States each year, and approximately 8,800 Americans die from the disease [5]. Furthermore, the 
incidence of SCC has risen 200 percent in America over the past 30 years. [5].  
A small proportion of SCC can metastasize deeper into the dermis, or even spread to 
other organs, yielding significant surgical removal and a life-threatening prognosis [5]. SCC 
“precancers” like actinic keratoses, actinic chelitis, leukoplakia, and Bowen’s Disease, are often 
benign and early stages of SCC [5]. The warning signs of SCC (Figure 4) include a crusty scaly 
patch, a bleeding growth, persistent bleeding open sore, and wart-like growth [5]. Early 
identification of precancers and abnormal lesions is essential for diagnosing and treating early 
stage cancer. 
    
Figure 4: Types of SCC Tumor Skin Growths [5]. (A) Scaly red patch. (B) Elevated growth. 
(C) Persistent open sore that bleeds. (D) Wart-like growth. 
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          The main cause of skin cancer is prolonged exposure to sun and most cancers occur in skin 
areas exposed to sun such as the face, back, neck, shoulders, and ears [5]. However, skin cancer 
can develop from artificial sources of light like tanning beds. Certain subpopulations such as the 
elderly, fair-skinned, and the immunocompromised are at increased risk of developing BCC [5]. 
          The treatments for BCC and SCC are commonly an outpatient procedure like Mohs 
Micrograph surgery, excisional surgery, cryosurgery, photodynamic therapy, and topic 
medication [5]. Often a biopsy is needed to make an accurate diagnosis [5]. 
2.2.2 Melanoma and Merkel Cell Carcinoma 
 
Although less common in the American population, Melanoma and Merkel Cell 
Carcinoma (MCC) are invasive, aggressive, and metastatic forms of cancer [5]. Melanoma 
involves mutations in the melanocytes of the basal layer, while MCC begins in the Merkel cells 
connected to the nerves responsible for the touch sensation [5]. MCC is 40 times rarer than 
melanoma, and three times as deadly, killing one in three patients diagnosed with the disease [5]. 
Although Melanoma and Merkel Cell Carcinomas are more fatal than NMSC, this thesis focuses 
on NMSC because it is more prevalent in the human population. 
2.3 UV Light 
 
Ultra Violet Radiation (UVR) is a detrimental exogenous agent responsible for genome 
damage in all species [4]. In general, UV light is composed of three separate types differentiated 
by their respective wavelengths: UVA (320-400 nm), UVB (280-320 nm), and UVC (200-280 
nm) [2]. UVA lies closest to the visible light spectrum (700-400nm) on a scale of increasing 
wavelength (Figure 5). Differing wavelengths yield differential penetration depths, with UVA 
penetrating deeper into the subcutaneous tissue while UVB only reaching the superficial 
epidermis/dermis layers [40].  
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Figure 5: Differing UV Wavelengths (UVA, UVB, UVC) and Skin Penetration Depths [40]. 
UVA and UVB are wavelengths of primary concern for skin cancer. UVA radiation penetrates 
deeper into tissue while UVB is absorbed by the epidermis. UVB is responsible for DNA 
damage. 
UVB radiation is the primary concern for skin damage. Comparatively, UVB, although 
only comprising 1% of the sun’s total energy, is the most damaging of the three because UVA 
does not efficiently generate DNA damage and the ozone in the atmosphere effectively filters out 
UVC [3]. Thus, UVB is most relevant to skin cancer and most damaging. Most of the deleterious, 
cancer-inducing effects of UVB are caused by direct damage to DNA as described in the 
subsequent section [40]. Furthermore, UVR-genome damage incidence is increasing in the world 
because of ozone depletion [4]. Assessing the mechanism of damage and potential 
photoprotective agents is crucial to prevent the persistence of NMSC and other skin cancers. 
2.4 UV-Induced DNA Damage 
 
     Deoxyribonucleic Acid (DNA) is the genetic instruction manual for a cell [15]. DNA is a 
molecule comprised of two interwoven complementary strands twisted into a ladder shape [15]. 
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The backbone is made of alternating sugar and phosphate groups joined by four nitrogenous 
bases: Adenine (A), Thymine (T), Cytosine (C), and Guanine (G) [15]. Adenine and cytosine 
selectively hydrogen bonds with thymine and guanine respectively to form AT and CG base pairs 
[41]. Structurally, A, T, C, and G are heterocyclic aromatic compounds, meaning they are organic 
compounds with one or two carbon atoms replaced with a different atom (e.g. nitrogen) [41]. C 
and T are classified as pyrimidines (one ring nitrogen-carbon compound) and A and G are purines 
(two ring structures with pyrimidine fused to imidazole) [15], [41]. Together, the nitrogenous 
base and sugar backbone form a nucleotide, the building block of DNA [15]. The order of bases 
along the sugar-phosphate backbone determines the genetic code by affecting transcription and 
translation [15]. During normal DNA replication, DNA polymerase “proofreads” for errors in 
nucleotide insertion along the DNA molecule and mismatch repair enzymes further correct for 
deformities in DNA structure [41]. However, if an error in DNA nucleotides is not corrected, the 
mutations become permanent [41]. The cell no longer recognizes the DNA as mutated and uses 
the incorrect strand as a template for subsequent replication processes [41]. Eventually, the cell 
propagates the mutation which can yield a disease phenotype like cancer [41]. Error can occur 
either spontaneously or as a result of the environment (i.e. UV radiation). 
     UV-B radiation leads to the formation of lesions in DNA that alter the structure and form 
mutations [3], [4]. The main types of lesions include cyclobutene pyrimidine dimers (CPDs) and 
pyrimidine(6-4) pyrimidone photoproducts, also referenced as (6-4) photoproducts [3], [4].  
2.4.1 DNA Mutations 
 
When a skin cell is subjected to UV light, the DNA strands absorb a photon of high 
energy light which is then used to form extra covalent bonds between bases, forming a dimer or 
lesion [4], [18]. The two common mutations caused by UV are CPDs and (6-4) photoproducts; 
both involve adjacent pyrimidines (C or T) in the DNA molecule [4], [18]. Adjacent pyrimidines 
are weak spots for DNA mutation and are the likely site for UV damage [18]. CPDs form at a T-T 
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site; the double bond between the C-4 and C-5 carbons breaks into a single bond and the energy is 
transferred to a bond between the C-4 carbons of the adjacent thymine [4], [18]. A ring structure 
connecting the two bases and mutating the DNA structure is ultimately formed [18]. On the other 
hand, (6-4) photoproducts occur between T-C adjacent bases and results when the C-6 carbon of 
the 5’side of the first base covalently binds to the C-4 carbon of the 3’ adjacent pyrimidine 
(Figure 6) [4], [18].   
 
Figure 6: DNA Mutations because of UV [18]. (A) T-T adjacent bases. (B) T-C adjacent bases. 
(C) After UV, a cyclobutene pyrimidine dimers (CPD) forms. (D) After UV, a (6-4) photoproduct 
forms. 
 
Both CPDs and (6-4) photoproducts greatly disturb and distort the DNA double helix, 
albeit (6-4) photoproducts to a greater degree [18]. Although CPDs are three times as likely to 
occur than (6-4) photoproducts and are more difficult to detect, the order of nucleotides, 
B 
C D 
A 
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wavelength of light, and location of DNA can all affect the prevalence and nature of the DNA 
damage [18].  
These mutations can lead to C->T or CC-> TT nucleotide substitutions where a cytosine 
is replaced by a thymine during DNA replication, leading to incorrect incorporation of bases into 
the genetic code [18]. The CC->TT substitution is so common in cancer cells that it is termed a 
‘UV signature mutation’ [18], [19]. When this mutation occurs in oncogenes like the p53 tumor 
suppressor gene, the risk of developing skin cancer later increases [18]. 
UV radiation can also cause several other mutations like purine photoproducts, single-
strand breaks, and double-strand breaks [4], [18]. UVA is also known to create intracellular 
damage by the formation of Reactive Oxygen Species (ROS) like singlet oxygen and hydrogen 
peroxide [18]. Intracellular proteins and lipids can also absorb UV and generate damaging ROS 
[18].  
Studies have also demonstrated that UVR can lead to local immunosuppression by the 
release of the cytokines TNF-alpha and IL-10, recruitment of macrophages, and decrease in 
Langerhans cells [19]. A reduced immune system increases the likelihood that a tumor cell will 
not be detected [19].  
2.5 DNA Damage Response Cascade 
 
     More specifically, how does a cell detect DNA damage and initiate repair before a 
mutation is propagated? The answer lies in the DNA Damage Response (DDR), a host of cell 
pathways initiated by a damaging agent like UV radiation, ionization, or chemotherapy [6]. Of 
particular interest for this thesis is the effects of UVB radiation on DDR initiation and signaling 
(Figure 7).  
     The most important role of the DDR is to maintain the cell’s DNA or genome [6]. When 
the DNA is damaged, molecular sensors on DNA like Mre11, NBS1, and Rad 50 detect the 
damage and signal to downstream proteins in the DDR cascade, ATM (Ataxia-Telangiectasia 
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Mutated Protein) and ATR (ATM and RAD3-related) [6]. ATM and ATR are protein kinases that 
phosphorylate downstream protein targets in response to DNA strand breaks or lesions [6]. These 
protein targets include p53, CHK1/2, and p21 [6]. 
 
Figure 7: UV-Induced DNA Damage Response and Cell Pathways [6]. The goal is to maintain 
genomic DNA identity. DNA damage initiates ATM/ATR proteins which signal to p53 and 
CHK1/2 to either induce apoptosis, DNA repair, or cell cycle arrest. 
 
In the DDR cascade, ATM/ATR eventually activates p53 and/or Checkpoint Kinase 1 
and 2 (CHK1 and CHK2). The DDR ultimately results in three cell actions – apoptosis, DNA 
repair, and cell cycle arrest [6]. Apoptosis, DNA repair, and cell cycle arrest are all essential in 
maintaining genomic stability. All three will be explored in the following sections, with a 
particular emphasis on proteins p21 and p53 in apoptosis and cell cycle arrest signal cascades. 
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2.5.1 Apoptosis and p53 Tumor Suppressor Gene 
 
The tumor-suppressor protein p53 is an important component of the DDR apoptosis 
pathway [6]–[8]. Apoptosis, or programmed cell death, is a p53-dependent pathway and cancer 
defense mechanism for damaged cells [6]. Following ATM/ATR activation by DNA damage 
molecular sensors, p53 initiates BAX-mediated caspase-3 activation [6]. Caspase-3 cleaves PARP 
(poly-ADP ribose polymerase) which is a marker for cell apoptosis [6]. Thus, p53 protein plays 
an integral role in apoptosis. 
Coined the “guardian of the genome”, p53 functions as a transcription factor that turns 
genes on/off to induce cell cycle arrest and apoptosis [8]. The p53 protein is a tumor suppressor 
demonstrated to influence up to 50% of all cancers [7]. In physiologically normal cells, p53 is 
required for apoptosis of mutated cells before cell division. However, when p53 experiences a 
loss-of-function mutation, the protein loses its ability to effectively halt DNA replication of 
mutated cells [7]. Since the p53 protein is crucial in preventing tumorigenesis, a mutation in the 
gene codon can be deleterious. Signature mutation hot spots commonly occur at 5’-CCG and 5’-
TCG sequences in codons 196, 213, 245, 248, and 282 of the p53 gene in human keratinocytes 
[18].  
The p53 protein is encoded by a gene located on chromosome 17 of humans [42]. 
However, the p53 protein needs to be activated and stabilized before it can directly activate or 
repress effector genes [8]. P53 can also indirectly regulate gene transcription by binding to 
transcriptional activators, repressors, and co-repressors [18]. Activation involves phosphorylation 
of the p53 protein at the amino terminus by ATM, ATR, CHK1, or CHK2 in response to DNA 
damage [8]. Phosphorylation prevents p53 binding with the MDM2 E3 ubiquitin-protein ligase 
which normally inactivates p53 when bound (Figure 8) [8]. As demonstrated in Figure 8, the 
tumor suppressor p14ARF is also responsible for activation of p53 by degrading p53-MDM2 
binding [43]. 
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Figure 8: p53 Regulation Leading to Apoptosis and Cellular Senescence [43]. P53 increases 
WAF1 and BAX leading to either apoptosis or cellular senescence.  
 
Once activated, p53 influences gene expression by binding to specific effector genes [6], 
[8], [43]. Via different pathways, p53 activation leads to both cell cycle arrest and apoptosis [6]. 
In terms of apoptosis, p53 functions both in the nucleus and cytoplasm via transcription-
dependent and independent methods respectively [8]. The main effector gene is PUMA, p53-up-
regulated modulator of apoptosis [8]. In the nucleus, p53 protein also activates BAX, which is a 
member of the Bcl-2 genes that regulate apoptosis [8]. P53 additionally moves out of the nucleus 
to the mitochondria, where it causes mitochondrial outer membrane permeabilization (MOMP); 
the mitochondria then releases pro-apoptotic cytokines [8] 
From a cell cycle arrest standpoint, p53 activates p21 (Waf1 or Cip1) which is a cyclin-
dependent kinase inhibitor that arrests DNA replication in the G1/S checkpoint [9]. P53 can also 
induce irreversible cell cycle arrest or senescence through a variety of different proteins [9]. P21 
is described further in the following section. It is also important to note that p53 function is a 
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highly context dependent and complicated pathway that varies based on the cell type, genome, 
microenvironment, and type of cellular stress [8]. 
2.5.2 DNA Repair 
 
DNA repair, in contrast to apoptosis, is a p53-independent pathway [6]. Independent of 
p53, Checkpoint Kinases (CHK1/CHK2) activate BRCA2 which initiates internal cellular repair 
mechanisms [6]. For humans (and other eukaryotes), the process to resolve bulky mutations like 
CPDs and (6-4) photoproducts in DNA is predominantly via Nucleotide Excision Repair (NER) 
[18]. NER occurs in several steps [18]. In general, the damage is recognized by DNA polymerase 
and binding proteins [18]. A transcription complex of proteins binds to the damaged DNA lesion 
and unwinds the strand with helicase [18]. The DNA single-strand is then removed by 
endonucleases [18]. Finally, the gap is ligated and polymerized [18].  
2.5.2.1 Cell Cycle Arrest and P21 Cyclin-CDK Inhibitor 
 
Lastly, cell cycle arrest is both p53-independent and p53-dependent (Figure 7), but the 
p53 dependent pathway is of interest to this thesis [6]. ATM/ATR can activate p53 which leads to 
activation of p21, a cyclin-CDK inhibitor [6]. P21, also designated WAF1 or Cip1, is a protein 
that induces cell cycle arrest in a p53-dependent manner [9]. Before delving into p21’s regulation 
of cell cycle arrest, it is important to detail the role of the cell cycle in a physiologically normal 
cell.  
The purpose of the cell cycle is to duplicate the genome of a cell into identical daughter 
cells during mitosis [44]. The cell cycle consists of S phase, M phase, and various gap phases 
(Figure 9) [44]. During the S or synthesis phase, cells duplicate their entire genome, which 
usually takes 10-12 hours on average [44]. In M phase, or mitosis, cells undergo division into two 
identical daughter cells [44]. During mitosis, the replicated sister chromatids align along the 
metaphase plate, separate to opposite poles of the cell, then pinch off during cytokinesis [44].  
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Figure 9: Normal Cell Cycle [44]. The cell cycle consists of G1, S, G2, and Mitosis with various 
checkpoints. 
Separating synthesis and mitosis are G1 and G2 gap phases, which delay replication and 
division to allow for cell growth [44]. During G1 and G2, cells also monitor their environment and 
assess whether conditions are suitable for division [44]. The cues of intracellular proteins like p21 
dictate whether the cell undergoes cell cycle arrest [44]. Within each phase is a series of 
checkpoints which allow the cell to stop, check for problems in the DNA, and halt the process for 
repair [44]. Cyclin-dependent Kinases (CDKs) regulate checkpoints by the binding of cyclins to 
the CDK to form a functional cyclin-CDK complex [38]. CDK2, CDK4, and CDK6 are important 
in interphase, while CDK1 is essential for mitosis [38].  
The p21 protein plays a critical role in CDKs and cell cycle arrest. P21 is a small 165 
amino acid protein that binds to CDK1 and CDK2 via a Cy1 motif in the N-terminal and Cy2 in 
the C-terminal of the protein [9]. Binding disrupts the interaction between CDK and its cyclin 
substrates, therefore halting the cell cycle [9]. Recent studies demonstrate that a higher expression 
of p21 is associated with inactivation of genes necessary for cell cycle progression [9]. 
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2.6 Carcinogenesis 
 
     Skin carcinogenesis initiates when a CPD or (6-4) photoproduct lesion evades the DNA 
repair process [18], [19]. The mutation is replicated, leading to a UV ‘signature mutation’ in a 
gene [18], [19]. When the mutation occurs in an oncogene or tumor suppressor gene, a tumor is 
likely to develop [18], [19]. 
     Oncogene and tumor suppressor gene mutations are deleterious because they control 
normal cell division, apoptosis, cell cycle repair, and DNA repair [18]–[20]. Oncogenes are 
generated when normal proto-oncogenes are mutated; since proto-oncogenes regulate cell 
proliferation, a mutated oncogene yields uncontrolled cell growth [18], [20]. Tumor suppressor 
genes, on the other hand, slow cell division and encourage apoptosis. When a tumor suppressor 
gene experiences a loss-of-function mutation, the cell evades DNA repair, slowed proliferation, 
and apoptosis. The proliferation and migration of mutated cells from a pre-malignant lesion to a 
primary tumor is often stepwise (Figure 10).  
 
Figure 10: Etiology and Progression of Cancer [20]. Cancer results from repeated genetic 
alterations. 
     Normal tissue is exposed to an environmental factor like UVB radiation and some cells 
mutate. However, in order to progress from a pre-malignant lesion to tumor and metastasis, 
repeated instances of genetic alterations need to occur [20]. NMSC often develops after a lifetime 
of skin exposure and repeated sunburns. 
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2.7 Current Prevention of UVR induced DDR 
 
     The main methods to circumvent UV damage in keratinocytes is prevention, 
predominantly by protective actions [5], [12]. These protective actions include avoiding sun 
during peak hours of the day, donning protective clothes like a hat and sunglasses, and applying a 
broad spectrum and high Sun Protection Factor (SPF) sunscreen [12]. Sunscreen is a crucial 
aspect of the photoprotection regime [5], [12]. In a 2016 poll of US dermatologists, 97% believed 
that the use of sunscreen lowers the risk of skin cancer, but 99% asserted that patients generally 
do not apply enough sunscreen during outdoor activities [21]. According to the Skin Cancer 
Foundation, any person over the age of 6 months should apply sunscreen daily, even if indoors or 
the day is cloudy [5].  
     Sunscreens are characterized by their Sun Protection Factor (SPF) and spectrum [5]. SPF 
is a quantitative gauge for the UVB protective ability. SPF 15, 30, and 50 filter 93%, 97%, and 
98% of UVB rays respectively [5].  A broad-spectrum sunscreen contains chemical and physical 
filters to protect skin from both UVA and UVB radiation. The Skin Cancer Foundation 
recommends applying about 1 oz (a full shot glass) of sunscreen to receive the advertised SPF 
and spectrum benefits; however, most users only apply half the recommended dose to their skin 
[5]. Furthermore, sunscreen should be applied 30 minutes before sun exposure, and reapplied 
every 2 hours and following water contact or sweating because they lose efficacy over time [5]. 
Most Americans do not use sunscreen as recommended. 
2.7.1 Sunscreen Active Ingredients and Limitations 
 
Sunscreen protects skin via chemical and physical means which decrease UVA and UVB 
penetration into the epidermis and dermis [5]. Chemical ingredients (e.g. oxybenzone, 
avobenzone, octisalate, octocrylene) absorb UV radiation, while physical ingredients (e.g. zinc 
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oxide, titanium dioxide) deflect UV rays [5]. A conventional sunscreen combines both chemical 
and physical filters. 
Although the Food and Drug Administration (FDA) has currently approved over 15 
sunscreen ingredients, some chemicals have received conflicting reports as to their safety and 
efficacy [10]–[12]. One such ingredient is the organic chemical filter oxybenzone 
(benzophenone-3). Oxybenzone provides broad spectrum protection by absorbing and quickly 
dissipating the UV energy by breaking chemical bonds [45]. 
Studies have demonstrated that oxybenzone causes allergic skin reactions, disrupts 
endocrine function, and pollutes the environment [10], [12]. In a 10-year study between 2001 and 
2010, 70.2% of approximately 24,000 patients exhibited dermatologic allergies to oxybenzone 
when patch tested [12]. In addition, a 2001 study conducted by Schlumpf et al. asserted that 21-
day-old rats fed doses of oxybenzone in their feed experienced hormone disruption [10], [12]. 
However, the dosage fed to the animal subjects were not physiologically relevant to the human. 
For example, it would take 277 years to reach the systemic concentration of oxybenzone in the rat 
study for a human applying a 6% oxybenzone FDA approved sunscreen at 2 mg/cm2 
concentration [11]. Although different studies dispute the degree to which oxybenzone is 
cytotoxic in humans, given the prevalence of skin cancer, the need for more natural alternatives is 
important. 
2.8 Sphingomyelin as a Natural Alternative to Sunscreen 
 
     Sphingomyelin (SM), a natural phospholipid, has demonstrated potential as a 
chemoprotective agent. Dietary administration of bovine milk sphingomyelin in mice reduced the 
formation and number of colon tumors [22]. Orally administered bovine milk SM was found to 
incorporate into the stratum corneum [23]. Additionally, the dietary SM that localized in the skin 
reduced Transepidermal Water Loss (TEWL) and increased the water content of skin after UVB 
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radiation [37]. Lab research on KRT monolayers by De Guzman and Campbell et al. have also 
demonstrated promising results for SM photoprotection [13], [14]. Before exploring past 
research, a general overview of lipids, SM, and metabolite roles in the DDR is necessary. 
2.9 Sphingolipids 
 
In general, lipids are organic compounds insoluble in water but soluble in organic solvents 
[46]. According to LIPID Metabolites and Pathways Strategy (LIPID MAPS®) database, there 
are eight main lipid classifications: fatty acyls, glycerolipids, slycerophospholipids, sterol lipids, 
saccharolipids, prenol lipids, polyketides, and sphingolipids [46]. Because of the complex 
structural nature of lipids, classification can be subjective, and the LIPID MAPS database 
categorizes lipids based on their chemically functional backbone in an effort to make organization 
more universal [46]. Two lipids that play integral roles in cell signaling and the DNA damage 
response are sphingomyelin and ceramide, both classified under the sphingolipids branch and 
often described as bioactive because they modulate cell signaling and function [46]. 
Sphingolipids are important cellular components, representing 10-20% of all cellular lipids [47]. 
Figure 11 depicts the structure of sphingomyelin and its common metabolites: ceramide, 
sphingosine, and sphingosine-1-phosphate [48]. More information regarding the structure and 
function is detailed in subsequent sections. 
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Figure 11: General Chemical Structures for Sphingomyelin, Ceramide, Sphingosine, and 
Sphingosine-1-Phosphate [48]. (A) Sphingomyelin, (B) Ceramide, (C) Sphingosine, (D) 
Sphingosine-1-Phosphate (S1P). 
 
 Sphingolipids regulate numerous biological functions and properties. For example, SM 
has been shown to influence the properties of the plasma membrane (fluidity, thickness and 
curvature) by closely associating with cholesterol and other sterols in lipid raft microdomains 
[47]. Subsequent cell signaling and protein sorting are influenced by membrane composition [47]. 
As previously described, SM also affects skin Transepidermal Water Loss (TEWL) [16]. Finally, 
SM is a precursor of bioactive lipid metabolites including ceramide and sphingosine-1-phosphate 
which mediate apoptosis, p21, and p53 levels after UV damage through cellular targets [6], [47]. 
Cells sense perturbations in lipid levels by soluble and transmembrane proteins that modulate 
sphingolipid metabolism [47]. Imaginably, maintaining lipid homeostasis is of utmost importance 
for the cell in order to ensure proper cell function and phenotype [49]. For example, Neiman 
A 
B 
C 
D 
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Picks, Tay-Sachs, Gaucher’s, and Farber’s disease result from deficient lipid homeostasis 
mechanisms [47], [49], [50]. The following sections highlight sphingomyelin and ceramide, with 
a particular emphasis on ceramide due to its implications in UV damage, apoptosis, p21, and p53 
[6], [47].  
2.10 Sphingomyelin and Ceramide Metabolism 
 
     Sphingomyelin (SM) is a complex phospholipid composed of a phosphorylcholine head 
and two nonpolar hydrocarbon chains of varying lengths (Figure 11A) [48]. SM is naturally 
present, in low levels, on the outer leaflet of the plasma membrane associated with cholesterol in 
lipid raft domains [49], [51].  SM is also generated intracellularly by the modification of ceramide 
by SM synthase in the Golgi body, then it is trafficked to the plasma membrane [27]. SM 
degradation is also a fundamental homeostasis mechanism. In the plasma membrane and 
endosomes/lysosomes, aSMase and nSMase cleave sphingomyelin into ceramide [6], [27]. 
Ceramide then influences downstream cellular processes [6]. 
     Ceramide is the hydrophobic backbone of complex sphingolipids including 
sphingomyelin, cerebrosides, and gangliosides (Figure 11) [52]. The structure of ceramide is a 
variable chain length fatty acyl bound to a sphingosine backbone [52]. The fatty acid bonds are 
generally saturated or monosaturated. Ceramides with chain lengths C16-24 are most common in 
mammalian cells, however, C26-C36 are present in some epidermal keratinocytes undergoing 
differentiation [52]. In addition, ceramide structures differ depending on the location of a hydroxy 
(-OH) group. Ceramides with an -OH functional group bound to the second carbon (C2) in the 
variable chain length are termed alpha-hydroxy fatty acids, and ceramides with -OH bound to the 
last carbon are appropriately termed omega-hydroxy fatty acids [52]. Because of their chemical 
structure, ceramides are highly hydrophobic (water-repellent) and exhibit low polarity and 
insolubility in water [52]. 
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     Ceramide metabolism is responsible for cell signaling which in turn regulates a myriad of 
cell responses including proliferation, apoptosis (programmed cell death), and cell senescence [6]. 
Lipid metabolism is a multi-faceted process with numerous sphingolipids that orchestrate cellular 
processes [6]. The focus of this thesis will be on the ceramide-sphingomyelin link, and the 
enzymes, proteins, and cellular machinery that regulate degradation and catabolism of these 
bioactive lipids. The generation, metabolism, and even location of ceramide in a cell is important 
for mediating cellular response [6], [27], [53].  
 
Figure 12: Pathways of Ceramide Generation and Metabolism [53]. Pathway 1 represents de 
novo synthesis, pathways labeled 2 are complex sphingolipid hydrolysis to ceramide, and 
pathway 3 is the salvage pathway. 
 
In the study of ceramide, it is useful to separate metabolic activities into pathways that 
result in the modification of ceramide (either through metabolism into simpler products or as a 
building block for more complex sphingolipids) and pathways that form ceramide (Figure 12) 
[53]. Ceramide is generated through three independent pathways, each involving different 
enzymes (Figure 12) [53]. The first pathway is de novo synthesis. The de novo pathway occurs in 
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the Endoplasmic Reticulum (ER) and starts with serine and palmitoyl CoA [6], [52], [53]. Serine 
and palmitoyl CoA are condensed to 3-keto-dihydrosphingosine by the enzyme serine 
palmitoyltransferase (SPT) [6], [52], [53]. Next, 3-keto-dihydrosphingosine is broken down to 
dihydrosphingosine (sphinganine) then further reduced to dihydroceramide by ceramide synthase 
(CERS) [6], [52], [53]. CERS is present in six different isoforms which have an affinity for 
different acyl CoA backbone lengths [6]. Finally, dihydroceramide is converted to ceramide by 
dihydroceramide desaturase (DEGS) [6], [52], [53]. After de novo ceramide formation in the ER, 
ceramide is trafficked to the Golgi by the Ceramide Transfer Protein (CERT) where it is further 
processed [52]. 
The second mechanism for ceramide generation involves hydrolysis of the complex 
sphingolipids SM and glucosylceramide [6], [52], [53]. Of interest for this thesis is the hydrolysis 
of SM to ceramide, which occurs in the plasma membrane and to some extent in the 
endosomes/lysosomes circulating in the cytosol of cells. The enzyme sphingomyelinase (SMase) 
degrades sphingomyelin to ceramide and a free phosphcholine head [6]. Three different SMase 
enzymes exist and vary based on the pH of the target location [6], [52], [53]. In the plasma 
membrane, both neutral SMase (nSMase) and acidic SMase (aSMase) are present to hydrolyze 
SM to ceramide [6]. In the endosomes/lysosomes of cells, aSMase is mainly responsible for the 
hydrolysis [6]. Lastly, alkaline SMase (alkSMase) is found in the digestive tract and remains the 
least characterized SM enzyme [6]. 
The third mechanism, the Salvage Pathway, involves the recycling of sphingosine from 
sphingosine-1-phosphate (S1P) by S1P Phosphatase in the lysosome and endosomes of cells [54]. 
S1P accumulates after sphingosine phosphorylation by Sphingosine Kinases and is a vital 
bioactive lipid implicated to cancer [6]. Figure 13 includes a summary representation of 
sphingolipid metabolites and relative locations in either the plasma membrane, Golgi, 
endoplasmic reticulum, and endosomes/lysosmes [27].  
30 
 
Ceramide degradation mainly occurs with acidic/neutral ceramidases which break down 
ceramide to sphingosine (Figure 13). Like ceramide generation via SMases, ceramide degradation 
by ceramidases occurs in the plasma membrane and endosomes/lysosomes of cells [6], [27]. The 
eventual byproducts of ceramide catabolism in the plasma membrane are sphingosine and S1P 
[6], [27]. In the Golgi of a cell, ceramide is modified by SM synthase to form sphingomyelin [6], 
[27]. Lastly, ceramide present in the ER can be degraded to sphingosine (and eventually S1P) by 
alkaline ceramidases [27].  
 
Figure 13: Summary of Sphingolipid Metabolism and Location in a Cell [27]. Ceramide is 
metabolized to sphingomyelin and S1P in different cellular locations. 
 
2.11 Sphingolipids, DDR Cascade, and Carcinogenesis 
 
     Phospholipids metabolites can have either pro-survival or pro-apoptotic effects, and the 
regulation of enzymatic metabolism is key to determining which sphingolipids are produced, and 
their effect on UV-irradiated skin cells [6], [55]. Various bioactive metabolites are responsible for 
initiating the DDR including ceramide (Cer), sphingosine, and sphingosine 1-phosphate (S1P) 
[6]. Ceramide is one of the central hubs of the DDR and regulates cell death by inducing a pro-
apoptotic cellular phenotype [6], [55].  
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     Ceramide apoptotic mechanisms originate by the targeting of CAPPs (ceramide-activated 
Ser-Thr protein phosphatases), enzymes that remove phosphate groups from proteins [55]. One 
such CAPP is PP2A (protein phosphatase 2A) which inactivates the anti-apoptotic kinase AKT 
(serine/threonine-specific protein kinase) also known as protein kinase B and upregulates 
expression of p53 (Figure 14) [55]. Ceramide also activates PKC (Protein Kinase C)-zeta which 
downregulates AKT [55]. In addition, ceramide signals to ASK1 (Apoptosis Signal-regulating 
Kinase 1) and upregulates pro-apoptotic JNK, p38, and BAX levels [55]. Furthermore, pro-
survival BCL-2 is downregulated [55]. These pathways eventually cause MOMP (Mitochondrial 
Outer Membrane Permeabilization) and release of the apoptotic protein cytochrome C and 
caspases [54]–[56]. Cathepsin D protein also enables apoptosis, in a mitochondria-independent 
manner [55]. 
 
Figure 14: Ceramide Mechanisms for Cellular Apoptosis [55]. Ceramide and S1P mediate 
contradictory cell functions. 
Figure 14 also demonstrates the importance of S1P, which has contradictory functions 
compared to ceramide [6], [55]. Ceramide, a pro-apoptotic lipid, and S1P, a pro-survival lipid, 
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form a hypothetical ‘rheostat’ or ‘scale’ that can be tipped towards either apoptosis or cell 
survival depending on the type and amount of lipid available in a cell  [6], [55]. Thus, the lipid 
metabolite produced in a cell greatly affects cell fate [6]. For example, in cancer cells, the pro-
survival genes for S1P are upregulated, and in turn, the pro-apoptotic genes for ceramide 
production are downregulated [53]. In addition, accumulation of ceramide is linked to more 
cellular apoptosis as a protection mechanism for damaged cells [6], [53], [55]. Current anti-cancer 
treatments point to the apoptotic and tumor suppressive nature of ceramide [55]. Therefore, 
common treatments either introduce exogenous ceramide supplements to encourage cellular 
apoptosis, or inhibit ceramide metabolism [55]. The ceramide-S1P rheostat and complexity of 
lipid metabolism necessitate further research into mechanisms, homeostasis, and potential 
treatments for UV-induced DDR and cancer. 
2.12 Bovine Milk Sphingomyelin Past Research and Limitations 
 
     Bovine milk SM has demonstrated significant potential as an anti-cancer treatment in the 
colons of mice [22]. In addition, oral consumption of SM in a mouse model demonstrated SM 
accumulation in the skin and a decreased skin TEWL after UVB [16], [37]. Previous work by De 
Guzman and Campbell from the Cal Poly Bioimaging Lab suggested bovine milk SM 
photoprotection for a monolayer of KRTs [13], [14]. P21 and p53 levels statistically decreased in 
SM-treated cells after UVB radiation compared to the control without SM [13], [14]. The results 
suggested photoprotective effects of bovine milk SM on KRT monolayers after UVB radiation. 
     However, these past studies were limited in that the mechanism of action for bovine milk 
SM photoprotection was not addressed. Direct visualization of intracellular FSM distribution by 
fluorescence for various conditions is necessary as a way to address this limitation. In addition, 
the cell model was a 2D monolayer, and moving to a third dimension could prove more 
physiologically relevant. 
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2.13 Probing In Vitro Lipid Dynamics with Fluorescence 
 
     In order to validate the mechanisms occurring in a cell, it is important to study lipid 
dynamics in vitro. Imaging proves to be a valuable method for assessing lipid distribution in a 
cell and provides more spatial information than High Performance Thin Layer Chromatography 
(HPTLC) and associated methods [57]. However, tracking intracellular distribution of bovine 
milk SM is difficult because the phospholipid is not fluorescent under normal conditions. 
Fluorescently tagged sphingomyelin has come to the forefront of lipid research, with multiple 
research groups developing novel methods to identify SM for intracellular trafficking studies and 
metabolism with imaging [58]–[60]. 
     C6- NBD Sphingomyelin (abbreviated FSM in this thesis), manufactured by Avanti Polar 
Lipids, is one such example (Figure 15). The chemical structure differs from their bovine milk 
chemical by the addition of a fluorescent tag, indicated by the dashed box [61]. Despite the NBD 
attachment, FSM proves to be a sufficient analogue because its compact shape limits functional 
disturbance of in vivo processes [62]. 
 
 
Figure 15: Avanti Polar Lipid Diagrams of Molecules [61]. 
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Koval and Pagano et al. led first efforts to characterize FSM in Chinese Hamster Ovary 
(CHO) cells. Plasma membrane staining followed by rapid entry and Golgi accumulation was 
observed [60]. FSM was introduced (pulsed) to cells at 370C, back-exchanged with BSA on ice to 
remove residual FSM outside the cell plasma membrane, then chased with a 370C media 
exchange to assess FSM trafficking [60]. Koval and Pagano’s research was also repeated by other 
groups including Hao et al. and Kok et al. [58], [59]. FSM internalization was found to be 
temperature-dependent and trafficking rate declined at lower temperatures [58], [59]. Exogeneous 
administration of FSM was determined to be internalized by endocytosis into vesicles and 
recycled by three main mechanisms: 1) Rapid recycling from endosomes to the plasma 
membrane, 2) endosome to lysosomes for degradation to downstream metabolites, 3) endosomes 
to Golgi [63]. 
A novel probe called Lysenin has recently been developed for fluorescence detection of 
endogenous cellular SM [64]. Lysenin is a 41-kDa protein obtained from purified coelomic fluid 
of the earthworm Eisenia foetida [64]. This protein binds selectively to SM, as demonstrated by 
ELISA, TLC, and other methods [64]. Mound et al. used lysenin, in conjunction with FSM, to 
visualize lipid raft organization in the plasma membrane of KRTs [65]. Colocalization of lysenin 
with FSM signal was quantified, and Mound demonstrated that lysenin signal diminished after the 
addition of SMase, an enzyme that degrades SM [65]. The signal obtained was predominantly 
concentrated around the plasma membrane [65]. The heterogeneity of lysenin staining was also 
described and the overall signal declined as the cells reached senescence [65].   
Although published research predominantly uses an exogenous version of ceramide or 
lysenin with a direct fluorescent tag, immunofluorescence assays have also been developed for 
both lysenin and ceramide [64], [66]. For endogenous SM staining, lysenin is first bound to SM, 
then an anti-lysenin primary antibody is introduced followed by secondary fluorescent tag [64]. 
Ceramide immunofluorescence also involves an antibody against ceramide and a secondary 
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fluorescent tag [66]. Optimization of each step in the staining procedure was necessary to obtain a 
quality signal. Both lysenin and ceramide antibodies prove useful for colocalization experiments 
and probing lipid trafficking in a cell. 
2.14 Tissue Engineered 3D Skin Culture 
 
     Tissue engineering is a field of regenerative medicine aimed at creating accurate in vitro 
models to mimic the in vivo characteristics of human tissue [67]. This field traditionally combines 
cells, a biomaterial scaffold, and growth factors or other chemical/external stimuli to guide cell 
proliferation into a structure that better recapitulates tissue [67]. From a tissue engineering 
standpoint, a 3D model proves potentially more advantageous over previously described KRT 2D 
monolayer studies because multiple layers of cells can be grown and studied  [13], [14]. The 
many layers of stratified KRTs in vivo can be mimicked in vitro. Developing tissue engineered 
skin for assessing BSM and FSM photoprotection after UV is a scientifically advantageous goal 
to progress research in this field [13], [14]. 
     Based on a 2017 review of current tissue engineered skin technologies, most in vitro skin 
models resemble a flat sheet, with keratinocytes and/or fibroblasts cultured on top a natural 
and/or synthetic biomaterial scaffold (Figure 16) [68]. For example, ApligrafTM combines 
keratinocytes with fibroblasts and collagen to recreate both the epidermis and dermis [68]  
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Figure 16: Review of Current Tissue Engineering Skin Products [68]. 
     Despite the success of many sheet-based tissue engineering products for skin, some 
limitations exist mainly involving time and cost [68]. For example, according to Vig et al., most 
skin products require 2-3 weeks of culture time and significant lab resources; for example, 
approximately $13,000 of lab resources are needed to produce enough of EpicelTM skin to cover 
1% of the body’s surface area [68]. Given the limitation of current techniques, research into more 
efficient 3D culture methods is important. 
     3D spheroids have recently risen to the forefront of research, mainly involving tumor 
cancer biology, brain organoids, angiogenesis sprouting, and drug testing applications [69]–[77]. 
Spheroids are essentially aggregates of cells stimulated to form 3D structures by a variety of 
culture methods including hanging drop, non-adhesive surfaces, spinner flask, and microcarrier 
beads (Figure 17) [77]. Spheroids have demonstrated success with numerous peer-reviewed 
papers [69]–[77]. Additionally, a number of groups have utilized the non-adherent culture 
conditions, with either low adherence 96-well culture plates or 1% agarose coating of flat-bottom 
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wells [71]–[74]. Cells at an optimized seeding density were combined with methylcellulose (15-
20% diluted in media) and seeded into non-adherent conditions [72], [73]. Methylcellulose 
functions as a binding agent to provide a high viscosity environment for optimal spheroid 
compaction [78]. After a week of culture, mature spheroids usually form and are ready for 
assessment [72], [73]. In addition, mixed culture spheroids are possible, with one group utilizing 
three cell types to form blood brain barrier spheroid organoids [70]. Spheroids were commonly 
assessed via immunostaining and fluorescence microscopy or histological embedding and 
sectioning [69]–[77]. Additionally, spheroids can be iteratively optimized by varying seeding 
density, methylcellulose concentration, culture time, and co-culture conditions among other 
variables. Given the relatively time-efficient protocols, reduced use of lab resources, and control 
over culture parameters, spheroids prove useful for investigation into skin applications. 
 
Figure 17: Methods of 3D Spheroid Formation [77]. 
     Due to the historical success of sheet-based skin models (Figure 16), few research groups 
have developed skin spheroids [79], [80]. Some research groups have found success combining 
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KRTs with dermal fibroblasts in a dual culture system [79]. Furthermore, Syntivia, a French 
biotechnology company, developed a skin model for in vitro cosmetic testing [80]. Following 
patent publication in August 2017, Syntivia created an epidermal keratinocyte-melanocyte co-
culture spheroid in Matrigel [80]. Their patent pointed to the highly optimized process and co-
culture method required for skin to stratify in a 3D spheroid structure [80]. Despite Syntivia’s 
success, their Matrigel scaffold is limited in that the constituent proteins are highly 
uncharacterized, derived from mouse sarcoma (a xenograph and potentially immune eliciting 
substance), and varies significantly between product lots and batches [81]. Further research into a 
consistent skin cell spheroid model is warranted to determine if the model is physiologically 
relevant to previous 2D monolayer studies and gold standard sheet-based constructs.  
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2.15 Overview and scope of thesis 
 
     Past research in the lab involving bovine milk SM and the p21 damage marker has 
demonstrated a photoprotective promise for SM. However, previous cell monolayer research has 
failed to demonstrate the mechanism of action for protection, link FSM with UVB, and 
recapitulate the 3D environment of skin. Thus, the goals of this thesis were three-fold and 
attempted to answer the following research question goals, each divided into separate subsets. 
1.) Goal 1: Does FSM intracellular trafficking change with varying incubation times, and 
after UVB radiation?  
a. Subset 1: Characterize FSM in KRT culture during live and fixed cell cultures 
using fluorescence confocal imaging 
b. Subset 2: Assess the localization of FSM in normal and UVB-stressed KRTs 
under varying incubation times 
c. Subset 3: Demonstrate functional equivalence of bovine milk SM to its 
fluorescent counterpart 
2.) Goal 2: Do endogenous SM and ceramide levels fluctuate with exogenous FSM 
incubations? Is it possible to characterize, with fluorescence microscopy, the identity of 
the observed FSM signal over time? 
a. Subset 1: Develop immunofluorescence staining protocols for both endogenous 
SM (lysenin) and endogenous ceramide 
b. Subset 2: Characterize how endogenous SM and ceramide levels change with 
varying FSM incubation timepoints 
3.) Goal 3: Are cell spheroids a viable platform to move future research from a 2D to 3D 
model? 
a. Subset 1: Develop a method to culture NIH 3T3 immortalized mouse fibroblast 
spheroids, for eventual incorporation of KRT cells and FSM 
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b. Subset 2: Quantify dye penetration over various concentrations and incubation 
times 
First, FSM was characterized in our model system of KRTs. A p21 immunofluorescence 
stain was employed as a substantial equivalence test to compare photoprotective benefits of FSM 
and bovine milk SM. The location and brightness of the stain was tracked both in live and 3.75% 
paraformaldehyde (PFA) fixed cells using confocal microscopy. The main purpose of localization 
quantification was to assess where the FSM stain is trafficked, and if fluorescence localization is 
perturbed with UVB exposure. Trafficking is valuable because different lipid metabolic processes 
occur in various cellular locations [27].  
It was hypothesized that total intracellular FSM levels would initially increase when 
added to the cells, then decrease with hydrolysis to ceramide and exocytic recycling mechanisms. 
With UV exposure, the FSM levels would diminish further because UV would stimulate the 
hydrolysis mechanism and increase levels of ceramide. Enhanced intracellular ceramide would 
then increase apoptosis levels in a cell, contributing to FSM photoprotection. 
Second, immunofluorescence staining protocols were developed for both endogenous SM 
(lysenin) and endogenous ceramide. The goal of incorporating these two stains was to assess, 
both qualitatively and quantitively, the location of endogenous SM and ceramide in a cell and if 
introduction of exogenous FSM disturbed lipid dynamics. Although not completed in this thesis, 
lysenin and ceramide stains could eventually be used to assess the fluctuations in localization and 
signal brightness after UVB exposure. Another future goal for immunostaining is to better 
characterize FSM by developing a repeatable and quantifiable fluorescence colocalization method 
for FSM, lysenin, and ceramide. As FSM is introduced and metabolized, it is unknown whether 
the fluorescence probe remains attached to a downstream metabolite (not a true sphingomyelin) 
or if the probe is cleaved and exocytosed from the cell. Measuring colocalization of lysenin with 
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FSM and ceramide with FSM provide first steps towards understanding the degradation of the 
fluorescent probe attached to FSM. 
Finally, the third main goal was to develop a culture method for 3D spheroids using 3T3 
cells. The nuclei of 3T3 spheroids were stained and imaged on the confocal microscope to assess 
dye penetration depth. The methods developed can be used to culture KRT-3T3 dual spheroids 
and quantify the effects of FSM incubation on a 3D culture system.  
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3. METHODS 
 
3.1 Keratinocyte Cell Culture 
 
     Primary Epidermal Keratinocytes (KRTs), Normal, Human, Neonatal Foreskin (HEKn, 
PCS-200-010, ATCC Manassas, VA) were cultured using aseptic technique in a 370C, 5% CO2 
incubator prior to experiments. KRT media was made following ATCC guidelines by combining 
one Keratinocyte Growth Kit (PCS-200-040, ATCC, Manassas, VA) with one bottle of Dermal 
Cell Basal Medium (PCS-200-030, ATCC, Manassas, VA), and 0.5 mL of Penicillin-
Streptomycin-Amphotericin (PCS-999-002, ATCC, Manassas, VA). The mixture was then sterile 
filtered with a 0.22µm filter. KRTs were expanded in canted T-75 Falcon from Corning Tissue 
Culture Flasks (BD353136, VWR, Visalia, CA) and passaged at approximately 70% confluence 
into 8-well Nunc Lab-Tek Chambered Coverglasses from Thermo Scientific (43300-774, VWR, 
Visalia, CA) for experiments. The 8-well plates were mounted on No. 1 borosilicate glass and 
allowed for inverted confocal imaging. During culture, the monolayer of cell was visually 
assessed via brightfield microscopy every 24-48 hours and media was exchanged every 48 hours. 
3.2 Sphingomyelin Treatment – BSM and FSM 
 
     Bovine Milk SM or BSM (860063P-25mg, Avanti Polar Lipids, Alabaster, AL) was 
obtained in powdered form. The BSM was weighed and added to KRT media to create a 0.1% 
BSM solution. The powder was mixed in the media via sonication and vortexing to create a 
homogenous solution. The solution was finally passed through a 0.22µm filter to sterilize then 
stored in the refrigerator. The BSM solution was discarded on the expiration date of the media. 
     Fluorescent SM or C6-NBD Sphingomyelin (810218P-1mg, Avanti Polar Lipids, 
Alabaster, AL) was also acquired in powdered form then dissolved in ethanol to yield a 1mM 
stock solution. The stock was stored at -200C in a tightly sealed glass container protected from 
light until further use. To make the FSM media treatment administered to cells, an appropriate 
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volume of ethanol-FSM stock was added to a 5uM Bovine Serum Albumin diluted in KRT media 
to yield a 5uM FSM final concentration.  
     When KRTs in the 8-well plates reached 70% confluence, approximately 200µL of SM 
treatment was added to each well. Cells were incubated for various times with the SM prior to 
UV radiation. 
3.3 UVB Irradiation 
 
     UVB radiation (302 nm) at a dose of 40 mJ/cm2 was administered to the cells in a two-
step process. First, the average intensity of the UV lamp (95-0251-01, UVP, LLC, Upland, CA) 
was measured with a UV sensor (S120UV, ThorLabs, Newton, NJ) and connected power meter 
(PM100, ThorLabs, Newton, NJ). Figure 18 provides a visual representation of the UV lamp 
calibration and treatment administration under aseptic technique. All equipment was sprayed with 
70% Isopropyl Alcohol (IPA) prior to use in the culture hood. 
  
Figure 18: UVB Radiation. (A) Calibration of Lamp, sensor (white arrow), power meter (red 
arrow), ABS plastic tray (green arrow). The white UV lamp is shown atop the black containment 
box. The exposure time was calculated based on the desired dose and average intensity of the 
lamp. (B) UV calibration and treatment to cells were conducted inside the culture hood after 
spraying all equipment down with 70% IPA. The cells were placed on the blue plastic tray and 
slid under the UV box/lamp. Spent media was replaced prior to UV. 
 
A B 
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The exposure time of cells to UV required for the radiation dosage was calculated using 
the following equation [13]. The measured irradiance was calculated by determining the average 
intensity of the UV sensor during calibration, and dividing by the sensor area of 0.7088cm2 [13]. 
The prescribed dose is equal to 40 mJ/cm2. The exposure time is roughly 60 seconds. 
Exposure Time (seconds) =  
Prescribed Dose (
mJ
cm2
) 
(
1mW
1000μW) ∗ Measured Irradiance (
μW
cm2
)
 
The UV lamp was housed in UV box constructed of Delrin plastic which contained the 
radiation and protected the user. The Acrylonitrile Butadiene Styrene (ABS) plastic tray was 3D 
printed to hold the sensor and 8-well culture plate, and ensure the system remains directly under 
the UV radiation source (green arrow Figure 18). 
The second step of the UV process was direct administration to the cells. KRTs in 8-well 
plates were removed from the incubator and the spent media (or SM solutions) were aspirated and 
replaced with 200µL of fresh KRT media. The plates were placed on top of the tray, slid under 
the UV lamp, and exposed to UV for the calculated time (based on the dose and irradiance). After 
UV, cells were placed back in the incubator and visually assessed for signs of contamination. 
Figure 19 provides an example plate layout used for SM and UV treatment.  
 
 
 
 
 
SM (+) SM (-) 
SM (-) SM (+) 
SM (+) SM (-) 
SM (-) SM (+) 
Figure 19: Typical Plate Distribution for SM and UV Treatments. SM was administered in a 
diagonal pattern with (+) meaning the presence of SM and (-) denoting the absence of SM. The 
entire plate was subjected to UV, as indicated by the lightning bolt. 
 
UV 
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SM was directly added to wells in a diagonal pattern, and the entire plate was UV’ed. The 
diagonal pattern randomized the treatment locations and reduced bias introduced by position-
dependent fluctuations in UV intensity. 
3.4 Cell Fixation and Staining 
 
     After UV exposure, cells were fixed in 3.7% paraformaldehyde (PFA). The time after UV 
was dependent on the experimental treatment. The media was gently removed from the wells, and 
one wash was performed with a 1X Phosphate Buffer Solution (PBS). 200µL of PFA was 
pipetted in each well, and the plate was incubated for 15 minutes at room temperature. After 
fixation, cells were washed three times with PBS. After fixation, cells were subjected to various 
immunostaining protocols depending on the experimental objective. 
3.4.1 p21 
 
The p21 indirect immunostaining protocol was previously optimized by the lab [13]. 
Following BSM or FSM incubation and UV exposure, p21 immunostaining was conducted 
according to established protocol shown in Table I. 
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Table I: p21 Immunostaining Protocol [13] 
Protocol Step Reagent Concentration Exposure Vendor Information 
Fixation Paraformaldehyde 3.7% 15 min Electron Microscopy 
Solutions (RT 15710) 
Permeabilization Trixon X-100 0.1% 20 min Invitrogen HFH10 
Blocking 10% Normal Goat 
Serum 
1% Overnight 
(~12 hrs) 
Life Technologies 
500622 
Primary Anti-p21 antibody 
(rabbit) 
1:400 9 Hours Abcam ab18209 
Secondary AF 647 (goat, 
anti-rabbit) 
1:400 1 hour ThermoFisher 
Scientific A-11008 
Nuclear Staining Hoechst 34580 0.03%  15 min Life Technologies 
H21486 
 
The monolayer of each well was exposed to 200µL of 0.1% TritonX-100 diluted in PBS 
for 20 minutes to permeabilize the cell membrane and allow antibody entry into the nucleus. 
200µL of a blocking solution, 10% goat serum diluted in PBS, was administered and allowed to 
incubate overnight at 40C. The blocking solution reduced non-specific binding of the primary and 
secondary while reducing image noise and enhancing signal to noise ratio. The next day, 200µL 
of 1:400 p21 antibody (raised in rabbit) diluted in PBS was added and incubated for 9 hours at 
40C. Next, 200µL of 1:400 goat, anti-rabbit AF 647 secondary diluted in PBS was administered 
for 1 hour. Finally, a Hoechst 34580 stain, 0.03% diluted in PBS was added to the well for 15 
minutes. Between each step in the process, the previous reagent was washed off 3 times with 
PBS. Care was taken to gently administer the liquid treatments to each well in order to prevent 
washing off of cells.  
3.4.2 Lysenin 
 
In order to visualize endogenous sphingomyelin in a cell, indirect immunostaining was 
conducted. The protein Lysenin was used to bind on to sphingomyelin, then an anti-Lysenin 
antibody and secondary were introduced to fluorescently tag the lysenin (Table II) 
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Table II: Lysenin Immunostaining Protocol 
Protocol Step Reagent Concentration Exposure Vendor Information 
Fixation Paraformaldehyde 3.7% 15 min Electron Microscopy 
Solutions (RT 15710) 
Permeabilization Trixon X-100 0.1% 20 min Invitrogen HFH10 
Blocking BSA 
10% Normal Goat 
Serum 
4%/4% Overnight 
(~12 hrs) 
Spectrum Chemicals 
AL 135 
Life Technologies 
500622 
Protein 
Attachment to 
SM 
Lysenin from 
Eisenia foetida 
1µg/mL 2 hours Millipore Sigma 
L3038 
Primary Anti-Lysenin pAb 
(rabbit) 
1:1000 1 hour Creative Diagnostics 
DPAB214905 
Secondary AF 594 (goat, anti-
rabbit) 
1:300 1 hour ThermoFisher 
Scientific A11012 
Nuclear Staining Hoechst 34580 0.03%  15 min Life Technologies 
H21486 
 
After fixation and permeabilization, the cells were blocked overnight at 40C with 4% 
BSA and 4% Goat Serum solution, abbreviated 4%BSA/4%Goat, diluted in PBS. This blocking 
solution was optimized specifically for lysenin and dual staining with ceramide to prevent non-
specific primary and secondary binding. Tween-20 was temporally tested in the blocking buffer 
to further reduce non-specific primary binding, but it was ultimately removed when the FSM 
signal was washed out.  
Lysenin from Eisenia foetida (L3038-50UG, Millipore Sigma, St. Louis, MO) was 
purchased in powder form and reconstituted in 2% BSA in PBS to make a 10µg/mL stock. 
Unused stock was aliquoted and stored at -200C. The lysenin was further diluted in PBS and 
incubated with cells at a 1µg/mL optimized concentration for 2 hours at room temperature. Next, 
a rabbit anti-lysenin polyclonal antibody (DPAB214905, Creative Diagnostics, Shirley, NY) was 
diluted 1/1000 in blocking solution and incubated for 1 hour at room temperature. The secondary 
AF594 Goat Anti-Rabbit (A11012, ThermoFisher Scientific, Waltham, MA) was diluted 1:300 in 
PBS and incubated for 1 hour at room temperature. Lastly, the nucleus was stained with 0.03% 
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concentration of Hoechst 34580 for 15 minutes at room temperature. Between each protocol step, 
the previous reagent was washed three times with PBS. 
3.4.3 Ceramide 
 
An indirect immunofluorescence staining assay was utilized to fluorescently visualize 
ceramide in a cell. Table III details the list of reagents and optimized staining procedure. After 
fixation and permeabilization, the cells were blocked overnight at 40C with 4% BSA and 4% Goat 
Serum solution, abbreviated 4%BSA/4%Goat, diluted in PBS. A mouse anti-ceramide 
monoclonal antibody (C8104, Millipore Sigma, St. Louis, MO) was diluted 1/400 in blocking 
solution and incubated for 9 hours at 40C. The secondary AF 647 Goat Anti-Mouse (A21235, 
ThermoFisher Scientific, Waltham, MA) was diluted 1:300 in PBS and incubated for 1 hour at 
room temperature. Lastly, the nucleus was stained with 0.03% concentration of Hoechst 34580 
for 15 minutes at room temperature. Between each protocol step, the previous reagent was 
washed three times with PBS. 
Table III: Ceramide Immunostaining Protocol 
Protocol Step Reagent Concentration Exposure Vendor Information 
Fixation Paraformaldehyde 3.7% 15 min Electron Microscopy 
Solutions (RT 15710) 
Permeabilization Trixon X-100 0.1% 20 min Invitrogen HFH10 
Blocking BSA 
10% Normal Goat 
Serum 
4%/4% Overnight 
(~12 hrs) 
Spectrum Chemicals 
AL 135 
Life Technologies 
500622 
Primary Anti-Ceramide 
mAb (mouse) 
1:400 9 hours Millipore Sigma 
C8104 
Secondary AF 647 (goat, anti-
mouse) 
1:300 1 hour ThermoFisher 
Scientific A21235 
Nuclear Staining Hoechst 34580 0.03%  15 min Life Technologies 
H21486 
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3.4.4 Dual Staining 
 
Cells were co-stained for both lysenin and ceramide. Cells were fixed and permeabilized, 
followed by overnight blocking at 40C with 4% BSA/4% Goat diluted in PBS. Next, the lysenin 
protein then subsequent lysenin antibody were introduced to the cells according to established 
protocol. Then the ceramide antibody was incubated for 9 hours, followed by simultaneous 
secondary incubations (AF 647 goat anti-mouse and AF 594 goat anti-rabbit) diluted in PBS and 
introduced at the same time at their respective concentrations. Finally, the nuclei were stained 
with Hoechst. Sufficient washing steps were performed between each step in the protocol. 
3.4.5 Nile Red 
 
     Nile Red powder (N3013-100MG, Millipore Sigma, St. Louis, MO) was reconstituted in 
methanol to from a 1mg/mL stock concentration which was stored long-term at 200C. The stock 
was further dissolved in PBS to make a 5µM/mL solution. Cells were exposed to Nile red for 15 
minutes than washed three times with PBS prior to imaging. 
3.5 Spheroid Cultivation, Staining, and Manipulation 
 
     Spheroids were formed by adding NIH-3T3 cells to methylcellulose binding agent. The 
cells plus methylcellulose were seeded into non-adherent U-well plates and cultured for 3-5 days 
prior to cultivation, staining, and confocal imaging. To reduce the cost associated with using the 
U-well plates, flat bottom U-wells were coated with agarose prior to cell seeding and culture. A 
co-culture of 3T3 and KRTs (stained with CellTracker Red) were also cultured in U-wells as a 
first step towards promoting KRT stratification into spheroids.  
3.5.1 3T3 Cell Culture 
 
NIH 3T3 Fibroblasts were cultured using aseptic technique in a 370C, 5% CO2 incubator 
prior to experiments. 3T3 media was made by adding Fetal Bovine Serum (F8317, Millipore 
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Sigma, St. Louis, MO) to DMEM media (12001-000, VWR, Visalia, CA), and Penicillin-
Streptomycin-Amphotericin (PCS-999-002, ATCC, Manassas, VA). The media was sterile 
filtered and stored at 40C for up to one month.  
3.5.2 Methylcellulose 
 
A 2% weight/volume solution was chosen for the concentration of methylcellulose based 
on previous literature [72], [73]. 5 grams of methylcellulose powder (M7140-100G, Millipore 
Sigma, St. Louis, MO) was weighed and added to 250 mL of Distilled H2O and slowly brought to 
a boil for 5-10 minutes. A stir bar was added to enhance mixing. The solution was agitated and 
heated until all methylcellulose particles were wet and evenly dispersed. The solution was 
immediately sterilized for 16 minutes at 1210C and 15 Pounds per Square Inch (PSI) steam 
pressure. The sterile methylcellulose was stored at room temperature to facilitate complete 
dispersion. 
3.5.3 Cell Seeding 
 
Cells were mixed with 20% methylcellulose solution diluted in cell media. The seeding 
density was varied per experiment. 200µL of cell-20% methylcellulose was pipetted into each 
well of 96-well Corning® spheroid microplates with ultra-low attachment surface (CORN4520, 
VWR, Visalia, CA) and incubated for 3-5 days. Spheroids were visually assessed for growth and 
health every two days. 
For co-culture dual experiments with 3T3 fibroblasts and KRTs, the seeding density ratio 
was matched by the media concentration. In some concentrations, the amount of methylcellulose 
was increased to 40%. 
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3.5.4 Agarose 
 
Agarose (V0710-25G, VWR, Visalia, CA) was used to coat the bottom of 96-well flat 
bottom plates to make the surface non-adherent and promote cell aggregation into spheroids. 
Agarose plates are a potentially less expensive alternative to the Corning® ultra-low attachment 
spheroid microplates. 
Each well was coated with 100µL of 1% sterile agarose. 0.1 gram of agarose powder was 
added to 10mL of distilled H2O and microwaved for about 1 minute until the agarose powder was 
dissolved. The heated solution was immediately sterilized with a 0.22µm filter then dispensed 
quickly into each well. Efficiency and rapid pipetting was required before the agarose solution 
cooled and solidified in the pipet tip. The agarose in each well was allowed to gel for at least 1 
hour at room temperature before seeding the cell-20% methylcellulose solution.  
3.5.5 Manipulation, Staining, Plating 
 
After 3-5 days of culture, each individual spheroid was removed from the well with a 
1000µL pipet tip and placed into a 1mL conical tube. Generally, 3-5 spheroids were pipetted into 
each tube. Given the density of the spheroids, they naturally accumulated at the bottom of the 
tube, and the residual media and/or stains were carefully removed/added without disturbing the 
spheroids at the bottom. One PBS wash was performed by slowly introducing 200µL to each 
conical tube, pipetting gently to mix, then removing the liquid. 
Spheroids were fixed with 3.75% PFA for 20 minutes, then rinsed three times with PBS 
to remove residual fixative. Hoechst stain in PBS was introduced at various concentrations to the 
spheroids by adding 200µL to each tube and gently mixing. After the staining treatment, Hoechst 
was gently removed and washed three times with PBS. 200µL of PBS was left in each conical 
between staining and imaging. 
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     Immediately prior to imaging, the stained and washed spheroids were plated in glass-
bottom 8-well plates by aspirating the 200µL PBS with a 1000µL pipet tip. The tip was pushed 
towards the bottom to ensure all the spheroids were aspirated into the tip. The entire 200µL liquid 
in the pipet was quickly ejected into one well of the 8-well plate. This process was performed 
rapidly to prevent spheroids from sticking to the plastic pipet tip. The spheroids sink to the 
bottom of the plate and are easily visualized under the confocal microscope. 
3.6 Confocal Imaging 
 
     Images were obtained with an Olympus FluoView FV1000 confocal microscope 
(Olympus America, Centerville, PA) with FluoView program. The software applied DAPI for 
Hoechst, 488 laser (for Alexa Fluor 488), 559 laser (for Alexa Fluor 594), and 635 laser (for 
Alexa Fluor 647). The 60X and 100X oil objectives were used to yield sufficient resolution for 
fluorescence distribution analysis. The laser scanning speed was set to 4.0 µs/pixel and image 
size was 512x512. Sequential was checked for multiple laser images.  
     Images were deliberately taken in the center of the well to ensure equal distribution of UV 
radiation exposure. Z-stacks with a 1µm step size were taken to provide a more realistic 3D 
image. The following settings were maintained between experiments used for quantification 
purposes (Table IV and V). 
Table IV: Fixed Trafficking with FSM and Post-UV 
Laser and Power Stain PMT Sensitivity 
488 (10%) FSM 540 HV 
 
 
Table V: Dual Staining with FSM, Lysenin, Ceramide 
Laser and Power Stain PMT Sensitivity 
488 (30%) FSM 645 HV 
559 (30%) AF 594 (Lysenin) 830 HV 
635 (30%) AF 647 (Ceramide) 715 HV 
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3.7 Image Analysis 
 
     The software used for image analysis was ImageJ/Fiji, a public software based on the Java 
programming language and developed by the National Institutes of Health. MATLAB was also 
used as a component of the 2D Fluorescence Distribution analysis, and for quantifying areas 
under the resulting curves.  
3.7.1 P21 Ratios 
 
To demonstrate a reduction in p21 DNA damage marker expression in SM-treated cells, 
the ratio of p21 positive to total cells was calculated. P21 positive cells exhibited bright nuclear 
fluorescence compared to cytoplasm expression. For each well, the number of positive p21 cells 
was manually counted with an ImageJ cell counter, then compared to the overall number of cells. 
3.7.2 2D Fluorescence Distribution 
 
A fluorescence distribution macro, developed previously by another student in the lab, 
was used to analyze all fluorescence distributions. Appendix A includes the code. Raw confocal 
images in .oib format were collected from the Fluoview imaging system and opened into 
ImageJ/Fiji. Color channels were separated. When analyzing z-stacks, an image representative of 
the middle of the cell was selected (as determined by a clear nuclear signal, and distinct absence 
of FSM signal colocalization in the nucleus). Each nucleus in the image was blurred (Gaussian), 
made binary, outlined, and counted. The borders of the FSM Region of Interest (ROI) were 
identified in a similar manner, and the nuclei was subtracted from the FSM ROI (so that only the 
cytoplasm was included). All pixels outside the cytoplasm and nuclei ROI were set to zero.  
A rotation ROI was run by finding the center of the ROI, rotating a line 360 degrees 
about the center, and measuring the profile plot distribution across the line for every 6 degree 
angle increment. In total, 60 profile plots were generated for each cell. Because the nucleus was 
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not exactly centered in all cells, the profile plots from nucleus to plasma membrane were not the 
same length and number of pixels. Therefore, MATLAB was used to average all 60 profile plots 
and normalize by interpolating data points (linear approximation between pixels) so that all plots 
had the same number of points (“0” through “100” with “0” and “100” representing the center of 
the nucleus and edge of the cytoplasmic ROI respectively). Within each image, cell profile plots 
were averaged, then all images within the same well were averaged. Finally, all wells within each 
treatment were averaged to yield a mean gray value fluorescence distribution versus distance 
from the nucleus. Standard errors were calculated based on well to well variability within each 
treatment. 
Relative amount of intracellular fluorescence was calculated by finding the area under 
each fluorescence distribution curve with the cumulative trapezoidal numerical integration 
function (CUM TRAPZ). The area was used as a method of comparison for fluorescence 
distribution curves. 
3.7.3 Depth of Dye Penetration into Spheroids 
 
The depth of Hoechst dye penetration was calculated by first subtracting all stack slices 
below a consistent threshold value used for all images. Then each stack was normalized and 
divided into 10 equal increments (i.e. one increment = total height/10) stepping through the entire 
stack from start to finish. The entire stack was z-projected and an ROI outline of the spheroid was 
generated with an ImageJ macro. For each increment slice, the fluorescence distribution codes 
were used with the same ROI generated in the previous step for all increment images. Finally, 
MATLAB was used to find the area under the fluorescence curves for each slice in order to 
determine the dye content over the depth of the spheroid. 
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4. SUMMARY OF EXPERIMENTS 
 
 All conducted experiments are listed in Table VI according to the thesis project goals. 
Table VI: Thesis Goals for Characterizing FSM, Staining Protocols, and 3D Cell Spheroids 
Goal Summary of Experiments Thesis 
Section 
1                                       
Characterize 
FSM 
Initial FSM Imaging                                                                          
Goal: Validate protocol methods for 5µM FSM 4.1 
Live FSM Intracellullar Trafficking                                            
Goals: Visualize FSM distribution differences over various FSM 
incubations; assess suitability of live imaging                                                                    4.2 
FSM Temperature Dependence                                                  
Goal: Assess temperature-dependent FSM uptake 4.3 
Fixed FSM Trafficking with Variable Incubation Times   
Goal: Quantify FSM distribution differences over several FSM 
incubation times in fixed cells 4.4 
Fixed FSM Trafficking with UV                                                                     
Goal: Detect UV perturbations in FSM distribution  4.5 
P21 Ratios for BSM and FSM Comparison                                          
Goal: Demonstrate functional equivalence of p21 photoprotection 
for FSM and BSM 4.6 
2                                            
Develop Staining 
Protocols 
FSM with Nile Red                                                                                    
Goal: Determine suitability of Nile red stain 4.7 
Lysenin Stain Optimization                                                                          
Goal: Determine optimal staining parameters 4.8 
Ceramide Stain Optimization                                                                              
Goal: Determine optimal staining parameters 4.9 
Dual Lysenin, Ceramide, and FSM Staining                                        
Goal: Validate protocol methods for dual immunofluorescence 4.10 
Troubleshooting FSM Degradation after Dual Treatment                                                                        
Goal: Identify one reason for FSM degradation dilemma 4.11 
Dual Lysenin, Ceramide,  and FSM Fluorescence Trafficking                                   
Goal: Quantify Lysenin, Ceramide, and FSM distribution 
differences over several FSM incubation times in fixed cells 4.12 
3                                        
Cultivate 3D 
Spheroids 
KRT and 3T3 Single Culture                                                                  
Goal: Validate spheroid protocol methods 4.13 
KRT and 3T3 Dual Culture                                                                      
Goal: Assess KRT-3T3 dual spheroids 4.14 
3T3 Culture with Agarose-coated Wells                                         
Goal: Test agarose coating, Triton X and FSM incubations 4.15 
Quantification of Spheroid Dye Penetration                                  
Goal: Quantify dye penetration into spheroids 4.16 
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4.1 Initial FSM Imaging 
 
4.1.1 Summary and Objectives 
 
The goal of the first FSM experiment was proof-of-concept to demonstrate that FSM at a 
5µM concentration is detectable by confocal imaging and yields a bright signal with low noise. 
This concentration is consistent in literature, with research groups employing either a 5µM or 
4µM FSM concentration [59], [65], [82]–[84]. Furthermore, ThermoFisher’s product guidelines 
for fluorescently labeled sphingolipids specified complexing 5µM FSM with 5µM BSA in PBS 
[82]. Therefore, a 5µM FSM diluted in 5µM BSA (in PBS) was chosen as the starting 
concentration for all experiments.  
The past FSM literature imaged live cells to visualize trafficking and intracellular 
localization [58], [59], [84], and fixing cells prior to imaging was not addressed. However, 
research with Bovine Milk SM (BSM) at the Cal Poly Bioimaging Lab involved cell fixation 
prior to imaging [13], [14]. Therefore, to bridge the gap between FSM and BSM research, a 
secondary goal was to fix FSM-treated cells with 3.75% PFA to determine if the exogenous FSM 
signal was conserved after fixation (i.e. FSM can survive cell fixation). 
200µL of 5µM FSM diluted in 5µM of BSA (in PBS) was introduced to a monolayer of 
live KRT cells cultured in glass coverslip 8-well plates and incubated at 370C for 1 hour. After 
incubation, the FSM media was removed and washed gently with PBS. Samples were either 
imaged live or fixed in 3.75% PFA immediately prior to imaging. Confocal images were taken on 
the 40x and 100x objective. 
4.1.2 Results 
 
Figure 20 includes images of the first FSM experiment. Figure 20A depicts fixed KRT 
cells with FSM, while Figures 20B-D involve live cell imaging without 3.75% PFA fixation. The 
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FSM signal for both fixed and live cells appeared robust with an apparent high signal to noise 
ratio. Visually, no differences in signal brightness was visualized between the fixed and live cells.  
 
Figure 20: First FSM Study. (A) Fixed cells at 40x objective demonstrating that FSM signal 
survives PFA fixation, but a higher objective is a better indicator of intracellular fluorescence 
distribution. (B) Live cells at 100x objective showing blebbing (white arrow) from 
endocytosis/exocytosis, a mechanism for cellular FSM entry/exit. (C) Time image of live cells at 
100x objective. FSM is predominantly concentrated in the plasma membrane, with some 
intracellular accumulation. (D) Time image, 100x objective, with intracellular distribution (white 
arrow) of FSM into cells. 
 
Figure 20B-D were also taken on a higher confocal microscope objective (100x oil) 
compared to Figure 20A (40x oil). The higher magnification with larger numerical aperture 
(N.A.) enabled better visualization of intracellular FSM distribution. As shown by the white 
arrow in Figure 20D, clusters of fluorescence around the nucleus were visualized with the 100x 
objective. In addition, cellular phenomena like blebbing were observed, as demonstrated in 
A B 
C D 
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Figure 20B. Blebbing, plasma membrane protrusions during endocytosis and exocytosis of lipid 
and cellular byproducts, is a scientifically characterized process. The blebbing observed during 
imaging most likely occurred as cells endocytose, metabolize, and exocytose exogenous lipids 
like FSM. 
4.1.3 Discussion  
 
     The previously described experiment demonstrates that FSM incubation in KRT cell 
monolayers yields a bright and easily detectable signal. Furthermore, FSM can undergo fixation 
without a significant change in brightness or visual appearance. In addition, a higher objective 
with larger N.A., like the 100x, yields better resolution and is the objective of choice for future 
trafficking experiments involving intracellular fluorescence visualization. Lastly, two phenomena 
were visualized, both supported by literature [58], [60], [63], [84]. First, blebbing - protrusions of 
the plasma membrane - was observed as a potential indicator of FSM endocytosis or exocytosis. 
The cell accumulated FSM from its external supply in the media, then released its contents back 
into the environment. Endocytosis and exocytosis potentially mediate lipid homeostatic levels and 
have been characterized in scientific literature [63]. Furthermore, FSM accumulated in the plasma 
membrane of the KRT cells, then moved intracellular as clusters of fluorescence around the 
nucleus. The intracellular migration of FSM to regions close to the nucleus is also documented in 
literature [58], [60], [84]. Both phenomena observed in this first FSM study – blebbing and 
intracellular fluorescence migration – are important because they mirror published results and 
demonstrate that the current protocols (i.e. 5µM concentration, solution preparation, incubation 
with cells, and imaging) are sufficient to obtain scientifically relevant results. 
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4.2 Live FSM Intracellular Trafficking 
 
4.2.1 Summary and Objectives 
 
In the context of this thesis, trafficking is defined as the fluorescence distribution of FSM 
both inside and along the plasma membrane of a cell. Differences in FSM trafficking were 
compared and qualitatively assessed among image treatments by location (i.e. near the nucleus 
versus concentrated in the plasma membrane) and/or in brightness of signal (correlated with the 
amount of FSM present in a specific location). Location could then be correlated with metabolic 
activity [27]. The main goal of the following experiment was to determine qualitatively if FSM 
trafficking in live KRT cell cultures changed as a result of the 370C incubation time. It is 
important to note that cultures were not washed with PBS prior to imaging because the goal of 
this study was to assess the native in vitro FSM trafficking dynamics during continuous FSM 
incubations. 
     A secondary goal was to assess the suitability of live cell confocal imaging for FSM 
trafficking experiments. Live imaging presents a method to visualize live FSM trafficking within 
the same cell culture system. However, live microscopy can yield challenges which can affect 
image quality and cell phenotype. For example, continuous laser exposure during time scans of 
the same cell can photobleach the signal and yield a decrease in fluorescence brightness.  
     For the experimental procedure, a 370C FSM incubation was used because previous 
experiments demonstrated FSM entry was temperature-dependent and a 370C incubation was 
chosen for consistency [58], [59]. KRTs were cultured in 8-well plates and incubated with 200µL 
of 5uM of FSM for 10 minutes, 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 12 hours, and 24 
hours. FSM media was not removed prior to imaging in order to probe the cell conditions during 
a continuous FSM incubation. Cells were then imaged on the confocal at 100x objective, and both 
static and time-lapse images were acquired. 
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4.2.2 Results 
 
For this experiment, FSM was continuously incubated for 10 minutes, 30 minutes, 1 
hour, 2 hours, 3 hours, 4 hours, 12 hours, and 24 hours. The 488 laser was used at 15% power and 
611 PMT sensitivity. Timescan images (sequential 2D images over a specified time range and 
laser pulse) were obtained for each timepoint. Specifically, each treatment Region of Interest 
(ROI) was imaged for 5 minutes, with 5 seconds between each laser pulse for a total of 60 
images). Even after only 10 minutes of incubation, FSM was observed both at the plasma 
membrane and in the cytoplasm (Figure 21). 
 
Figure 21: Representative Images for Live FSM Trafficking with Variable Incubation 
Times. (A) 10 Minutes (100x), (B) 1 Hour (100x), (C) 12 Hours (100x). No difference in 
trafficking was observed between all timepoints, suggesting endocytosis and exocytosis 
homeostasis is reached early in the cell. The plasma membranes had a “shaggy” or coarse FSM 
staining because cells were directly probed during FSM media incubation and a wash step with 
PBS was not performed prior to imaging. 
 
More specifically, a bright plasma membrane staining was observed, and the staining was 
more intense compared to the first experiment. The reason for this could be due to the lack of 
FSM media washing prior to imaging. In the previous experiment, one gentle PBS wash was 
performed to remove residual extracellular FSM staining. The increase in plasma membrane 
fluorescence and coarse “shaggy” FSM appearance could be due to residual FSM weakly 
adherent to the plasma membrane that is usually washed off with PBS rinses. 
A B C 
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No qualitative change in fluorescence distribution or intensity was observed for all the 
timepoints. Whitelight overlaid with AF 488 images indicated that fluorescence distribution 
seemed to locate around the nucleus in the Golgi bodies, an observation which is supported by 
literature [58], [60], [84]. Figure 22 includes one static image of a 3 hour incubation, which 
serves as a representative image for all timepoints. 
 
Figure 22: Three Hour Incubation Live Cells with FSM and DIC. Representative image of all 
timepoints (10 minutes – 24 hour incubation) at 100x objective. Relatively consistent staining 
was observed among all timepoints. Intracellular fluorescence was concentrated around the 
nucleus in what appeared to be Golgi bodies (black arrow). Inset is an overlay of AF 488 (A) and 
DIC (B - whitelight). 
 
While taking timescans, significant photobleaching was observed. In addition, the cells 
appeared to move during the scan. In some cases, the cells shifted upwards and away off the 
coverglass. To demonstrate observed cell movement and photobleaching during imaging, Figure 
23 shows an image at the beginning of the scan (Figure 23A), and after 5 minutes of imaging with 
5 second pauses between laser scans (Figure 23B). Figure 23C shows an overlay of the first and 
last image of the timescan with Figure 23B pseudocolored blue.  
 
 
 
 
 
A B 
A B 
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Figure 23: Severe Photobleach of Live FSM Timescans. (A) First image of live timescan. (B) 
Last image of live timescan (after 5 minutes with 5 seconds between laser pulses) showing 
photobleaching, especially evident in the intracellular space. (C) Overlay of first image with 
pseudo-colored blue last image. The blue signal plasma membrane forms a halo around the green 
plasma membrane, suggesting the cell is pulling away from the plate and shifting upward in the z-
axis. 
A profile plot for the purple line in Figure 23 was generated through ImageJ and 
reproduced in Figure 24. The green and blue curves represent the first and last image in the time 
series respectively.  
 
Figure 24: Profile Plot of Signal Degradation and Cell Movement Over Time. The profile 
plot was constructed from the line drawn across the image in Figure 22. Green represents the first 
image and blue the last image in the scan. (A) intense plasma membrane localization, (B) 
intracellular fluorescence clusters near the Golgi elicit small spikes in fluorescence, (C) lack of 
signal in the nucleus. The blue plot has a significantly lower mean gray value and is shifted 
outward compared to the green line. 
 
A 
B B 
C 
A 
C B
 
A
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The intense peaks labeled with “A” in Figure 24 represent the plasma membrane, where 
two spikes in fluorescence are observed. In between the plasma membrane peaks are smaller 
peaks as indicated by “B”. These correspond to intracellular fluorescence outside the nucleus, 
possibly in the Golgi. Finally, the drop in fluorescence at “C” indicates the nucleus, where a lack 
of fluorescence signal is observed. 
Comparing the two curves, the blue exhibited a noticeably lower mean gray value than 
the green curve, demonstrating the observed photobleaching or fluorescence decrease in signal 
intensity due to prolonged laser exposure. The two peaks representing the plasma membrane also 
appeared to shift slightly outward, suggesting movement of the cell during imaging. 
4.2.3 Discussion 
 
The live trafficking with different continuous 370C incubation times suggested no 
difference in FSM intensity or localization over time. Both intracellular and plasma membrane 
staining was apparent even after just 10 minutes of incubation, and the location and relative 
intensities of the FSM signal during the start of each timescan were comparable. However, after 
the duration of the imaging, severe photobleaching and slight cell movements were observed. In 
addition, the plasma membrane fluorescence was brighter with an uneven, coarse FSM staining 
appearance compared to the previous live imaging experiment, potentially because the FSM 
solution was not washed off prior to imaging and residual FSM weakly adherent to cells was not 
removed with washing. 
Moving forward, treating the cells with FSM, washing off residual weakly adherent FSM, 
then fixing the cells with 3.75% PFA prior to imaging is preferable to live imaging because of the 
extra variability live imaging exhibits. Although live imaging warrants a more physiologically 
relevant real-time view of the cell, photobleaching and cell movement can skew data and make 
image analysis difficult. In addition, the lab was not equipped with a stage heat plate to keep the 
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cells at 370C so extended imaging durations could negatively affect cell phenotype. Extended 
imaging of the same cell culture past 1 hour is not possible with the equipment available in lab. 
Given the difficulty accounting for photobleaching and cell movement, future work proceeded 
with a more consistent fixed cell approach. 
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4.3 FSM Temperature Dependence 
 
4.3.1 Summary and Objectives 
 
     The goal of the subsequent experiment was to determine if the uptake of FSM is 
dependent on whether FSM is incubated at 370C prior to imaging. In other words, the goal was to 
assess if FSM entry into cells is temperature-dependent. It is hypothesized that a 370C incubation 
with the FSM media facilitates faster FSM incorporation into the cell [59]. In previous 
experiments with BSM, the lipid was also introduced to cells and incubated at 370C prior to UV 
radiation and imaging [13], [14]. If FSM uptake is indeed temperature-dependent for KRT 
monolayers, ensuring that cells are consistently incubated with FSM at 370C prior to 
experimentation is necessary in order to reduce extraneous variability. For this experimental 
protocol, freshly-made FSM was introduced to cells at room temperature and then immediately 
imaged by taking consecutive time series images. Images were compared to results obtained in 
previous experiments. 
4.3.2 Results 
 
Figures 25A-D represent various timepoints within an almost 2-hour imaging session. In 
the beginning, FSM accumulated in the plasma membrane (Figure 25A-B). Only after about 60-
90 minutes of live imaging at room temperature did FSM move intracellularly (Figure 25C-D). 
Furthermore, the intracellular movement was found to be highly heterogeneous and inconsistent, 
with some cells displaying bright cytoplasmic expression (Figure 25B white arrow). 
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Figure 25: Rapid FSM Entry and Temperature Dependence. (A-D) FSM after approximately 
90 minutes (100x objective). Heterogeneous staining is apparent. Some cells start rapidly 
accumulating FSM, but uptake is highly variable among cells. (E-H) Representative time images 
between C and D panel of plasma membrane blebbing and release of FSM into extracellular 
space after 90 minutes. 100x objective. 
Blebbing was again observed, as a cell released FSM to the extracellular space. Figure 
25E-H are zoom-in time-lapse images of cells contained within the white box in Figure 25C. As 
indicated by the white arrows in Figures 25E-H, the cell bleb diminishes in diameter, then 
eventually releases its fluorescent contents into the extracellular space, most apparent in Figures 
25G-H.  
 
 
 
E F G H t ~ 75 min t ~ 90 min 
C D 
B A t ~ 30 min t ~ 60 min 
t ~ 75 min t ~ 90 min 
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4.3.3 Discussion 
 
The previously described experiment suggests that FSM entry and intracellular staining 
does indeed depend on the temperature. Even after 60-90 minutes of imaging, cytoplasmic 
staining was inconsistent and heterogenous within the Figure 25 ROI. Some cells displayed bright 
intracellular fluorescence while others did not. The images suggest endocytic and exocytic 
blebbing processes are conserved, but perhaps occur at a slower rate because the cells were not 
cultured at physiologically relevant temperatures (370C). Incubation with FSM prior to imaging 
seems to ensure consistent, homogenous fluorescent labeling of the cells. This experiment 
suggests that the temperature of FSM incubation is one, of potentially many variables, that need 
to be conserved in subsequent experiments to reduce variability. It also serves to explain the 
behavior of BSM which could not be assessed in past research. In the future, all experiments will 
involve FSM incubation at 370C. 
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4.4 Fixed FSM Trafficking with Variable Incubation Times 
 
4.4.1 Summary and Objectives 
 
The goal of this experiment was to quantitively determine if FSM localization in a cell 
varied over a spectrum of continuous incubation times (10 minutes, 30 minutes, 1 hour, 2 hour, 3 
hour, 4 hour, 12 hour, 24 hour). Previous live images suggested that the distribution did not 
fluctuate significantly, but more consistent methods need to be utilized to yield data worthy of 
analysis (i.e. PBS wash to remove residual FSM, image a fixed cell culture). In addition, a larger 
sample size and image analysis program to quantify fluorescence are both necessary to make a 
conclusion. The results of this experiment are important because fluorescence distribution 
analysis could point towards an optimal incubation time for the SM treatments. 
Eight 8-well plates with monolayers of KRTs were independently incubated with FSM at 
370C for varying timepoints. Immediately after treatment, cells were gently washed once with 
PBS then fixed with 3.75% PFA. Six wells (n=6) per treatment (3 images/well) were imaged on 
the confocal using identical laser settings. 2D images were post-processed in ImageJ using the 
trafficking and rotation ImageJ and MATLAB programs to obtain the mean gray values over 
normalized distances from the nucleus. Finally, the area under each curve was calculated using 
MATLAB and plotted. ANOVA and Tukey HSD post-hoc tests were performed on the area data.  
4.4.2 Results 
 
Figure 26 includes representative images of fixed images during variable FSM 
incubations. Figure 26A-D show representative images for 10 minutes, 1 hour, 12 hour, and 24 
hour, respectively. Throughout all incubation times, the signal intensity and localization appeared 
to be conserved. Figure 26E and F includes a profile plot of a line drawn across the boxed cell in 
Figure 26A. The plot demonstrates that a brighter intracellular signal (red arrow) and dimmer 
plasma membrane signal (black arrow) are present in most cell images. 
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Figure 26: Fixed FSM Trafficking with Variable Incubation Times. (A) 10 min, (B) 1 hour, 
(C) 12 hour, (D) 24 hour, (E) Profile plot line draw across the boxed cell for the 10 minute 
treatment. (F) Corresponding profile plot. Red and black arrows denote intracellular and plasma 
membrane fluorescence respectively. Fluorescence localization and brightness appears to remain 
consistent regardless of incubation time. 100x objective. 
 
 To quantify intracellular fluorescence distribution, the 2D Fluorescence Distribution 
macros were utilized. Briefly, Region of Interests (ROIs) were drawn around each cell to outline 
the cytoplasm and nucleus. Lines were extended from the center of each cell nucleus and rotated 
3600 at 60 increments. The profile plots along each line were averaged. Finally, a MATLAB code 
A B 
C D 
E 
t ~ 10 min t ~ 1 hr 
t ~ 12 hr t ~ 24 hr 
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was used to normalize the average profile plot. Figure 27 includes three representative profile 
plots (Figure 27A-C) and an outlined cell ROI with corresponding profile plot lines extending 
radially from the nucleus center (Figure 27D). 
 
 
 
 
Figure 27: Example Workflow of 2D Fluorescence Distribution. (A-C) Profile Plots 
corresponding to the lines in (D). For each cell within the image, an ROI was drawn to 
encompass the cytoplasm and exclude the nucleus (purple outline). Lines extending radially from 
the centroid were formed and rotated 3600 at 60 increments. In total, 60 profile plots per cell were 
generated. The profile plots along each line were averaged, then the distance was normalized in 
MATLAB by linear interpolation between points. 
The final result of the fluorescence distribution macros was one curve of mean gray value 
on the y-axis and normalized distance from the nucleus on the x-axis. Data from each cell within 
the image was averaged. Then all three images/well were averaged to obtain one mean gray value 
vs. normalized distance for each well. Finally, each of the six wells were averaged to yield an 
average fluorescence intensity curve.  Figure 28 includes results of the trafficking data analysis 
for all eight continuous incubation times (10 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 
12 hour, 24 hour).  
A 
C 
B 
D 
(A) 
(B) 
(C) 
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Figure 28: FSM Trafficking with Different Continuous Incubation Times (n=6). Standard 
error bars are represented. 
 
Over time, the mean gray values slightly fluctuated close to the nucleus, but the variation 
and intensity considerably diminished farther from the nucleus. The results were supported by 
previous visual assessment (Figure 26). Independent of the incubation time, the signal was bright 
around the nucleus, and decreased in intensity farther from the nucleus. 
The amount of intracellular FSM corresponding to each treatment was also quantified by 
calculating the area under each curve with the CUM TRAPZ function in MATLAB. This was 
done to verify that FSM did not fluctuate significantly over various incubation times. It was 
expected that curves with a similar shape would yield similar area-under-the-curve 
measurements. Figure 29 includes a graphical representation of the area calculations. The relative 
amount of cytoplasmic fluorescence is plotted over 1 hour, 2 hour, 3 hour, 4 hour, 12 hour, and 
24 hour FSM continuous incubations.  
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Figure 29: Relative Amount of FSM in a Cell over Various Timepoints (n=6). # is p<0.05 for 
pairwise comparisons. $ is p<0.05 compared to global mean. No other significant pairwise 
differences between the groups according to Tukey HSD. Standard error bars are represented. 
The statistical assumptions were met. Data was normally distributed with equal variances 
(Appendix B). Furthermore, since each datapoint represented an average of all images within six 
different wells on a plate, independence was assumed. The 3 hour treatment (M 100.8k, SE 9.2k 
summative mean gray value) was statistically greater (16.6%) than the global mean (M 96.7k, SE 
5.28k summative mean gray value) with p-value of 0.0050. The 12 hour average (M 82.93k, SE 
6.09k summative mean gray value) was statistically lower (11.3%) than the global mean with p-
value of  0.0413. Tukey HSD p-value correction was performed on the data and an ordered 
differences report was generated to perform pairwise comparisons among the timepoints. The 
data demonstrated that no significant pairwise differences existed when comparing each 
timepoint to the other except for 3 hour versus 12 hour. Specifically, the average relative amount 
of fluorescence for 12 hours was 23.9% lower than the average relative amount for 3 hours (p 
0.0279). 
 
#,$ 
#,$ 
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4.4.3 Discussion 
 
Since data matched observed images, the trafficking and rotation program proved to be a 
useful analysis technique for the experimental data. The fluorescence distribution in a cell did not 
change significantly among the timepoints. Although the relative amount of FSM differed 
between 3 hours and 12 hours, the biological mechanism or significance is unknown. Since this 
was the only pairwise difference observed in the entire dataset, the difference was deemed to be 
an artifact of imaging error rather than biological significance. The amount of FSM added is finite 
and a cell cannot spontaneously generate more intracellular FSM at 3 hours, as the data possibly 
indicates. For example, fluctuations in laser performance between imaging sessions or small 
differences in FSM media volume introduced to the cells could induce slight deviations in FSM 
cytoplasmic fluorescence brightness.  
The data suggests that with a continuous supply of FSM in the media, an equilibrium is 
reached and the cell endocytoses and recycles FSM back to the plasma membrane for exocytosis 
at an equal rate. Intracellular fluorescence occurs even after just 10 minutes of 370 C incubation. 
The distribution, brightness, and amount of intracellular FSM is also independent of continuous 
incubation duration. Although contrary to the preliminary hypothesis (Section 2.15), these 
experimental results suggest that a shorter timepoint for SM incubation prior to UV could be 
sufficient (i.e. possibly a 1 hour incubation instead of 24 hours). The previous 24 hour incubation 
was chosen based on literature and prior to FSM adoption [13], [14]. Incubating for one hour can 
decrease experiment time enabling more convenient and efficient experiments. 
 Limitations of this experiment include potential error and bias introduced by the analysis 
program (Figure 30). For example, it was difficult for the program to distinguish surrounding 
bubbles or blebs from the cytoplasmic outline.   
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Figure 30: Troubling ROIs. (A) Inaccurate cellular outlines encompassing localized bubbles 
and blebs (white arrow). (B) Potential cell area data bias. 100x objective. 
 
Resulting protrusions in the outline (Figure 30A white arrow) can potentially skew data 
since all fluorescence within the ROI is quantified. Furthermore, a large cell versus small cell 
area potentially introduces data bias that could affect data. Cells with a larger area (Figure 30B) 
have more cytoplasm and more space between the concentrated Golgi fluorescence and plasma 
membrane, thus changing the fluorescence gradient and line profile plots. Although data 
normalization attempts to account for differences in cell size, the full extent of the cell area 
contribution to the data is unknown. In the future, accounting for cell size would be desirable to 
determine if a significant interaction exists between fluorescence distribution and cell area.  
Finally, the analysis program excludes multi-nucleated cells, and cells along the edge of 
the image field of view. Furthermore, the program has difficulty outlining out-of-focus images. 
Improvements to the actual program and implementation for 3D image sets would prove 
advantageous for the future. 
  
A B 
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4.5 FSM Trafficking with UV 
 
4.5.1 Summary and Objectives 
 
The next step in the progression of goal 1 was to introduce UV to the system. The main 
goals of the following experiments were to determine if a 40 mJ/cm2 UV radiation to a monolayer 
perturbs intracellular FSM fluorescence distribution and relative amount. Based on a search of 
recent literature, ceramide levels have been shown to increase after UVB radiation in KRT skin 
cells which offers photoprotection by increasing the apoptosis rates of potentially damaged cells 
[24]–[26]. However, the intracellular levels of SM in an irradiated cell are less characterized. 
Currently, no research groups combine exogenous SM treatment with UVB radiation in KRTs to 
quantify intracellular SM levels. Wanner et al. added a bolus of 5µM exogenous FSM to KRT 
cells and used High Performance Thin Layer Chromatography (HPTLC) to demonstrate a 25% 
decrease in SM levels to ceramide after 3 hours because of increased hydrolysis by SMase as the 
cell reaches homeostasis [85]. No UV was introduced to the system. Furthermore, Charruyer et al. 
and Uchida et al. claimed that ceramide levels increased, but SM levels surprising remained 
unchanged and did not fluctuate after UV [24], [25]. The ceramide increase was more likely due 
to CERT dysfunction after UV and was independent of SM levels [24]. However, exogenous SM 
was not administered, and endogenous levels were only quantified with HPTLC. Additionally, a 
fluorescence imaging methodology to visualize cellular fluorescence was not employed.    
Despite the recent studies, it is unknown whether the addition of both exogenous FSM 
and UV perturb lipid levels in a significant manner in KRT cells based on fluorescence 
intracellular distribution analysis. Based on previous research, it was hypothesized that FSM 
levels would either clearly decrease compared to the no UV control (as FSM is metabolized to 
ceramide) or remain relatively stable compared to the no UV control (because other mechanisms 
account for the increase in ceramide). However, the fate of the fluorescent probe is unknown. In 
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this current experiment, cells were introduced to FSM for 1 hour or 24 hour continuous 
incubations, FSM was removed, media was exchanged, and cells were immediately subjected to 
40 mJ/cm2 of UVB radiation. Cells were fixed 1 hour, 2 hour, 12 hour, and 24 hour post-UV. 
Three confocal images were taken of each well for a total of 6 wells (n=6) in the 1 hour 
incubation case and 4 wells (n=4) in the 24 hour incubation case. For the control, exact conditions 
were replicated for the 24 hour plate, except no UV was administered. The role of the control was 
to delineate metabolism from UV effects when explaining sources of observed FSM fluctuations 
in cells.  
4.5.2 Results 
 
Figures 31 and 32 include results of the post-UV fluorescence distributions for a 1 hour 
and 24 hour continuous incubation. Within each FSM incubation treatment, cells were fixed 1 
hour, 2 hours, 12 hours, and 24 hours post-UV and imaged on the confocal. 2D fluorescence 
distribution analysis was conducted on 3 images per well for a total of 6 wells and 4 wells in the 1 
hour and 24 hour incubation treatments respectively. Within each incubation time, the shape of 
the distribution curve remained consistent, with a spike around the nucleus and decreasing signal 
approaching the plasma membrane.  
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Figure 31: Fluorescence Distribution for 1 Hour Incubation (n=6 wells). Control (no UV) for 
the 24 hour timepoint is denoted in black. All post-UV timepoints exhibit similar mean gray 
values and are grouped close together, with the exception of the no UV control with demonstrates 
a visible reduction in average mean gray value around the nucleus and throughout the cell. 
Standard error bars are represented.
 
Figure 32: Fluorescence Distribution for 24 Hour Incubation (n=4 wells). Control (no UV) 
for the 24 hour timepoint is denoted in black. All post-UV timepoints have similar mean gray 
values throughout the cell and are grouped close together including the no UV control. Standard 
error bars are represented.  
For the 1 hour FSM incubation, the 12 hour curve exhibited a more gradual decline in 
FSM with higher mean gray values. Additionally, the no UV control (Figure 31 black curve) had 
a lower mean gray value throughout the cell. All post-UV timepoints within the 24 hour FSM 
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incubation including the no UV control (Figure 32 black curve) demonstrated similar mean gray 
values and curves were grouped close together.  
When comparing 1 hour and 24 hour incubation after various post-UV fixation times, one 
trend was apparent (Figure 33). In the 1 hour, 2 hour, 12 hour, and 24 hour post-UV conditions, 
the 1 hour FSM incubation time (indicated by the black curve) consistently exhibited a larger 
mean gray value compared to the 24 hour FSM incubation (gray curve). 
  
 
 
Figure 33: Comparison of Post-UV Fluorescence Distributions for 1 Hour and 24 Hour 
FSM Incubation. The 1 hour FSM incubation (black curve) had a consistently larger mean gray 
value compared to 24 hour FSM incubation (gray curve) along the entire cell distance from the 
nucleus. Standard error bars are represented. 
Finally, to confirm the trends demonstrated by the fluorescence distribution graphs, and 
to provide numbers for statistical data analysis comparisons, the area under each curve was 
quantified and plotted in Figure 34. Data was normally distributed with equal variances 
(Appendix B). 
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Figure 34: Relative Amount of Cytoplasmic Fluorescence for Various Times after UV. #, $, 
%, ε, *, & denote statistically different comparisons between the two with the same symbol 
(p<0.05). Standard error bars are represented. 
 
Tukey HSD pairwise comparisons were conducted in two ways: 1) within the same FSM 
incubation time (either 1 hour or 24 hour) to compare among post-UV timepoints, 2) within each 
post-UV timepoint (either 1 hour, 2 hours, 12 hours, or 24 hours) to compare between FSM 
incubation times. Within the 24 hour FSM incubation treatment, no significant pairwise 
differences in average cytoplasmic FSM fluorescence were observed among all post-UV 
timepoints and the no UV control. However, within the 1 hour FSM incubation treatment, some 
differences in FSM cytoplasmic fluorescence was observed. In particular, the 12 hour post-UV 
area under the curve (M 137.95k, SE 15k summative mean gray value) was significantly greater 
than 1 hour (M 92.1k, SE 6.55k summative mean gray values) (p 0.009) and 2 hour (M 97.85k, 
SE 5.92k summative mean gray values) (p 0.0331) by approximately 50% and 41% respectively. 
Furthermore, the no UV control (M 69.96k, SE 9.22k summative mean gray values) was 
significantly lower compared to the 24 hour post-UV timepoint (M 92.14k, SE 6.55k summative 
ε % & 
$ % ε *  
$ 
#*  
# * 
& 
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mean gray value)  (p-value 0.0065, 24% decrease) and 12 hour post-UV timepoint (p-value 
0.0002, 49.29% decrease). 
Within the same post-UV timepoint, comparisons between the 1 hour and 24 hour FSM 
incubations were conducted. The 1 hour incubation had a significantly higher average 
cytoplasmic mean gray value compared to the 24 hour incubation for both the 12 hour (1hour 
incubation: M 137.95k, SE 15k; 24 hour incubation: M 73.24k, SE 40.3k) (p-value 0.0004, 88% 
increase), 2 hour (1 hour incubation: M 97.84k, SE 5.92k, 24 hour incubation: 75.54k, SE 6.86k) 
(p-value 0.0418, 29.53% decrease), and 24 hour (1hour incubation: M 92.14k, SE 6.55k; 24hour 
incubation M 66.5k, SE 69.7k) (p-value 0.005, 38.5% increase) post-UV timepoints. 
4.5.3 Discussion 
 
Based on trafficking curves and area under the curves, there appears to be an increase in 
intracellular cytoplasmic cell expression for all post-UV timepoints after just 1 hour of FSM 
incubation compared to 24 hours FSM incubation. Additionally, FSM levels spiked at 12 hours 
post-UV for the 1 hour incubation while remaining fairly consistent throughout the 24 hour 
incubation. Within the 1 hour timepoint, 24 hour post-UV had more fluorescence expression than 
the control, 1 hour, and 2 hour post-UV timepoints. Lastly, no difference between the no UV 
controls were observed.  
It is unknown at this time why the intracellular fluorescence significantly increased at 12 
hours, especially since no new FSM is introduced to the system after UV exposure. Perhaps the 
increase is artificial and a result of variability or error in the measurement system or experimental 
parameters. More replicates are needed to further investigate this observation. Also, given the 
variability in the post-UV timepoints within the 1 hour incubation, more experiments are 
warranted to further understand the effects of a 1 hour incubation. A 1 hour FSM incubation 
shows promise because more variability among timepoints was observed, suggesting a 1 hour 
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incubation could elicit more biologically relevant changes post-UV. For example, the significant 
difference between 24 hour post-UV and control for 1 hour FSM incubation might suggest that 
UV alters cells to stop metabolizing FSM. No significant difference was exhibited between 24 
hour post-UV and 1 hour post-UV for the 1 hour FSM incubation. Furthermore, it is unknown 
why all 1 hour incubation FSM amounts were greater than 24 hour, especially since the previous 
FSM trafficking experiment demonstrated no significant difference among continuous incubation 
timepoints. Perhaps a combination of variable FSM metabolism rates and UV perturbation cause 
a significantly greater signal after 1 hour incubation.  
According to the preliminary mechanism hypothesis (Section 2.15), intracellular levels of 
post-UV FSM were expected to be lower than the no-UV control because FSM is hydrolyzed to 
ceramide and the fluorescent probe is cleaved and exocytosed from the cell. The exocytosed 
probe after FSM hydrolysis would result in a diminished total intracellular fluorescence. 
However, the data demonstrated contrary results (post-UV timepoints had greater intracellular 
FSM compared to control), highlighting the need to identify exactly where the downstream 
fluorescent probe localizes in a cell after FSM hydrolysis. Future colocalization experiments with 
FSM, lysenin (endogeneous SM), and ceramide could help elucidate the identity of the 
fluorescent signal – whether the fluorescence is an SM (colocalized with lysenin) or a fluorescent 
ceramide (colocalized with ceramide).    
This experiment demonstrated the value of controls. Comparisons cannot be made 
between UV and no UV for each timepoint because of the experimental conditions. The 
trafficking experiments involved continuous incubations with FSM. Experimental plates for the 
UV experiments, on the other hand, were incubated continuously with FSM for 1 hour or 24 
hours then the media was removed and non-FSM media was replaced immediately prior to UV. 
Post-UV, the cells were incubated in the regular KRT media for 1 hour, 2 hours, 12 hours, and 24 
hours. Thus, a direct comparison between each trafficking timepoint and the UV timepoint cannot 
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be made because two variables – the UV exposure and latent post-UV incubation in clean media 
prior to fixing – confound the results. The latent incubation without a constant supply of FSM 
would most likely decrease FSM intensity due to metabolism and decrease the fluorescence 
intensity. If a change was observed, it is unknown whether the difference would be from UV 
perturbation or FSM metabolism. The only control performed in this experiment was for the 24 
hour timepoints. In the future, controls for each timepoint are necessary to draw more relevant 
conclusions. 
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4.6 p21 Ratios for BSM and FSM Comparison 
 
4.6.1 Summary and Objectives 
 
The UV photoprotection benefit of BSM was compared to FSM, a fluorescent analogue 
of BSM, by quantifying the p21 positive to total cells within each well. P21 is an indicator of 
DNA damaged cells. Past studies have suggested BSM photoprotection for KRTs by 
demonstrating decreased p21 levels in UV exposed cells after BSM treatment compared to 
control [13], [14]. However, the functional equivalence of FSM as a suitable analogue for BSM 
has not been demonstrated. The goal of this experiment was to determine if FSM treatment 
reduces p21 levels in KRT cells after UV radiation in a similar manner to BSM. 
4.6.2 Results 
 
Cells were incubated with either BSM or FSM for 24 hours, washed, and exposed to 40 
mJ/cm2 of UV radiation. 24 hours post-UV, cells were fixed and stained for p21. The ratios of 
positive p21 to total cells were quantified for each treatment. Figures 35 and 36 include 
representative images of the SM treatment and control cases for both no UV and UV respectively. 
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          Merge            DAPI     AF 488 (FSM)    AF 647 (p21) 
 
BSM (-)  
UV (-) 
  
 
 
 
BSM (+)  
UV (-) 
    
 
FSM (-) 
UV (-) 
 
   
 
FSM (+) 
UV (-) 
    
Figure 35: No UV with BSM and FSM Treatment. (Top Row) BSM (-), UV (-). (2nd Row) 
BSM (+), UV (-). (3rd Row) FSM (-), UV (-). (Bottom Row) FSM (+), UV (-). Images 
demonstrate relatively low p21 nuclear expression (white arrow) suggesting that SM incubations 
are not cytotoxic. 40x objective. 
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           Merge           DAPI    AF 488 (FSM)     AF 647 (p21) 
 
BSM (-)  
UV (+) 
    
 
BSM (+)  
UV (+) 
   
 
 
FSM (-) 
UV (+) 
    
 
FSM (+) 
UV (+) 
 
   
Figure 36: UV with BSM and FSM Treatment. (Top Row) BSM (-), UV (+). (2nd Row) BSM 
(+), UV (+). (3rd Row) FSM (-), UV (+). (Bottom Row) FSM (+), UV (+). Reduced amount of 
nuclear p21 levels (white arrow) are apparent in the SM treatment cases compared to control no 
SM treatments. 40x objective. 
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 The above figures are separated by treatment and channel (either merge, DAPI, AF 488, 
or AF 647). DAPI shows nuclei, AF 488 shows the presence (or absence) of green FSM signal, 
and AF 647 indicates p21 fluorescence. The white arrow in Figure 35 demonstrates a clear lack of 
p21 nuclear signal (although faint baseline cytoplasmic expression is observed). Furthermore, the 
white arrow in Figure 36 denotes clear nuclear p21 expression which is easily distinguished and 
brighter than the baseline cytoplasmic expression. 
 Visual comparison of nuclear p21 expression among the images demonstrates that the no 
UV case has lower p21 expression regardless of SM treatment. The lower p21 levels suggest 
introducing BSM or FSM does not elicit cytotoxicity or increased cell cycle arrest levels 
compared to control. When 40 mJ/cm2 of UVB is introduced to the cells, nuclear p21 expression 
increases but the number of nuclei stained in the BSM and FSM treatments are lower. This 
observation supports photoprotective hypotheses for SM. Lower nuclear p21 levels correspond 
with decreased cell cycle arrest and photoprotection after UV. The observations were confirmed 
by calculating p21 ratios (p21 positive nuclei divided by total nuclei) for each image (Figure 37). 
Three confocal images were obtained per well, and four wells were analyzed per treatment (n=4). 
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Figure 37: p21 Ratio Results (n=4 wells). (A) BSM p21 Ratios. (B) FSM p21 Ratios. (C) 
Comparison Between Bovine Milk SM and C6-NBD SM p21 Ratios for UV Cases. Standard 
error bars are represented.  
 
P21 ratio results displayed photoprotective trends. Appendix B includes normality 
assumptions. Within the UV cases, the number of positive p21 cells was lower after treatment 
compared to no treatment for both FSM and BSM. As shown in Table VII, either adding BSM or 
FSM to UV(-) cells did not increase the p21 ratios. Furthermore, adding BSM and FSM 
decreased the p21 ratio after UV treatment. BSM and FSM decreased p21 levels by 51% and 
21.6% respectively. BSM exhibited a significant difference (p-value 0.0004). Although Tukey 
HSD pairwise comparisons did not indicate significance for FSM because of the low sample size, 
the trends are promising and would most likely demonstrate statistical significance given more 
replicates.  
A 
C 
B 
* 
* 
* 
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Table VII: Averages for All Treatments Demonstrating Trends 
Treatment Average (ratio of p21 
positive nuclei to total 
nuclei) 
SE 
BSM (-) 
UV (-) 
0.18 0.0125 
BSM (+) 
UV (-) 
0.13 0.0345 
BSM (-) 
UV (+) 
0.39 0.075 
BSM (+) 
UV (+) 
0.19 0.05 
FSM (-) 
UV (-) 
0.18 0.05 
FSM (+) 
UV (-) 
0.12 0.0419 
FSM (-) 
UV (+) 
0.37 0.0373 
FSM (+) 
UV (+) 
0.29 0.0358 
 
4.6.3 Discussion 
 
Although no significant differences were observed between FSM treatments, data 
suggests that FSM provides similar photoprotection to UVB exposed KRTs while not inducing 
cytotoxic effects. FSM decreased p21 levels by 21.6% compared to the no FSM control. 
Similarly, BSM decreased p21 levels by 51% compared to the control, which was statistically 
significant.  
The lack of significance for FSM and the smaller decrease in p21 ratio could be due to 
concentration discrepancies between FSM and BSM. Based on the molecular weight of bovine 
milk SM on the Avanti Polar Lipids website, the 0.1% BSM is equivalent to a 1.3 mM 
concentration [61]. Thus, the concentrations of FSM and BSM are not equivalent and the FSM 
concentration is significantly lower, possibly contributing to the reduced levels in photoprotection 
compared to BSM. Further research is needed to reconcile the concentration differences and 
optimize the concentration of FSM to yield maximum levels of p21 photoprotection. 
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4.7 FSM with Nile Red 
 
4.7.1 Summary and Objectives 
 
Nile red was introduced as a general lipid stain with a purpose to co-stain FSM in order 
to help with characterization. Colocalization of FSM with another stain could potentially help 
with identification (i.e. if the fluorescent signal is SM, if fluorescent SM has been degraded to 
ceramide, or if the signal is freely floating fluorescence). Specifically, FSM signal colocalization 
with Nile red would suggest whether the signal was attached to a general lipid (SM, ceramide, or 
another metabolite) or just a freely floating probe.  
The goal of this experiment was to determine the appropriateness of Nile red as a general 
lipid stain for colocalization with FSM. FSM was incubated with cells for 1 hour then removed, 
washed once with PBS, then fixed. 200µL of 5µM/mL Nile red was introduced to cells for 15 
minutes, then washed off. A nuclei counterstain was also performed.  
4.7.2 Results 
 
As Figure 38 demonstrates, the Nile red stain was robust with a high signal to noise ratio 
and yielded an intense signal throughout the entire cell. Figures 38A-D represent Nile red and 
FSM dual staining while Figures 38E-H correspond to cells only stained with Nile red (no 
exogenous FSM incubation).  
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Figure 38: Nile Red Representative Images. A-D Nile Red and FSM Dual Staining (100x 
objective) (A) Merge of Nile Red, FSM, and Hoechst. (B) Hoechst, (C) FSM, (D) Nile Red. E-H 
Nile Red Only (100x objective) (E) Merge, (F) Hoechst, (G) AF 488 channel (no FSM), (H) Nile 
Red. Some bleed through was observed from Nile red into the AF488 channel. With the addition 
of exogenous FSM, the brightness of the Nile red increased in (D) compared to (H). 
 
Visual comparison between the two Nile red images (Figure 38D and 38H) indicate that 
the dual stain with exogenous FSM yielded a brighter Nile red general lipid stain. This suggests 
Nile red was successful in demonstrating the increase in total cellular lipid content that occurs 
when exogenous FSM is introduced to a cell. However, some slight bleed through was observed 
in Figure 38G, most likely due to the bright Nile red signal and spectral overlap between the AF 
488 and AF 594 filters used to detect FSM and Nile red respectively. 
4.7.3 Discussion 
 
     Nile red proved to be a robust, bright stain with high signal to noise ratio. Furthermore, the 
Nile red brightness increased after FSM incorporation, suggesting it is sensitive enough to detect 
an increase in intracellular lipid content. However, the applications for Nile red are limited 
because it is a general lipid stain and not specific to either ceramide or lysenin. Ideally, a stain 
that only binds to endogenous SM or ceramide would provide a better way to identify FSM 
identity with colocalization quantification. Nile red was removed from future protocols, and 
A B 
C D 
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optimization was conducted on two new immunofluorescence stains, lysenin and ceramide, to 
quantify natural endogenous levels of sphingomyelin and ceramide and assess how exogenous 
introduction of FSM affects intracellular localization and relative abundance.  
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4.8 Lysenin Stain Optimization 
 
4.8.1 Summary and Objectives 
 
Lysenin is a novel probe that has been recently developed for fluorescence detection of 
endogenous cellular SM. Lysenin, is a 41-kDa protein obtained from purified coelomic fluid of 
the earthworm Eisenia foetida that binds selectively to SM [64]. Recent work has used lysenin 
and FSM to mark plasma membrane lipid rafts [65]. Building off of past research, a lysenin 
immunofluorescence protocol for this thesis was developed based on concentrations in published 
literature [64]. Immunofluorescence staining generally involves incubating the sample in the 
lysenin protein, washing off residual, incubating with a primary antibody against the lysenin 
protein, washing off residual primary, subsequently introducing a secondary against the species of 
the primary antibody, then washing and imaging [64] . A blocking buffer is also introduced to 
prevent non-specific binding of the lysenin protein, primary antibody, and secondary antibody 
[64].  
The goals of these lysenin optimization studies were to identify the optimal lysenin, 
primary antibody, and secondary antibody in order to reduce non-specific binding while obtaining 
a high signal to noise ratio. Three experiments were conducted to vary the blocking, lysenin 
concentration, primary concentration, and stain incubation times. Secondary concentration 
remained at a consistent concentration and incubation time throughout all experiments. The 
following results section includes a chart of experimental factors corresponding to each 
optimization step followed by images. 
4.8.2 Results 
 
Table VIII includes the experimental variables tested for in the first optimization study. 
Both the lysenin protein and primary antibody concentrations were varied while incubation time 
and blocking remained consistent. First, fixed 8-well plates were blocked with 2% BSA in PBS 
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overnight, then lysenin protein (at a concentration of 1µg/mL or 3µg/mL) was incubated with 
cells for 2 hours. Anti-lysenin primary antibody was subsequently introduced at dilutions of 
1/1000, 1/500, or 1/300 in PBS for 9 hours. Finally, a secondary antibody was added at a 1/300 
concentration in PBS for 1 hour and a Hoechst counterstain was performed. Thorough washing 
steps with PBS were added between each staining step. Table VIII also indicates the controls 
performed in the study, to assess whether non-specific binding or bleed through is a common 
occurrence. In the table, “X” denotes the indicated procedure was performed and “N/A” means 
that particular step was skipped. 
Table VIII: Optimization 1: Pilot Study 
IF Stain Concentration Incubation Time 
Blocking (B) 2% BSA in PBS Overnight 
Lysenin (L) 1µg/mL or 3 µg/mL 2 hr 
Anti-Lysenin Primary Ab (1) 1/1000, 1/500, 1/300 9 hr 
Secondary (2) 1/300 1 hr 
Hoechst (H) 0.05% 15 min 
Control Blocking Lysenin Primary Secondary Hoechst 
H X N/A N/A N/A X 
H+1 X N/A X (1/300, 9hr) X (1/300, 1hr) X 
H+1+2 X N/A X (1/300, 9hr) X (1/300, 1hr) X 
H+L+1 X X (1µg/mL, 2hr) X (1/300, 9hr) N/A X 
H+L+2 X X (1µg/mL, 2hr) N/A X (1/300, 1hr) X 
 
 
 Controls ensure that the fluorescence observed in the experimental condition (H+L+1+2) 
is truly an indicator of endogenous sphingomyelin levels and not a result of random binding or 
fluorescence by lysenin, primary, or secondary antibodies. The roles of the H, H+1, and H+L+1 
controls were to confirm that Hoechst does not bleed through into channels of interest and 
singular primary and lysenin are not demonstrating fluorescence when they should not (because 
the secondary fluorescence tag is not introduced in these controls). Furthermore, the role of 
H+1+2 and H+L+2 controls are to test for non-specific binding. If fluorescence is observed in the 
H+1+2 case, this means primary antibody is binding to non-specific regions of the cell even 
though lysenin protein is not present. Similarly, if the H+L+2 controls yield fluorescence, the 
94 
 
secondary antibody is non-specifically binding to the lysenin protein and other regions of the cell 
even when the primary antibody against lysenin is not present. Figure 39 includes unsatisfactory 
control images for H+1+2 and H+L+2. 
 
 
Figure 39: Control Images. (A-C) H+1+2 demonstrating non-specific primary binding (60x 
objective). (A) Merge, (B) DAPI, (C) AF 488. (D-F) H+L+2 demonstrating slight non-specific 
secondary fluorescence (60x objective). (D) Merge, (E) DAPI, (F) AF 488. 
 
An important takeaway from the images was that bright non-specific primary binding 
was observed in the H+1+2 case, meaning fluorescence was still observed even when lysenin, the 
protein that binds to sphingomyelin directly, was not present. This means the primary was 
binding randomly to locations in a cell. Further optimization was needed to attenuate the non-
specific primary binding in the H+1+2 case. 
Figure 40 includes images of the experimental images with all components of the staining 
procedure (H+L+1+2).  Lysenin and primary concentration were varied and overall image quality 
was assessed. 
A B C 
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Left and Right: 
Lysenin 1µg/mL (2 hours) 
Primary 1/1000 (9 hours) 
 
 
 
 
Left and Right: 
Lysenin 1µg/mL (2 hours) 
Primary 1/500 (9 hours) 
 
 
 
 
Left: Lysenin 1µg/mL (2 hours) 
Primary: 1/300 (9 hours) 
 
Right: Lysenin 3µg/mL (2 hours) 
Primary: 1/300 (9 hours) 
 
Figure 40: Experimental H+L+1+2 Images. (A-B) Two representative merge images of lysenin 
(1µg/mL) and primary (1/1000). (C-D) Two representative merge images of lysenin (1µg/mL) 
and primary (1/500). (E) Representative merge image of lysenin (1µg/mL) and primary (1/300). 
(F) Representative merge image of lysenin (3µg/mL) and primary (1/300). 60x objective. 
 
The figure demonstrates that bright staining and slight image oversaturation was 
observed for cells stained with 1/300 diluted primary and/or 3µg/mL lysenin protein (Figures 40E 
and 40G). 1µg/mL lysenin with 1/1000 primary yieded distinct plasma membrane staining 
(Figures 40A-B). Finally, the 1µg/mL lysenin with 1/500 resulted in image brightness between 
the two extremes.  
After this initial experiment, it was decided to progress with a 1ug/mL concentration of 
Lysenin and 1/500 primary dilution for 9 hours because the images matched observed staining 
morphology in published literature (bright plasma membrane staining) [65]. However, a 
subsequent experiment with the previously chosen settings still demonstrated significant non-
specific binding in the controls. Therefore, the primary incubation time was reduced to 1 hour. 
E F 
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The objective for reducing the primary incubation times was to decrease the saturation of primary 
and decrease the likelihood of non-specific binding. A more concentrated blocking buffer, 4% 
BSA in PBS/4% Goat Serum, was also introduced to the cells in a second optimization 
experiment with variables highlighted in Table IX. The role of the blocking buffer was to more 
thoroughly block free non-specific antigen sites. The goal of the following second optimization 
was to compare 1/500 and 1/1000 primary dilutions in order to choose the concentration with the 
least non-specific binding in the H+1+2 control. 
Table IX: Optimization 2: Comparison of Primary Concentrations 
IF Stain Concentration Incubation Time 
Blocking (B) 4% BSA in PBS/4% Goat Serum Overnight 
Lysenin (L) 1ug/mL 2 hr 
Anti-Lysenin Primary Ab (1) 1/500 
1/1000 
1 hr 
9 hr 
Secondary (2) 1/300 1 hr 
Hoechst (H) 0.05% 15 min 
Control Blocking Lysenin Primary Secondary Hoechst 
H+1+2 X N/A X (1/300, 9hr) X (1/300, 1hr) X 
 
Figure 41 includes representative images of H+1+2 controls for both 1/1000 and 1/500 
dilution of primary. However, both primary concentrations still exhibited slight non-specific 
fluorescence. Therefore, in the final optimization experiment, additional blocking buffer recipes 
were tested (Table X). 
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Figure 41: 1/1000 versus 1/500 Primary Dilution Comparison. (A) H+1+2 merge with primary 
(1/1000). (B) H+1+2 merge with primary (1/500). Insets zoomed-in views of (A) and (B) are 
included in the right panel. 100x objective. 
 
Buffers included the previously tested 4% BSA in PBS/4% Goat Serum, but the mild 
detergent Tween-20, was also introduced to the blocking buffer and washing solutions to help 
prevent further non-specific binding by more efficiently washing off weakly adherent bonds 
between the primary and random binding sites. Finally, a 4% nonfat milk powder in PBS/4% Goat 
Serum was introduced as an alternative blocking solution. 
Table X: Optimization 3: Blocking Buffer 
IF Stain Concentration Incubation 
Time 
Blocking (B) 4% BSA in PBS/4% Goat Serum 
4% BSA in PBS/4% Goat Serum + 0.05% PBS-Tween 
4% Milk in PBS/4% Goat Serum + 0.05% PBS-Tween 
Overnight 
Lysenin (L) 1ug/mL 2 hr 
Anti-Lysenin 
Primary Ab (1) 
1/1000 in Blocking 1 hr 
Secondary (2) 1/300 in PBS 1 hr 
Hoechst (H) 0.05% in PBS 15 min 
Control Blocking Lysenin Primary Secondary Hoechst 
H+1+2 X  X (1/300, 
9hr) 
X (1/300, 1hr) X 
H+L+2 X X (1ug/mL, 
2hr) 
 X (1/300, 1hr) X 
 
A B 
(B) 
(A) 
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Figure 42: Blocking Buffer Optimization Non-Specific Binding for H+1+2 Control. (A) 
4%BSA/Goat, (B) 4%BSA/Goat+PBS-Tween, (C) 4%Milk/Goat+PBS-Tween, (D) No Blocking. 
100x objective. 
 
Figure 42 includes representative control image results of the final blocking buffer 
optimization. Qualitatively, all three blocking buffers reduced the fluorescence observed in the 
blocking conditions and yielded relatively low green fluorescence signal. Ultimately, 
4%BSA/Goat+PBS-Tween was chosen for the final, optimized blocking buffer because the BSA 
and goat serum are more characterized than milk. Although some slight fluorescence was 
observed in all images (most apparent in the Figure 42A-D insets), the signal was deemed 
negligible and blocking was determined to be sufficient. Lab resources and time were directed 
towards further characterizing the stain in dual experiments. 
Finally, Figure 43 includes representative images of experimental H+L+1+2 treatments. 
The use of blocking and reducing primary incubations did not significantly affect staining 
efficiency. 
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Primary Optimization 
Left: Primary 1/1000 (1 hour) 
Right: Primary 1/1000 (9 hours) 
 
 
 
Blocking Optimization 
Left: Blocking 4% BSA/Goat in PBS 
Right: Blocking 4% BSA/4% Goat in PBS-Tween 
 
Lysenin 1µg/mL (2 hours) 
Primary 1/1000 (9 hours) 
 
 
 
Blocking Optimization 
Left: Blocking 4% Milk/4% Goat in PBS-Tween 
Right: No blocking 
 
Lysenin 1µg/mL (2 hours) 
Primary 1/1000 (9 hours)  
 
Figure 43: H+L+1+2 Staining Efficiency Comparisons During Optimization Steps. (A-B) 
1/1000 Primary optimization comparison demonstrating incubating for 1 hour. (A) results in a 
similar staining efficiency as the 9 hour incubation (B). (C-F) Blocking optimization images (60x 
objective) demonstrating that all blocking varieties yielded similar images. 100x objective. 
 
Staining efficiency did not seem to change when the primary incubation time was 
reduced from 9 hours to 1 hour (Figure 43A, B). Furthermore, keeping the lysenin and primary 
concentrations consistent, and changing the blocking variety did not yield remarkable differences 
in image quality. The characteristic bright plasma membrane with some intracellular expression 
was observed in all images. However, some heterogeneous lysenin staining among cells within 
the same images exists. This inconsistency has been cited in literature and is hypothesized to be a 
result of replicative cell senescence; KRTs from a higher passage number (P10) exhibit lower 
levels of lysenin staining compared to lower passage number (P4) cells [65]. Although cells with 
A B 
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a relatively low passage number were used (<P5) in all experiments, cell-to-cell variation could 
contribute to the observed heterogeneity. 
4.8.3 Discussion 
 
After extensive optimization experiments, the final lysenin staining parameters were 
optimized as the following in order to yield the best quality image (Table XI). These 
immunofluorescence staining parameters were utilized for subsequent dual staining with FSM. 
Table XI: Final Lysenin Staining Parameters 
IF Stain Concentration Incubation Time 
Blocking (B) 4% BSA in PBS/4% Goat Serum + 0.05% 
PBS-Tween 
Overnight 
Lysenin (L) 1ug/mL 2 hr 
Anti-Lysenin Primary Ab (1) 1/1000 in Blocking Solution 1 hr 
Secondary (2) 1/300 in PBS 1 hr 
Hoechst (H) 0.05% in PBS 15 minutes 
 
     The lysenin stain appears to mainly concentrate in the plasma membrane with some 
intracellular pockets of fluorescence. Although some very slight non-specific secondary binding 
was observed, the blocking capabilities of 4%BSA/Goat+PBS-Tween was deemed sufficient. 
Some heterogeneity was also observed among cells within the same image. These observations 
were consistent among all staining optimization stages and are cited in published literature to be a 
result of cellular senescence [65]. To confirm that cell senescence is leading to differences in 
lysenin staining, a cell division marker or proliferation assessment like alamarBlue® could be 
correlated with lysenin staining.   
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4.9 Ceramide Stain Optimization 
 
4.9.1 Summary and Objectives 
 
The goals of these ceramide optimization studies were to identify the optimal ceramide 
primary antibody and secondary antibody concentration in order to reduce non-specific binding 
while obtaining a high signal to noise ratio. Three experiments were conducted to vary the 
blocking, primary concentration, and stain incubation times. Similar to the lysenin experiments, 
secondary concentration remained at a consistent concentration and incubation time throughout 
all experiments. The following results section includes a chart of experimental factors 
corresponding to each optimization step followed by images. 
4.9.2 Results 
 
Table XII includes the experimental variables tested in the first optimization study. The 
primary antibody concentrations were varied while incubation time and blocking remained 
consistent. First, fixed 8-well plates were blocked with 2% BSA in PBS overnight, then anti-
ceramide primary antibody was subsequently introduced at dilutions of 1/200 or 1/300 in PBS for 
1 hour or 9 hours. Finally, a secondary antibody was added at a 1/300 concentration in PBS for 1 
hour and a Hoechst counterstain was performed. Thorough washing steps with PBS were added 
between each staining step. Table XII also indicates the controls performed in the study, to assess 
whether non-specific binding or bleed through is a common occurrence. In the table, “X” denotes 
the indicated procedure was performed and “N/A” means that particular step was skipped. 
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Table XII: Optimization 1: Primary and Controls 
IF Stain Concentration Incubation Time 
Blocking (B) 2% BSA in PBS/2% Goat Overnight 
Anti-Ceramide Primary Ab (1) 1/200, 1/300 1 hr, 9 hr 
Secondary (2) 1/300 1 hr 
Hoechst (H) 0.05% 15 min 
Control Blocking Lysenin Primary Secondary Hoechst 
H X N/A N/A N/A X 
H+1 X N/A X (1/300, 9hr) X (1/300, 1hr) X 
H+2 X X (1ug/mL, 2hr) N/A X (1/300, 1hr) X 
 
Figure 44 includes representative images of the controls H+2 (Figure 44A) and H+1 
(Figure 44B). The ceramide was conjugated with an AF 647 secondary and appears as white in all 
subsequent images. Some non-specific secondary binding was observed in the H+2 control, 
meaning secondary antibody was randomly binding to locations in a cell instead of selectively 
binding to just the ceramide primary antibody. No AF 647 ceramide channel fluorescence was 
observed in the H+1 control.  
 
Figure 44: Control Merged Images with DAPI. (A) H+2 control exhibits non-specific 
secondary binding, (B) H+1 control shows no random, unattributable fluorescence of the primary 
or Hoechst into the AF 647 ceramide channel. 100x objective. 
 
 Figure 45 includes representative images of H+1+2 experimental images for the four 
different treatments (1/200 for 1 hour, 1/200 for 9 hours, 1/300 for 1 hour, 1/300 for 9 hours). 
Within each well, heterogeneous staining was observed. Some cells exhibited diffuse, even 
A B 
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cytoplasmic staining (e.g. Figure 45C and 45D, while others had bright, uneven pockets or 
ceramide expression (e.g. Figure 45B). 
 
 
 
 
Primary: 1/200 (1 hour) 
 
 
 
  
 
 
 
 
Primary: 1/200 (9 hours) 
 
 
 
 
 
 
 
 
Primary: 1/300 (1 hour) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary: 1/300 (9 hours) 
 
 
Figure 45: Experimental H+1+2 Images. (A-B) Two representative merge images of primary 
(1/200) for 1 hour. (C-D) Two representative merge images of primary (1/200) and 9 hours. (E-F) 
Two representative merge image of primary (1/300) for 1 hour. (G-H) Two representative merge 
image of primary (1/300) for 9 hours. Within each treatment, inconsistent ceramide results were 
observed. Some cells had diffuse ceramide staining, while others exhibited pockets of intense, 
bright staining. 100x objective. 
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 Moving forward, the 1/300 primary concentration for 9 hours was selected because no 
differences in signal brightness was observed between the concentration variables, and 1/300 
conserves more reagent. Furthermore, 9 hours was chosen as the incubation timepoint because the 
image results suggested the cells were stained more evenly and consistently than the 1 hour 
staining treatment (Figure 45C versus 45A and Figure 45G versus 45E). Incubating for a longer 
time period allows more stain to penetrate the cell and potentially reduces heterogeneous staining 
occurrences. In the second follow-up optimization study, more blocking buffer variants (4% Goat 
in PBS, 4% BSA in PBS, and 4% BSA/4% Goat) were tested to reduce the non-specific 
secondary binding observed in the H+2 control (Table XIII). 
Table XIII: Blocking to Reduce Non-Specific Secondary Binding 
IF Stain Concentration Incubation Time 
Blocking (B) 4% Goat in PBS 
4% BSA in PBS 
4% BSA/4% Goat 
Overnight 
Anti-Ceramide Primary Ab (1) 1/300 9 hr 
Secondary (2) 1/300 1 hr 
Hoechst (H) 0.05% 15 min 
Control Blocking Lysenin Primary Secondary Hoechst 
H X    X 
H+1 X  X (1/300, 9hr) X (1/300, 1hr) X 
H+2 X X (1ug/mL, 2hr)  X (1/300, 1hr) X 
 
 
Figure 46: Control H+2 with 4% BSA/4% Goat Serum Blocking Merge Image with DAPI. 
No non-specific secondary staining is observed. 100x objective. 
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 Figure 46 depicts an image of a successful control with the 4% BSA/4% Goat Serum 
Blocking solution. In the last optimization experiment, primary ceramide antibody 1/300 and 
1/400 dilution concentrations were compared to further optimize the primary concentration and 
potentially save more reagent. Table XIV lists all other experimental factors and controls. Only 
primary concentration was modified. 
Table XIV: Further Reduction in Primary Concentration 
IF Stain Concentration Incubation Time 
Blocking (B) 4% BSA/4% Goat Overnight 
Anti-Ceramide Primary Ab (1) 1/300 
1/400 
9 hr 
Secondary (2) 1/300 1 hr 
Hoechst (H) 0.05% 15 min 
Control Blocking Lysenin Primary Secondary Hoechst 
H X N/A N/A N/A X 
H+1 X N/A X (1/300, 9hr) X (1/300, 1hr) X 
H+2 X X (1ug/mL, 2hr) N/A X (1/300, 1hr) X 
 
Figure 47 demonstrates that no difference in ceramide stain brightness or morphology 
was observed between the 1/300 and 1/400 primary concentrations. Both conditions yielded 
heterogeneous images with diffuse cytoplasmic staining in some images (Figure 47A, C) and 
patchy staining in others (Figure 47B, D). The 1/400 dilution was selected as the final ceramide 
concentration in order to conserve reagent and no difference was observed between 1/400 and the 
higher concentration. 
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Figure 47: 1/300 versus 1/400 Ceramide Primary Comparison. (A)1/300 dilution (60x 
objective) demonstrating diffuse staining. (B) 1/300 dilution (40x objective) with patchy staining. 
(C) 1/400 dilution (60x objective) with diffuse staining. (D) 1/400 dilution (60x objective) with 
patchy staining.  The ceramide stain again displayed inconsistent cytoplasmic expression. 
 
4.9.3 Discussion 
 
After several optimization experiments, the final ceramide staining parameters were 
optimized as indicated in Table XV in order to yield the best quality image: 
Table XV: Optimized Ceramide Immunofluorescence Parameters 
IF Stain Concentration Incubation Time 
Blocking (B) 4% BSA in PBS/4% Goat Serum  Overnight 
Anti-Ceramide Primary Ab (1) 1/400 in Blocking Solution 1 hr 
Secondary (2) 1/300 in PBS 1 hr 
Hoechst (H) 0.05% in PBS 15 minutes 
 
     These parameters will be utilized for subsequent dual staining with FSM and lysenin. The 
ceramide stained cells also demonstrated heterogeneous staining morphologies which was 
observed despite varying blocking, primary concentrations, and primary incubation time. The 
reason for the inconsistent staining is unknown at this time, but could be a result of the replicative 
A B 
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senescence hypothesis cited in the lysenin optimization studies [65]. In addition, few research 
groups employ immunofluorescence to stain ceramide, therefore a deficit of direct image 
comparisons exists. The localized pockets of inconsistently stained cells within the same well 
could indicate some biological or regional cell signaling effecting ceramide concentration in a 
cell. Senescence or proliferation markers could be correlated with ceramide to visualize any 
staining patterns. Further investigation into the inconsistency will be directed to future work for 
the lab, outside the scope of this thesis. 
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4.10 Dual Lysenin, Ceramide, and FSM Staining 
 
4.10.1 Summary and Objectives 
 
Dual immunofluorescence staining was performed with two main experiments focused 
first on exploratory qualitative assessment, and second, on quantitative fluorescence distributions 
of FSM, lysenin, and ceramide together. The goal of this first dual stain experiment study was 
mainly proof-of-concept to determine whether dual immunofluorescence staining of FSM treated 
cells with both lysenin and ceramide was possible. Dual staining with lysenin and ceramide 
immunofluorescence is novel and currently no published primary literature characterizes how 
ceramide and endogenous SM levels fluctuate in a cell after continuous incubations with 
exogenous FSM using immunofluorescence and imaging. Being able to visualize intracellular 
distributions of endogenous SM, ceramide, and FSM in a cell could potentially elucidate the 
cell’s response to exogenous SM treatments. Optimization of the dual staining protocol is 
warranted for future UV experiments to determine how lysenin, ceramide, and FSM change with 
UV perturbation.  
Given the time and resources available, only one exploratory experiment was performed 
prior to the main quantitative fluorescence trafficking study, and the optimized lysenin and 
ceramide protocols were used. 8-well plates with monolayers of KRTs were independently 
incubated with FSM at 370C for 24 hours. Immediately after treatment, cells were gently washed 
once with PBS then fixed with 3.75% PFA. Using the previously optimized immunofluorescence 
protocols for lysenin and ceramide, FSM treated cells were stained individually with lysenin and 
ceramide, then dual stained with both. Individual immunofluorescence followed previously 
established protocol. For the dual staining, plates were again blocked overnight at 40C with 4% 
BSA/4% Goat diluted in PBS-Tween. Next, the lysenin protein was incubated for 2 hours, 
washed, and followed by the lysenin primary antibody for 1 hour. Then the ceramide antibody 
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was incubated for 9 hours, followed by simultaneous secondary incubations (AF 647 goat anti-
mouse and AF 594 goat anti-rabbit) introduced to the cells at their respective concentrations. 
Finally, the nuclei were stained with Hoechst. Sufficient washing steps were performed between 
each step in the protocol. During imaging, z-stacks with a 1 µm step size were obtained to 
generate a 3D picture of cell staining. 
4.10.2 Results 
 
Figure 48 shows representative images for FSM and lysenin staining. Consistent with 
previous experiments, lysenin mainly stained the plasma membrane, but some intracellular 
fluorescence clusters were observed in a few cells (Figure 48A). Again, some heterogeneity was 
observed with some cells brightly stained with lysenin and others not. The FSM signal was still 
observed after immunofluorescence and the merge image with lysenin (Figure 48C) suggesting 
future colocalization analysis is possible.   
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Figure 48: 2D and Maximal Z-Projections of FSM and Lysenin Immunofluorescence. (A) 
2D image of AF 594 lysenin channel. Staining mostly concentrates along the plasma membrane 
(B) Z-projection of lysenin channel. Adding the 3D component to the images better represents 
lysenin distribution. (B) inset shows some regions of concentrated lysenin fluorescence (C) 
Merge 2D image AF 594 lysenin with AF 488 FSM. (D) Merge z-projection of lysenin and FSM. 
100x objective. 
 
 Since z-stacks were obtained for each image, Figure 48B and D show maximal 3D z-
projections of the z-stacks. 3D images are useful to show fluorescence distribution across the 
entire cell volume. Comparing 2D (Figure 48A) to the 3D projection (Figure 48B), a bright 
plasma membrane translates to a bright shell around the nucleus because the projection also 
includes plasma membrane on top of the nucleus that was excluded in the 2D confocal image. 
The boxed cell zoom inset further demonstrates the utility of these 3D renderings in showing 
bright pockets of concentrated lysenin fluorescence not visible with the 2D images. Furthermore, 
colocalization of the FSM and lysenin is easier to visualize by the bright orange and yellow shells 
surrounding the nucleus. 
B A 
C D 
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Figure 49: 2D and Maximal Z-Projections of FSM and Ceramide Immunofluorescence. (A) 
2D image of AF 488 FSM channel. (B) Z-projection of AF 488 FSM channel. (C) 2D image of 
AF647 ceramide. (D) Z-projection of AF 647 ceramide channel. 100x objective. 
 
 Figure 49 demonstrates that ceramide immunofluorescence staining with FSM was also 
successful because both fluorescence signals were visualized in both the AF 488 and AF 647 
channels. The z-projection images (Figure 49B and D) are again useful for visualizing holistic 
cell fluorescence. For example, the 3D image collects all ceramide fluorescence above the 
nucleus (Figure 49D). Entire cell volume images will most likely prove valuable for future 
fluorescence distribution and colocalization analysis. 
 Based on qualitative visual assessment of all images, two staining phenotypes were 
observed for both lysenin and ceramide (Figure 50). First, lysenin staining was either 
concentrated in the plasma membrane (Figure 50A-C), or intracellular in bright pockets (Figure 
50D-F). 
 
A B 
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Figure 50: Differential Staining of Lysenin and Ceramide. (A-C) Bright plasma membrane 
lysenin staining as demonstrated in the z-projection (A), 2D image (B), and orthogonal view (C) 
which shows distinct fluorescence far from the nucleus (white arrow). (D-F) Bright lysenin 
staining directly around the nucleus as demonstrated by the z-projection (D), 2D image (E), and 
orthogonal view (F) which shows distinct fluorescence only close to the nucleus (white arrow). 
(G-I) Distinct plasma membrane and intracellular ceramide staining as demonstrated in the z-
projection (G), 2D image (H), and orthogonal view (I) which shows fluorescence clustered 
around the nucleus (white arrow). (J-L) Absence of a definitive ceramide fluorescence signal as 
demonstrated in the z-projection (J), 2D image (K), and orthogonal view (L) which only shows a 
slight signal above the nucleus (white arrow). 100x objective. 
 
The orthogonal views (Figures 50C&F for lysenin and Figures 50I&L for ceramide) 
helped with visualization and confirmed the observations in both 2D slices and z-stacks. In a 
similar manner, ceramide also demonstrated two different staining characteristics observed within 
each treatment. Ceramide staining either yielded diffuse staining with some concentrated 
fluorescence around the nucleus (Figure 50G-I), or pockets towards the edges of the cell with 
varying degrees of brightness (Figure 50J-L). It is important to note that some cells within the 
same image field of view sometimes completely lacked fluorescence staining.  
Finally, Figure 51 includes images of dual immunofluorescence staining for both lysenin, 
ceramide, and FSM. With the current protocol, the FSM signal appeared to disintegrate and was 
severely degraded (Figure 51A&D). The laser power and sensitivity of the confocal PMT was 
manually increased to detect the demonstrated fluorescence levels in Figure 51B&D. 
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Figure 51: Z-Projection of FSM, Lysenin, and Ceramide after Dual Immunostaining. (A-C) 
60x objective image. (A) FSM demonstrating significant signal degradation, (B) Lysenin, (C) 
Ceramide. (D-F) 100x objective. (D) FSM, (E) Lysenin with pocket of weakly stained cells, (F) 
Ceramide. 
 
 The lysenin and ceramide signals did not seem to change after dual staining. Lysenin was 
still heterogeneous, with some bright plasma membrane. Ceramide was either diffuse or 
concentrated in pockets.  The reason for the FSM signal degradation was unknown and many 
factors could have contributed to the signal degradation (i.e. time, extra wash steps, using 
excessive detergent). The Tween-20 detergent added to the blocking and wash buffers was 
hypothesized to contribute to FSM degradation. 
4.10.3 Discussion 
 
     Dual immunostaining was successful because all three signals (FSM, lysenin, ceramide) 
were visible in the images. However, significant signal degradation of the FSM stain was 
observed, warranting future troubleshooting to elucidate the reason.  
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4.11 Troubleshooting FSM Degradation Observed after Dual Immunofluorescence 
 
4.11.1 Summary and Objectives 
 
The goal of the following experiment was to formulate a hypothesis for the FSM signal 
degradation observed during imaging. Multiple hypotheses can potentially explain this 
observation. 1) Time – FSM signal degrades over time when stored in PBS between experiments 
prior to imaging, with timepoints ranging from immediately after staining to up to two weeks. 2) 
Detergent – introducing extra Tween-20 detergent into the blocking and washing buffers leached 
FSM from the cell. 3) Protocol specific – the extra PBS washing steps could slowly remove the 
FSM signal. Furthermore, the addition of two antibodies could mask the FSM signal. The reason 
for decreased FSM is unknown, but the goal of the following experiment was to assess the effects 
of introducing Tween-20 to the blocking buffer and PBS wash. Tween-20 was identified as the 
target for the first optimization because its removal from the existing protocol was easier to 
implement. Briefly, FSM was introduced to cells at 370C for 1 hour, then the media was washed 
once with PBS and fixed. Cells were subsequently permeabilized with Triton X and either 
washed with PBS or 0.05% PBS-Tween. A control without permeabilization and washing was 
used to assess the extent of photobleaching. 
4.11.2 Results 
 
As the images demonstrate in Figure 52, introducing Tween-20 washes to the image 
system induced some degradation, as indicated by the reduced green fluorescence brightness in 
Figure 52C. The degradation in FSM signal was visibly greater than the Triton X with PBS wash 
treatment (Figure 52B). This result suggests that Tween-20 detergent in the blocking buffer and 
washing steps could potentially contribute to some signal degradation observed in the dual 
immunofluorescence images. 
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Figure 52: Signal Degradation from Various Staining Treatments. (A) Control, (B), Triton X 
permeabilization with PBS washes, (C) Triton X permeabilization with 0.05% Tween-20 Washes. 
100x objective. 
 
4.11.3 Discussion 
 
Although a decrease in signal was observed after adding a 0.05% Tween-20 to PBS wash, 
this troubleshooting experiment failed to recapitulate all the other variables in the dual 
immunostaining procedure. Tween-20 is merely one piece of the degradation dilemma, because 
dual stained FSM images exhibited significantly more photobleaching than what was observed in 
this troubleshooting experiment (Figure 53). For example, Figure 53A shows the FSM signal 
using the FSM laser power settings employed during 2D fluorescence trafficking experiments 
(Table IV). Figure 53B is an image of FSM incubated with cells for 1 hour then immediately 
fixed and imaged using the same laser power settings from Figure 53A and all fluorescence 
trafficking experiments. Finally, Figure 53C is an image of the same cells from Figure 53B, 
except the imaging settings were modified to match the laser power and PMT sensitivities used to 
obtain the images in Figure 51A&D (dual immunofluorescence settings Table V). The images 
demonstrate that dual immunostaining drastically degrades the FSM signal (lack of signal in 
Figure 53A). This means the laser and PMT settings need to be increased in order to detect a 
signal (as demonstrated by severe saturation of Figure 53C when Figure 53B was imaged with the 
new image settings). 
 
A B C Control Triton X Triton X Tween 
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Figure 53: Additional Signal Degradation Demonstrations. (A) Dual immunofluorescence 
FSM channel imaged using trafficking settings. (B) Normal FSM with no extra treatment imaged 
using trafficking settings (no dual staining). (C) Same FSM image but with dual 
immunofluorescence settings. 100x objective. 
Additional explanations for the diminished fluorescence could be FSM degradation in 
PBS during storage over time or numerous washing steps during the protocol. Further 
troubleshooting to identify the source of FSM degradation is currently being investigated in the 
lab but is outside the scope of this thesis. For the final experiment – FSM, lysenin, and ceramide 
fluorescence distribution – an increased laser power and PMT sensitivity was consistently used to 
image the FSM. 
 
  
A B C Trafficking Settings, 
Dual Staining 
Trafficking Settings, 
no Dual Staining 
Dual Settings, no 
Dual Staining 
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4.12 Dual Lysenin, Ceramide, and FSM Fluorescence Trafficking 
 
4.12.1 Summary and Objectives 
 
The goal of final dual immunostaining protocol was to quantitively determine if FSM, 
lysenin (endogenous SM), and ceramide localization in a cell varied over a spectrum of 
continuous incubation times (10 minutes, 1 hour, 2 hour, 12 hour, 24 hour, and control without 
exogenous FSM incubation). The same 8-well plates used for FSM fluorescence distribution in 
Experiment 4.4 were dual immunostained for both lysenin and ceramide according to previously 
established protocol. Four wells (n=4) per treatment (3 images/well) were imaged on the confocal 
and z-stacks with 1µm step sizes were obtained using identical laser settings. 2D images were 
post-processed in ImageJ using the trafficking and rotation ImageJ and MATLAB programs to 
obtain the mean gray values over normalized distances from the nucleus for all three stains. The 
ceramide channel was used to create the cytoplasmic ROI which was then applied to the FSM and 
lysenin channels. Finally, the area under each curve was calculated using MATLAB CUM 
TRAPZ function and plotted. ANOVA and Tukey HSD post-hoc tests were performed on the 
area data.  
4.12.2 Results 
 
Figure 54 includes representative images of FSM, ceramide, and lysenin after 10 minutes, 
1 hour, 2 hour, and 12 hour continuous incubations. The 24 hour and control timepoints were not 
analyzed because of high variability among all three stains which made determining each cell 
ROI difficult. Two representative images for the 1 hour and 2 hour timepoints are included to 
demonstrate ceramide staining inconsistency observed throughout all timepoints. The only 
noticeable differences among all the channels was within the lysenin staining. A brighter plasma 
membrane fluorescence was observed in the 1 hour cases. Furthermore, in the 2 hour cases, more 
intracellular fluorescence around the nucleus was apparent.  
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Timepoint            DAPI                          FSM                          Lysenin                    Ceramide 
 
 
 
10 Min 
 
 
 
1 Hour 
Example 
#1 
 
 
 
1 Hour 
Example 
#2 
 
 
 
2 Hour 
Example 
#1 
 
 
 
2 Hour 
Example 
#2 
 
 
 
 
12 Hour 
 
 
Figure 54: Representative Dual Immunofluorescence 2D Images for Various Continuous 
FSM Incubation Times. 100x objective. 
Two 1 hour and 2 hour examples are provided to demonstrate that the inconsistent 
ceramide staining made fluorescence distribution quantification difficult. Because the ceramide 
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channel was used to generate the ROI for the program quantification, uneven ceramide 
cytoplasmic staining means the automated macro cannot reliably outline the cell, thus introducing 
potential bias by only outlining and quantifying cells with a more even cytoplasmic ceramide 
fluorescence. 
 Figures 55 and 56 include fluorescence localization results generated from the 2D 
fluorescence distribution program. The results for FSM, lysenin, and ceramide after different 
continuous incubation times are presented in separate graphs. Comparisons between stains (in 
terms of brightness) cannot be made because the signal intensity for one stain (i.e. FSM) is not 
directly related or proportional to the signal intensity of another stain (i.e. ceramide). This is due 
to a variety of factors including different dilutions of secondary antibodies were used for 
immunofluorescence. It is interesting to note that a peak close to the plasma membrane was 
observed in the 1 hour (Figure 55B black arrow). This correlates with the 1 hour images which 
displayed a bright plasma membrane staining (Figure 54). Furthermore, the 2 hour lysenin 
timepoint fluorescence distribution curve exhibited a spike in fluorescence close to the nucleus 
(Figure 55B red arrow). The data also appears to correlate with images (Figure 54). No other 
differences in fluorescence distribution curves for FSM, lysenin, and ceramide were observed. 
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Figure 55: FSM, Lysenin, and Ceramide Fluorescence Distributions over Variable 
Continuous Incubation Times (n=4 wells). (A) FSM, (B) Lysenin, (C) Ceramide. 
 
Figure 56: Relative Amounts of Ceramide, FSM, and Lysenin. No significant differences 
among ceramide and FSM timepoints. # significant difference from global mean. * significant 
difference from each other. Standard error bars are represented. 
* 
# * 
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Tukey HSD pairwise comparisons were only employed for comparisons within each stain 
(Figure 56). Appendix B includes results of statistical assumptions. No significant differences 
were observed among FSM and ceramide timepoints. However, for the lysenin stain, the 2 hour 
(M 53.9k, SE 3.64k summative mean gray value) was significantly greater than the global mean 
(M 41.53k, SE 4.3k) (p 0.0083 increase of 30%) and 10 minutes (M 33.7k, SE 3.51k) (p 0.0366 
increase of 60%). 
4.12.3 Discussion 
 
After immunofluorescence staining and trafficking analysis, results demonstrated that no 
significant differences existed within the individual ceramide and FSM stains for 10 min, 1 hour, 
2 hour and 12 hour incubation timepoints. Furthermore, FSM data mirrored results from the prior 
FSM trafficking experiment, even though signal degradation was observed. Within the lysenin 
stain, the 2 hour was significantly greater than the 10 minute incubation (60% increase). The 
fluorescence distribution graphs for lysenin also mirrored the intense plasma membrane staining 
in the 1 hour and predominant intracellular fluorescence in the 2 hour.  
Despite the significant difference between lysenin 2 hour and 10 minutes, the biological 
significance is unknown and could be attributed to measurement error or variability within the 
system. The lysenin fluctuations suggest endogenous SM levels are changing in a cell, but 
differences in FSM intensity alone were not detectable with the current analysis method. The 
inability to detect significant differences in the ceramide stain could also be a result of 
heterogeneous staining that biased or diluted observable differences. The variability was most 
apparent in the 24 hour and control plates making fluorescence distribution analysis impossible. 
More replicates are needed to obtain scientifically relevant data.  
 Future steps include troubleshooting the reason for inconsistent staining, and either 
developing a novel analysis technique to reduce bias or analyzing diffuse and patchy ceramide 
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cells separately. Another improvement is analyzing fluorescence distribution in 3D to account for 
signal above/below the nucleus. Finally, more experiments are needed to isolate the cause for the 
FSM signal degradation. Although Tween-20 was removed from all washes and blocking buffers, 
degradation was still observed, which suggests the problem is multifaceted and dependent on 
multiple variables. Instead of quantifying dual immunofluorescence images, the colocalization 
analysis could be implemented in FSM cells stained either with lysenin and ceramide 
individually; taking a step back reduces variability and simplifies the complex staining protocol.  
     Before developing an accurate colocalization method, the stains need to be further 
optimized to reduce variability within ceramide and isolate the cause for FSM degradation. 
Overall, the experiment is promising and demonstrates that dual immunostaining is possible, with 
more optimization in the future. Eventually, the improved staining protocol could be applied to 
irradiated cells in order to assess post-UV lysenin and ceramide fluctuations. 
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4.13 Spheroid Trial 1: KRTs and 3T3 Single Culture in Non-Adherent U-Wells 
 
4.13.1 Summary and Objectives 
 
Spheroids prove to be a novel method of 3D culture in order to recapitulate the dynamics 
of cell behavior in a microenvironment similar to tissue [69]–[77]. One goal within the Cal Poly 
Bio Imaging Lab is to generate a 3D model of physiologically relevant skin to test the BSM and 
FSM lipid treatments and assess UV photoprotection. Spheroids could potentially serve as one 
solution but require extensive testing to demonstrate the model is physiologically accurate and 
equivalent to current 2D monolayers employed in the lab. In general, spheroids can form in a 
variety of methods with one being non-adherent static culture [69]–[77]. A binding agent, such as 
methylcellulose, is introduced to the cell suspension and mixed before being dispensed into non-
adherent 96-well plates [69]–[77]. The well culture surface prevents cell attachment while the 
methylcellulose aids in binding among the cells [69]–[77]. After several days of culture, spheroid 
formation is usually visible under the whitelight microscope, then various treatment conditions 
(i.e. Hoechst nuclei staining and imaging) can be performed on each individual spheroid. 
For this thesis, several experiments were conducted on spheroids, the first being proof-of-
concept to assess the ability of 3T3 and KRT cells to form single-culture spheroids in non-
adherent culture conditions. 3T3 cells were chosen as a cell type because they were readily 
available in lab, possess robust growth characteristics, and proliferate rapidly as an immortalized 
cell line. Both 3T3 and KRT cells were cultured under normal conditions, then trypsinized and 
suspended in a 2% v/v methylcellulose suspension diluted in 3T3 or KRT media. The appropriate 
cell number was suspended in the methylcellulose media to ensure approximately 1000 cells were 
seeded per spheroid. 100µL of cell suspension was pipetted into each well of the 96-well plate (at 
a seeding density of 1000 cells per spheroid). Spheroids were allowed to grow in their non-
adherent condition for about 5 days and morphology was assessed visually under the whitelight 
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microscope every two days. At the end of the 5 day culture, each spheroid was aspirated with a 
1000µL pipet tip, then placed into a conical tube; about three spheroids were added to each tube. 
Spheroids were gently washed once with PBS, fixed for 20 minutes with 3.75% PFA, then 
stained with 0.1% Hoechst diluted in PBS for 20 minutes. The working volume of the solutions 
added to each conical was 200µL. Finally, spheroids were washed three times with PBS, then 
pipetted into 8-well glass coverslip plates for imaging. Spheroids were located on the confocal 
then z-stacks with a 1µm step size were obtained from the start of the spheroid (at the glass 
coverslip interface) to the limit of working distance for the confocal. 
4.13.2 Results 
 
After two days of culture, spheroids in non-adherent U wells were inspected under the 
whitelight microscope. While 3T3 spheroids formed a definitive spherical shape (Figure 57A), 
KRT spheroids were not visible and only small, less distinct clusters of KRTs were observed 
(black arrows in Figure 57B). 
  
Figure 57: Whitelight Images of 3T3 and KRT Spheroids after 2 Days for Culture. (A) 3T3 
cells formed a distinct spheroid. (B) KRT cells failed to form spheroids and instead small clusters 
of cells were visible (e.g. black arrow). 
 
 Figure 58 includes z-projections of the confocal z-stacks for a representative KRT spheroid 
(Figure 58A) and 3T3 spheroid (Figure 58B). The confocal z-stacks mirrored the whitelight images 
A B 
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in Figure 57. Only small aggregates of KRTs were observed while a distinct spheroid (with 
diameter of approximately 200µm) formed in the 3T3 culture. 
 
  
 
  
Figure 58: Representative Images of KRT and 3T3 Spheroids. (A) KRT cells failed to form 
spheroids. (B) 3T3 spheroid. (C) Orthogonal view of 3T3 spheroid showing that the Hoechst dye 
did not penetrate into the depth of the spheroid. (D) 2D image of start of z-stack, (E) 2D image of 
middle of z-stack, (F) 2D image of end of z-stack demonstrating the lack of Hoechst dye visibility 
at the interior core of the spheroid. 40x objective. 
 
 Due to the thickness of the spheroid and limited working distance of the 40x confocal 
objective, the entire spheroid was not able to be imaged. Figure 58C shows an orthogonal view to 
demonstrate that only the tip of the spheroid was imaged. As the z-stack depth increased, the 
intensity of the Hoechst stain diminished. Figures 58D-F include representative 2D images of the 
spheroid during z-stack sectioning. At the start of the spheroid, bright fluorescence is visible in 
the middle of the frame (Figure 58D), then progressively radiates outward as the scan depth 
increases (Figures 58E-F). 
A B C 
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 Another observation during imaging was that the Hoechst dye failed to penetrate into the 
interior of the spheroid.  In Figure 58F, a clear lack of Hoechst dye was observed in the center. 
4.13.3 Discussion 
 
3T3s, but not KRTs, were able to form robust spheroids, and confocal imaging 
demonstrated that the Hoechst dye did not penetrate sufficiently into the interior of the spheroid. 
In order to encourage KRTs to form spheroids, it was hypothesized that fibroblasts were needed 
to facilitate adhesion. The concentration of methylcellulose and seeding density (among other 
factors) could also affect spheroid formation. Therefore, in the subsequent experiment, co-culture 
spheroids of 3T3s and KRTs were cultivated for different seeding densities and methylcellulose 
concentrations. 
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4.14 Spheroid Trial 2: KRT and 3T3 Dual Culture 
 
4.14.1 Summary and Objectives 
 
The goal of the following experiment was to assess whether culturing KRTs with 3T3s 
facilitated spheroid formation. Multiple parameters (methylcellulose concentration, total cells per 
spheroid, and seeding density ratios) were varied as indicated in Table XVI. Note that the media 
composition ratio matched the seeding density ratio (i.e. if cells were mixed 1:1, the media for the 
spheroid was also mixed 1:1). In order to distinguish the KRTs from 3T3s, CellTracker Red was 
incubated with the KRTs to stain their cytoplasm. All cells were stained with Hoechst. 
Table XVI: Experimental Parameters Varied for Dual 3T3 KRT Spheroids 
Experimental Parameter Value 
Methylcellulose Concentration 20% v/v 
40% v/v 
Total Cells 1,000 
5,000 
Seeding Densities Ratio (3T3:KRT) 1:1 
2:1 
1:2 
Media Composition Ratio (3T3 media: KRT 
media) Matched seeding density ratio 
1:1 
2:1 
1:2 
Culture Time 5 Days 
 
4.14.2 Results 
 
Visual inspection under the whiltelight microscope after 3 days of culture suggested that 
spheroids formed in the dual culture cases with 3T3s and KRTs (Figure 59A&B). No spheroids 
were generated in the KRT only culture (Figure 59C). Furthermore, in the dual culture, some 
satellite colonies or small aggregates of cells formed around the main spheroid (black arrow). 
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Figure 59: Whitelight Images after 3 Days of Culture. (A) 2:1 40%. (B) 1:1 40%. (C) KRT 
only 40%. Satellite colonies of KRTs are observed surrounding the main spheroid (arrow). No 
spheroids formed in the KRT only culture. 
 
Figure 60 includes representative images of dual spheroids of different parameters. The 
bright red fluorescence with blue nuclei stain corresponded to KRTs stained with CellTracker red 
cytoplasmic stain. Hoechst nuclei without CellTracker staining distinguished 3T3 from KRT 
cells. The representative images demonstrate that KRTs were present in the spheroids, but the 
degree to which they integrated into the spheroid varied. In most cases, the KRTs did not evenly 
distribute and instead formed satellite colonies (as demonstrated by the intense red fluorescence 
clusters). 
 
 
 
 
 
A B C 
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Figure 60: Z-Projections of Confocal Spheroid Z-Stacks. (A) 3T3: KRT at 1:1 ratio with 1,000 
cells total and 40% methylcellulose (B) 3T3: KRT at 1:1 ratio with 5,000 cells total and 40%, 
methylcellulose (C) 3T3: KRT at 2:1 ratio with 5,000 cells and 20% methylcellulose (D) 3T3: 
KRT at 2:1 ratio with 5,000 cells total and 40%, methylcellulose (E) 3T3: KRT at 1:2 ratio with 
5,000 cells total and 40% methylcellulose. 40x objective. 
 
4.14.3 Discussion 
 
The dual spheroid experiment suggests that 3T3 fibroblasts are needed to encourage KRT 
spheroid formation. However, KRT integration was limited and satellite colonies were observed 
adjacent to the main 3T3 spheroid. Future steps include repeating this study and investigating 
other factors to encourage full KRT incorporation into spheroids. Furthermore, using a more 
relevant dermal fibroblast model could potentially encourage KRT spheroid formation. 
  
A B 
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4.15 Spheroid Trial 3: Culture with Agarose-coated Flat Bottom Wells with Triton X and 
FSM Incorporation 
 
4.15.1 Summary and Objectives 
 
The main goals for this final trial were three-fold. Table XVII summarizes the 
experimental parameters used for this third experimental trial. First, flat bottom wells were coated 
with agarose to substitute for the more expensive Corning® non-adherent U-well utilized in past 
experiments. 96-well flat bottom plates were coated with 200µL to form a meniscus and 
nonadherent surface. Approximately 1,000 3T3 cells suspended in 20% v/v methylcellulose were 
seeded per 8-well plate and incubated for 5 days. 
The second goal was proof-of-concept to determine if FSM fluorescence would be 
present after incubation with the spheroids. 5uM FSM solution was introduced to 3T3 spheroids 
for 1 hour and 24 hours. Immediately after the incubation, the spheroids were fixed and prepped 
for subsequent staining. 
Finally, the third goal was to assess whether Triton X permeabilization could encourage 
Hoechst penetration into spheroids. Half of the 3T3 spheroids were incubated with 0.1% Triton X 
for 20 minutes, then all spheroids were stained with 0.1% Hoechst for 24 hours.  
Table XVII: Spheroid Trial 3 Experimental Parameters 
Methylcellulose Concentration 20% 
Total Cells 750-1000 cells/spheroid 
Culture Time 5 Days 
Treatment 5uM FSM for 1 hour or 24 hours 
Permeabilization 
 
0.1% Triton X 20 minutes 
No Triton X 
Staining 0.1% Hoechst for 24 hours 
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4.15.2 Results 
 
Figure 61 includes white light images of 3T3-methylcellulose solutions seeded onto 
agarose coated wells (Figure 61A) and non-agarose coated wells (Figure 61B). Spheroid 
formation under agarose conditions was successful. Agarose coating formed a concave meniscus 
and simulated the U-well shape of the previously used Corning® plates (Figure 61C). 
 
Figure 61: Agarose is Necessary and Sufficient to Create a Non-Adherent Environment for 
Spheroid Formation of 3T3 Cells. (A) Agarose, (B) No Agarose, (C) Agarose Meniscus (black 
arrow) 
 
Finally, Figure 62 includes representative images of the spheroids incubated with FSM 
then permeabilized with Triton X prior to Hoechst staining. Even with permeabilization, Hoechst 
did not penetrate the interior of the spheroids (Figure 62 C&E). Furthermore, the FSM fluorescence 
was only observed along the top of the spheroid, independent of the incubation time and Triton X 
incubation (Figure 62 F, G, H). 
 
 
C 
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Figure 62: Orthogonal View of 3D Spheroid with FSM and Triton X. (A) Representative 
FSM spheroid z-project. (B) Start of z-stack for representative FSM spheroid. (C) Corresponding 
orthogonal view. (D) Middle of z-stack for representative FSM spheroid (E) Corresponding 
orthogonal view. (F) FSM 1 hour, no Triton X (G) FSM 24 hours, no Triton X (H) FSM 24 hours, 
Triton X. 40x objective. 
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4.15.3 Discussion 
 
Results from this final experiment suggest that agarose coating is a sufficient alternative 
to Corning® U-well plates in terms of promoting 3T3 spheroid formation. Furthermore, agarose 
provides a more cost-effective alternative.  
Unfortunately, Triton X incubation did not mitigate the Hoechst penetration 
insufficiencies. FSM also failed to penetrate deep into the spheroid and instead collected at the 
top of the spheroid regardless of incubation duration. Future steps include running more studies 
on the agarose coated wells and investigating other factors responsible for the lack of Hoechst 
and FSM penetration into the interior of the spheroids.  
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4.16 Spheroid Quantification: Dye Penetration 
 
4.16.1 Summary and Objectives 
 
For the final spheroid experiment, a method was developed to quantify dye penetration 
into 3D spheroids. This analysis method could potentially be used for future studies into FSM dye 
penetration.  
4.16.2 Results 
 
Figure 63 includes multiple images of the process for spheroid depth of penetration 
analysis. Each image in the z-stack was thresholded to remove slices without a fluorescence 
signal (Figure 63 A&B). A projection of the entire z-stack was used to outline the spheroid 
(Figure 63 C). Using the spheroid outline, the 2D fluorescence distribution macro was run on 
slices corresponding to the start, 1/10, 2/10, 3/10, 4/10, 5/10, 6/10, 7/10, 8/10, 9/10, and end of 
the z-stack. Figures 63D-F show representative images of divisions 1/10, 3/10, and 8/10. Figure 
63G is a graphical representation of the fluorescence distributions for each division. Note that 
divisions 2/10 and 3/10 have bright staining close to the center, then the fluorescence moves 
outward towards the end of the outline as the depth increases. Finally, Figure 64 shows results of 
the CUM TRAPZ area under the curve calculations for each image division across all treatments. 
The amount of fluorescence peaks at 2/10 divisions then gradually drops as the depth increases. 
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Figure 63: Analysis Method for Spheroids. (A) Slice in Spheroid, (B) Binary, (C) Z-projection 
with outlines, (D) 1/10 division, (E) 3/10 division, (F) 8/10 division. (G) Graphical representation 
of the fluorescence distribution. 
 
E 
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Figure 64: Relative Amount of Hoechst Dye over Normalized Spheroid Depth. Standard error 
bars are represented. 
 
Despite a high concentration of Hoechst and 24 hour incubation, the dye failed to 
penetrate the interior of the spheroid. Nevertheless, the quantification method can be used to 
assess future FSM trafficking in a 3D spheroid model. 
4.16.3 Discussion 
 
The described image analysis method provides a way to analyze FSM and Hoechst dye 
penetration into spheroids for future work. The data matches visual results from the spheroid 
image over varying z-stack depths and demonstrates quantitatively that Hoechst insufficiently 
penetrates the spheroid core independent of incubation time and dye concentration.  
The results could potentially be a confocal imaging limitation, and it is unknown whether 
the result is an artifact of insufficient imaging. For example, the confocal objective working 
137 
 
distance is not appropriate or the spheroid is too thick to allow sufficient laser penetration for 
imaging. Furthermore, it is unknown if cells are even present in the center, or if a necrotic core 
formed in each spheroid due to insufficient nutrient diffusion (thus suggesting a reason for the 
lack of nuclear staining). Future steps include using multiphoton and conducting histology to 
physically section through the spheroids and stain them. 
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5. DISCUSSION AND CONCLUSIONS 
 
The following describes the three main goals, implications, limitations, and future steps 
from the completed experiments. 
Goal 1: Does FSM intracellular trafficking change with varying incubation times, and after 
UVB radiation?  
a. Subset 1: Characterize FSM in KRT culture during live and fixed cell cultures 
using fluorescence confocal imaging 
b. Subset 2: Assess the localization of FSM in normal and UVB-stressed KRTs 
under varying incubation times 
c. Subset 3: Demonstrate functional equivalence of bovine milk SM to its 
fluorescent counterpart 
The application of Goal 1 was to determine an optimal incubation time by studying FSM 
trafficking differences after various continuous incubation times and after UV radiation. First, the 
functionality of the 5µM Fluorescent Sphingomyelin (FSM) concentration in a live and fixed 
Keratinocyte (KRT) skin cell monolayer using confocal fluorescence microscopy was 
demonstrated. Results indicated that a 5µM FSM incubation yielded robust fluorescence and was 
able to undergo fixation prior to imaging. Blebbing and both plasma membrane intracellular 
staining was observed, consistent with literature [63]. A higher magnification, like the 100X 
objective, was deemed more suitable for higher resolution intracellular imaging. Subsequently, 
FSM was incubated for various timepoints at 370C and imaged live. Images suggested that FSM 
intensity and location does not change significantly with incubation time over 24 hours. Although 
live imaging is advantageous for time studies, without the proper equipment to maintain 
physiologic temperatures, cell phenotype and FSM trafficking can be affected. In addition, FSM 
photobleaching and cell movement was also deemed problematic, necessitating future fixed 
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experiments for FSM trafficking quantification. Furthermore, cells were incubated with FSM at 
room temperature to demonstrate the FSM endocytic and exocytic temperature dependence and 
demonstrate that temperature, along with many other extraneous variables, need to be controlled 
in experiments.  
To obtain quantifiable data, two experiments were conducted. First, cells were incubated 
with FSM for 10 minutes, 30 minutes, 1 hour, 2 hour, 3 hour, 4 hour, 12 hour, and 24 hour, fixed 
in 3.75% PFA, imaged, then analyzed with a fluorescence distribution macro developed 
previously in the research lab. Area under the curve data mirrored the live time study and 
demonstrated that intracellular FSM trafficking was independent of the continuous incubation 
time.  
Second, cells were continuously incubated with FSM for 1 hour or 24 hours, subjected to 
UV radiation, and fixed at different timepoints after UV. Area under the fluorescence distribution 
curves demonstrated no difference among the 24 hour incubation post-UV timepoints, but some 
slight variation for the 1 hour incubation timepoints. In particular, the 12 hour post-UV area 
under the curve was significantly greater than 1 hour and 2 hour by approximately 50% and 41% 
respectively. In addition, the no UV control was significantly lower (24% decrease) compared to 
the 24 hour post-UV timepoint (24% decrease) and 12 hour post-UV timepoint (49.29% 
decrease). Across all post-UV timepoints, the 1 hour incubation had a consistently higher average 
cytoplasmic mean gray value compared to the 24 hour incubation, with statistical significance for 
12 hour and 24 hour post-UV.  
The results potentially point towards a shorter timepoint for BSM/FSM incubation prior 
to UV (1 hour) and warrant further investigation into the photoprotective effects of a shorter 
incubation timepoint. Replication and a larger sample size are both necessary before making 
definitive conclusions. In the future, use of 1-well plates (instead of 8-wells) may prove 
advantageous to provide a more consistent UV dosage without the plastic division reflecting and 
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obstructing UV light. Confocal images could be taken in the center of the well and repeated for 
multiple plates, where each plate is treated as an independent unit (instead of each well, as in the 
case of this thesis). Replicating with multiple 1-well plates per treatment will ensure complete 
independence among treatments and an even UV dosage. 
Finally, FSM was deemed functionally equivalent to BSM in terms of p21 
photoprotection. FSM decreased p21 levels by 21.6% compared to the no FSM control. Similarly, 
BSM decreased p21 levels by 51% compared to the control, which was statistically significant. 
The lack of significance could be due to concentration mismatch between the FSM 5µM and 
0.1% BSM (a 1.3 mM concentration). In the future, the concentration of FSM should be 
optimized by diluting the 1mM stock to yield incremental concentrations of FSM, exposing to 
cells for a consistent incubation time, quantifying dosage-dependent p21 effects, then selecting 
the concentration that offers the most photoprotection. 
The FSM trafficking studies are limited in that a low sample size (n = 4 or 6) was used 
for both quantification experiments. The 2D fluorescence distribution analysis could potentially 
introduce bias by improperly drawing cell ROIs. In addition, fluctuations in the amount of FSM 
added, the positioning of the plate under the UV lamp, or changes in the day-to-day confocal laser 
characteristics could all affect data. Additionally, harsh washing of cells before fixation could 
remove weakly adherent and damaged cells, thereby skewing data. Finally, it is unknown whether 
the measurement system is actually sensitive enough to detect small significant differences in 
brightness, and furthermore, what a difference in fluorescence means biologically.  
Future work includes more replication, using 1-well plates for experiments, refining the 
2D fluorescence distribution analysis, extending analysis to 3D images, reducing the severity of 
wash steps, and implementing various controls. First, a SMase enzyme, known to degrade SM, 
could be introduced to cells loaded with FSM as a positive control to validate the analysis system. 
Subsequent images/analysis could demonstrate how/if FSM intensity degrades after the SMase 
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enzyme, and if the current 2D image analysis is sensitive to detect a difference. The SMase 
control will help isolate problems with the current analysis. Furthermore, experiments could be 
validated with HPTLC, a traditional technique to quantify lipid content. Finally, a 3D analysis 
system, similar to the MABLAB code developed by Pike et al., could be used to obtain more 
accurate data and encompass FSM plasma membrane expression surrounding the cell [86]. 
Replication, tight control of extraneous variables, SMase controls, validation with HPTLC, and 
3D image analysis are all necessary future steps.  
Goal 2: Do endogenous SM and ceramide levels fluctuate with exogenous FSM incubations? 
Is it possible to characterize, with fluorescence microscopy, the identity of the observed FSM 
signal over time? 
a. Subset 1: Develop immunofluorescence staining protocols for both endogenous 
SM (lysenin) and endogenous ceramide 
b. Subset 2: Characterize how endogenous SM and ceramide levels change with 
varying FSM incubation timepoints 
     For goal 2, immunofluorescence stains were optimized for both endogenous 
sphingomyelin (lysenin) and ceramide in order to reduce non-specific binding. The staining 
parameters were then implemented in a dual staining protocol with FSM, lysenin, and ceramide 
staining to quantify 2D trafficking of the respective stains. Results demonstrated that no 
significant differences existed within the individual ceramide and FSM stains for 10 min, 1 hour, 
2 hour and 12 hour incubation timepoints. However, within the lysenin stain, the 2 hour was 
significantly greater than the 10 minute incubation (60% increase). Despite this difference, the 
biological significance is unknown and could be attributed to the aforementioned measurement 
and imaging errors. The data could also indicate homeostatic fluctuations in lysenin levels not 
visible with just FSM staining alone. However, without validating the sensitivity of the 
measurement system with a positive aSMase control, conclusions about biological significance 
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cannot be drawn. The results demonstrate that dual immunofluorescence staining is possible and 
the images are appropriate for future colocalization experiments to better characterize FSM 
metabolism over time. 
     Future steps include troubleshooting the reason for inconsistent staining and refining the 
analysis technique because further optimization is needed before quantifying colocalization of 
FSM with lysenin and FSM with ceramide. Senescence or proliferation markers could be 
correlated with lysenin and ceramide to assess differences in the state of the cell. In addition, 
adopting the previously mentioned MATLAB 3D fluorescence distribution code could account 
for differences in the observed heterogeneous ceramide and lysenin staining [86]. Finally, lysenin 
could potentially serve as a fluorescence marker for BSM localization in a cell. Studies similar to 
FSM could be run in parallel to assess differences in localization between the two SM analogues. 
Goal 3: Are cell spheroids a viable platform to move future research from a 2D to 3D model? 
a. Subset 1: Develop a method to culture NIH 3T3 immortalized mouse fibroblast 
spheroids, for eventual incorporation of KRT cells and FSM 
b. Subset 2: Quantify dye penetration over various concentrations and incubation 
times 
The final goal of this thesis was to provide initial results towards development of a 3D 
KRT spheroid model to better recapitulate the dynamics and microenvironment of tissue. 
Spheroids were plated with 3T3 fibroblasts and mixed with KRTs in non-adherent U-well plates 
from Corning®. KRTs failed to integrate into the spheroid and instead formed satellite 
clumps/colonies adjacent to the main spheroid. Agarose coated wells were tested as an alternative 
to Corning® non-adherent U-wells. 3T3 spheroids successfully formed in the agarose wells, but 
Hoechst dye failed to penetrate even with Triton X permeabilization. Finally, in the last 
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experiment, FSM was introduced to the spheroids, and a method to quantify dye penetration was 
developed for future studies. 
  Future work includes developing a more consistent method to handle the spheroids in a 
high-throughput manner. Histological (either paraffin or frozen embedded) sections of the 
spheroids can be obtained to definitively characterize the spheroid core. Given the difficulty with 
handling and sectioning individual spheroids, Gong et al. developed methods for controlling 
location and growth of spheroids by manufacturing micro-wells [75]. Ivanov et al. micropatterned 
agarose, cultured spheroids into each individual well, then sealed the wells with agarose before 
sectioning [76]. Furthermore, Wong et al. embedded spheroids in HistoGel® prior to paraffin 
embedding and sectioning [74]. High-throughput spheroid handling techniques and assessment 
methodologies are possible but require optimization. 
 Furthermore, methods to encourage KRT spheroid incorporation need to be developed. A 
more relevant dermal fibroblast cell line, instead of 3T3 mouse fibroblasts, should be used to 
replicate the work of a few recent research groups [79]. In addition, the use of calcium 
supplements in media could encourage skin cell stratification [16], [79]  Spheroids can be treated 
with the same experimental parameters as the monolayers (including FSM incubation, UV, 
immunofluorescence staining, and imaging).  
Finally, the use of spheroids as an appropriate tissue engineered skin equivalent needs to 
be validated and justified against gold-standard (flat sheet-based culture) and previous lab 
methods (2D monolayers). Although 3T3 spheroids were successfully generated, more work is 
needed to demonstrate the utility of the model. 
 In summary, this thesis aimed to expand on past BSM research by clarifying the 
mechanism for photoprotection with a fluorescent analogue. FSM was found to yield similar 
photoprotection as its BSM counterpart, and FSM intracellular fluorescence distributions were 
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independent of continuous incubation time. Future investigation into shorter incubation 
timepoints prior to UV is needed, especially considering the observed post-UV fluctuations in 
total cellular fluorescence compared to the conventional 24 hour incubation. Furthermore, lysenin 
and ceramide immunostaining hold promise for further endogenous sphingolipid studies in 
addition to colocalization analysis. Finally, a 3T3 fibroblast spheroid model demonstrated proof-
of-concept for more relevant 3D skin models. The goal of future research is to ultimately 
elucidate the photoprotective potential of sphingomyelin in order to provide a natural alternative 
to sunscreen and prevent NMSC incidence in the general population.  
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APPENDICES 
 
A.  2D Fluorescence Distribution Codes 
 
The following ImageJ and MATLAB codes were written by Tyler Fraser and Stephanie 
Switalski. 
FSM Doughnut ROI 
//Hoechst/DAPI ROI merge 
run("Maximum...", "radius=1"); 
run("Remove Outliers...", "radius=10 threshold=1 which=Bright"); 
setOption("BlackBackgroud"); 
run("Gaussian Blur...", "sigma=1"); 
run("Make Binary"); 
run("Erode"); 
run("Fill Holes"); 
run("Watershed"); 
run("Analyze Particles...", "size=70-Infinity circularity=0.50-1.00 exclude include add"); 
//select and merge ROI 
array1 = newArray("0");;  
for (i=1;i<roiManager("count");i++){  
        array1 = Array.concat(array1,i);  
        Array.print(array1);  
}  
roiManager("select", array1);  
roiManager("Combine"); 
roiManager("Add"); 
roiManager("Delete"); 
run("From ROI Manager"); 
roiManager("select", 0);  
run("Make Inverse"); 
roiManager("Add"); 
roiManager("Delete"); 
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//opens fSM channel 
run("Open Next"); 
//fSM ROI 
run("Maximum...", "radius=1"); 
run("Subtract Background...", "rolling=70"); 
run("Enhance Contrast...", "saturated=0.1"); 
run("Gaussian Blur...", "sigma=1"); 
run("Find Edges"); 
run("Make Binary"); 
run("Fill Holes"); 
run("Dilate"); 
run("Dilate"); 
run("Dilate"); 
run("Fill Holes"); 
run("Watershed"); 
run("Analyze Particles...", "size=100-Infinity circularity=0.05-1.00 exclude include add"); 
run("Revert"); 
//Select each ROI and 'add' to the inversed combined DAPI channel 
for (i=1;i<roiManager("count");i++){  
 roiManager("Select", newArray(0,1)); 
 roiManager("AND");  
 roiManager("add"); 
 roiManager("Deselect"); 
 roiManager("Select", 1); 
 roiManager("Delete"); 
} 
roiManager("Select", 0); 
roiManager("Delete"); //deletes the combined DAPI 
//Measure doughnuts  
roiManager("Deselect"); 
roiManager("Measure"); 
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String.copyResults(); 
selectWindow("Results"); 
run("Close"); 
FSM Doughnut ROI Rotation 
run("Set Measurements...", "area mean standard min centroid perimeter display redirect=None 
decimal=3"); 
dir = getDirectory("Choose a Directory");  
imageTitle=getTitle(); 
for (d=0;d<roiManager("count");d++){ 
 run ("16-bit"); 
 roiManager("Select", d); 
 ROIname=getInfo("roi.name"); 
 roiManager("Select", d);  //roiManager("Deselect");  
 roiManager("Measure");  
 run("Clear Outside"); 
 getVoxelSize(width, height, depth, unit);  
 X1=getResult("X")/width; 
 Y1=getResult("Y")/width;  
 //Draw overlay line  
 Length=200; 
 theta=0; 
 run("Clear Results");  
 for (i=1;i<61;i++){ 
  //run("Clear Results");  
  name= " "+theta+"_Degrees"; 
  path=dir+imageTitle+"_Cell_"+d; 
  radians=theta*(PI/180); 
  X2=X1+(Length*cos(radians)); 
  Y2=Y1+(Length*sin(radians)); 
  makeLine(X1, Y1, X2, Y2,4); 
  profile = getProfile();  
  for (n=0; n<profile.length; n++) {  
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     setResult(name, n, profile[n]);  
  }  
  updateResults;  
  theta=theta+6; 
} 
 run("Revert"); 
 saveAs("Results",path+".csv"); 
} 
array1 = newArray("0");;  
for (i=1;i<roiManager("count");i++){  
        array1 = Array.concat(array1,i);  
        Array.print(array1);  
}  
roiManager("select", array1);  
roiManager("Delete"); 
close(); 
selectWindow("Results"); 
run("Close"); 
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MATLAB Code 
clear all  
close all  
sad = transpose(dir); 
s=size(sad) 
for n=1:s(2); 
     
wholecell =  xlsread(sad(n+2).name); 
[rownum,colnum] = size (wholecell);  
  
for a = 1:(colnum-1)  
    len = length(wholecell(:,a));  
    b = 1; 
    for i = 1:len 
        if wholecell(i,a+1) > 0 
            donut(b) = wholecell(i,a+1); 
            b = b+1; 
        end 
    end 
    dl = length(donut); % length of donut vector 
    for j = 1:dl 
        op(j) = (j-1)*100/dl; 
    end 
    np = 0:1:100; 
    norm_donut = interp1(op,donut,np); 
%     figure  
%     plot(np,norm_donut,'r', op,donut,'.b') 
    norm_wholecell(:,a) = norm_donut; 
end 
  
avg_wholecell = mean(norm_wholecell, 2); 
  
% plot(np,avg_wholecell) 
SD = std(norm_wholecell,0,2); 
SE = SD./sqrt(rownum); 
wholecell_data = [avg_wholecell, SE]; 
  
%write to column then export to excel 
xlswrite('FILE LOCATION', TITLE, n+1); 
  
end 
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B. Normality Assumptions (from JMP) 
 
Normal quantile plots and one-way Analysis of Residuals are included for each experiment. The 
normal quantile plots appear reasonably linear so there is no substantial evidence of non-
normality in the residuals. All data falls within the bounded red lines. Furthermore, slight 
differences in variation among the treatment groups are apparent, but the differences are not 
extreme. There is no substantial evidence of unequal variance. Independence is met by assuming 
each well is an experimental unit. 
2D FSM Fluorescence Distribution Trafficking 
 
 
 
 
UV FSM Fluorescence Distribution Trafficking  
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BSM p21 Ratios 
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FSM p21 Ratios 
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FSM, Lysenin, and Ceramide 2D Fluorescence Distribution Trafficking  
 
 
 
 
 
 
 
